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3 PREAMBLE 
The  Treaty  on the  European  Union  created  new  responsibilities  in  public  health  for  the 
European Community. Articles 3(o) and 129 ofthe Treaty lay down a general objective for the 
Community to contnbute towards ensuring a high level of  human heahh protection and make 
provisions for Community action that should be undertaken to meet this objective. 
The Conmrission Communication on the framework  for  action in the  field  of public  health 
(COM(93)  559  final  of 24  November  1993)  sets  out  how  the  Commission  intends  to 
implement thiS new Commpnity competence. Among proposals made, it was envisaged that a 
health status report should be prepared for the European Community (EC) on a regular basis. 
The aim of  these reports iS to provide a source of-information on particular health topics of 
interest and to promote discussion and initiate debate.  · 
This is the second such report. The first report (COM(95) 357 final) provided an overview oL 
heahh status in the EC in 1994. It included a description of  the main demographic trends and 
patterns of mortality  and  morbidity,  and  a discussion of the  ~jor determinants  of health. 
B~use  health trends and determinants only change slowly over time,  there would be little 
new this year .in a report of  similar nature. ThiS report, therefore, focuses on a particular topic -
women's health issues - which is emerging as an important issue both of  the general public and 
ofheahh care providers and policy-makers in the EC. 
The report contains an overview of  major health trends, patterns of  mortality and morbidity as 
well as relevant  health determinants.  In addition,  it descnbes  in greater detail a number of 
special health issues for women at various ages.  This discussion includes information a,bout 
determinants as well as re~vant  policies developed in the Member States. 
This report is largely based upon work carried about by the University of Limerick, Ireland, 
using  information from  national  sources,  the  World  Health  Organizltion's  Health  For All 
database,  the:~ Organization for Economic Co-operation and Development, the Statistical Office 
of the  European Connmmities,  and  other readily  available  data.  -Where  poSSible,  the  data 
obtained ha,·e been verified by national experts in each Member State. 
4 EXECUTIVE SUMMARY 
1. Introduction 
This report provides an overview of the health of women in the European Community 
(EC), high1igbting both differences and similarities within and between the Member States. 
It examines the main causes of mortality and morbidity at different phases of women's 
lives as well as a number of individual and social determinants which influence women's 
health within the context of  evolving demographic and social trends. 
The  main data sources include the  World Health Organization's Health for  All  (HFA) 
database,  various  reports  and  data  from  the  Statistical  Office  of  the  European 
Communities (Eurostat), and an EC-wide Euroharometer survey, sponsored by DG V and 
carried out in early.1996. The latter survey contained a number of  questions on women's 
health which are analysed in this report. 
The  data  obtained  from  sources  are,  despite  -continuing  improvements  in  quality, 
somewhat  limited  in their  comprehensiveness  and  comparability.  The  choice  of topics 
included  in  this  report is  to  a  large  extent  the resuh of these  constraints.  The  report 
focuses on women aged 15 years and older, because most gender-specific health data at 
the EC level concentrate on this age-group. 
The report consists of 8 sections. Section 1 introduces the report, Section 2 summarises 
the social and demographic trends affecting women, and Section 3 provides an overview 
of  selected health indicators. Supplementing this information, Section 4 descnbes selected 
morbidity measures, while  Section 5 concentrates on the main causes of death among 
women. Section 6 contains a discussion of various health determinants, while Section 7 
describes a number of  emerging health issues for women. .section 8 concludes the report. 
2. Social and Demographic Trends 
Women - totalling  191  million  - constitute  51.2% of the population in  the  EC.  This 
percentage is  remarkably stable across the Member States, varying only from a  low of 
50.4% in Ireland to a high of  51.8% in Portugal. There is, however, considerable variation 
in the percentage ofwomen across age-groups. In the group of  women under 20 years of 
age, there are only 95  women for every 100 men,  while  among 80-year-olds, there are 
about  221  women for every 100 men. This so-called feminization ratio is particularly high 
in the older age-group because in the EC women on average live over 6 years longer than 
men. 
Women's lives have changed significantly in the EC during the past three decades.  The 
rate of marriage has declined (by almost one third) since  1960, while the rate of divorce 
has almost doubled(  except in Ireland). At the same time, the average age of  first marriage 
and the age at first birth have risen to 26.1 and 28.6 years, respectively. 
At  the  same  time,  women's  labour  force  participation  has  increased  tremendously, 
although considerable variations exist in this area across the Member States. Concomitant 
with  the  increase  in  labour  force  participation  has  been  an  increase  in  women's 
unemployment rates, which tend to be higher than those of  men. 
5 When measuring women's position in society relative to men, women in the EC do well in-
comparison- with women elsewhere.  Within the EC, the Nordic Member States have the 
highest rates of gender equality, in part because of high levels of education and income 
relative to men. 
3. Selected Health Indicators 
Women in the EC  ~njoy a  high  level  of health as  measured  by  a  variety  of health 
indicators. Life expectancy has been rising continuously for decades and has reache4 80 
years, which is well over 6 years higher than the corresponding average for EC men. This 
average, however, hides considerable variation across the Member States, ranging from a 
high of81.9 years in  France to a low of77.8 years in Denmark. 
Infant mortality has  also been improving to the poinf that the most recent data (1992} 
indicate that only 6.9 (female) children out of  1000 live births die before the age of  1 year. 
This  is  a  decline  of 68%  since  1970.  Maternal  mortality  rates  have  also  declined 
significantly (79% since 1970) to 7 deaths per 100,000 women. 
According to ratings of  self-perceived health status, women in the EC regard themselves  , 
as healthy (or very healthy). On average just over 62% report being in good or very good 
health. Rates vary across the Member States and across age-groups, with older women 
reporting lower levels of  health, which is to be expected. 
' 
Height measurements indicate that women have been getting considerably taller during the 
past decades. Younger cohorts (18-29 year-olds) are almost 5 em taller than older cohorts 
(60 years and older). 
4. Morbidity 
Disease-specific morbidity measures are virtually non-existent at the EC leveL  Instead 
aggregate measUres, such as short- anulong-term disability and health care utilisation, are 
reported. 
In spite of  women's generally-good health status, they report significant levels of  disability 
due to long-term illness. On average, almost one out of  four women report limitations in 
_their daily activities to some extent (17.3%) or severely (6.3%) because oflong-standing 
illness. This average varies from a high of  30% (in Fi.Dland and Portugal) to a low of  15% 
(in Luxembourg) and increases with age. More than half of  all women aged 75 years and 
older report such activity limitations. 
On a short-term basis, women also report considerable activity limitations. About 14% of 
women report having had to cut down on their activities in the past two weeks because of 
illness  and  injury,  while  3%  report  having  experienced  such  restrictions  because  of 
emotional  or mental  health  problems.  Among  women  aged  65  years  and  older,  the 
corresponding figures are 25% and 5% respectively. 
While  not all chronic  and  short-term disability  necessarily needs  a  doctor's attention, 
apparently a  significant  amount does.  The  results  of the _1996  Eurobarometer  survey 
indicate that on average one out of  three women has consulted with a physician (in person 
or by telephone} in the past two weeks. Not surprisingly, older women report higher rates 
of  consultation. 
6 A small percentage of 'serious illnesses  is  likely  to  require hospitalisations.  On average 
· 10% ofEC women report having bad one or more (non-birth) hospitalisations in the past 
year, staying about 10 days in the hospital in total. Older women are about twice as likely 
as younger women to have been hospitalised, and they tend to stay longer as well. 
5. Causes of Death and Trends in. Female Mortality 
Across all ages,  the most  frequent  causes of death among women are diseases of the 
circulatory system, accounting for 43% of  all deaths, and cancer, which accounts for 26% 
of these.  Diseases of the  respiratory  system are responsible  for  6% of deaths  among 
women, and suicide and accidents fot 5%. The remaining 20% of  deaths are due to other 
causes. 
As might be expected, the major causes of death vary with age.  Motor vehicle accidents 
are the main cause for women under 30 years, while suicide is for the 30-34 age-group. 
Cancer, specifically 'female cancers', such as breast and cervical cancer, is the main cause 
of  death for women aged 35-64 years. For elderly women (65  years and older), diseases 
of  the circulatory system account for most deaths, approximately half of  all deaths in this 
age-group. 
Average  mortality  (for  all  women)  from  motor  vehicle  accidents  is  6.42  deaths  per 
100,000,  while  ruortality  from  suicide  and  self-inflicted  injury  is  6.24  Jrer  100,000. 
Mortality from cancer among women of all ages is about 150 deaths per 100,000, while 
mortality from diseases of  the circulatory system (heart disease and stroke) i'5  about 248 
d~aths per 100,000. Mortality due to ischaemic heart disease alone amounts to about 85 
deaths per 100,000, while stroke mortality is almost 76 per 100,000. 
Breast cancer accounts for 21% of all female  cancer deaths in the  EC, witb  a mortality 
rate of about 31  per 100,000. By contrast, cervical cancer is responsible for only about 
2% of  all cancer deaths in women, with a mortality rate of  about 3 per 100,000: 
Mortality  from  cancer  of the  respiratory  system  - predominantly  lung  cancer  - has 
increased by almost 70%  since  1970. It currently accounts for  about 9% of all cancer 
deaths in women, with a mortality rate of 14 per 100,000. 
6. Health Determinants and Health Promotion 
To a very large extent the two major causes of mortality (bean disease and cancer) are 
preventable through primary (healthier life styles) or secondary prevention (early detection 
through, for example, screening). The main risk factors as..c;ociated  with mu~h  premature 
mortality (death before aged 65 years) include smoking, (excessive) alcohol cor.swnption, 
unhealthy diet, and physical inactivity.  · 
About 28% of all women in the EC smoke, although the rate varies across the Member 
States. Denmark and Portugal stand out because of  their respectively very high (  42%) and 
·low rates  (12%)  of smoking  among  women.  There  are  no  data  on average  alcohol 
conswnption by women at the EC level, although it is known that women drink less than 
men. 
While  data on diet  are  scarce,  data  on the  outcome  of eating  patterns  (weight)  are 
available from the  1996 Eurobarometer.  Specifically,  one out of every  five  women are 
overweight (or severely overweight) as measured by the body mass index (BMI), while 
7 15%  are  underweight.  Being  overweight  is _a  significant  risk  factor  for  a  number  of 
· diseases, in particular heart· disease and diabetes. 
This survey also provided information about the extent to which, and what types of  health 
check-ups EC women receive. These vary by age-group and by country. For example, 
44% of EC women over the age of 65 years has had  a heart check-up in the past year, 
about  the  same  percentage  as  has  had  a  cholesterol  test.  The  rates  for  the  entire 
population of  women are, of  course, lower. 
Diabetes testing is .less frequent, with around 22% having had a diabetes test in the past 
year, although among severely overweight women·(aged 40 years and older) the rate is· 
44%. As obesity is a risk factor for non-insulin dependent diabetes, this is to be expected. 
About  16% of EC women report having had an osteoporosis test in the past 'year.  In 
contrast,·cancer screening rates are much higher. About 40% of  women report a cervical 
sbear in the past year, the same percentage as reporting having had a breast examination 
by hand. About 18% ofwomenreport having had a mammography during the past year. 
Because controversy surrounds the topic of mammography in many Member States, the 
Eurobarometer survey inquired about women's feelings  on the subject.  Overwhelmingly 
(more  than  90%),  and  with  little  variation,  women  endorsed  (free)  mammography 
screening in the age-groups where it has the potential to reduce mortality. 
7. Special Issues in Women's Health 
Several health iss~es have emerged during the past decades because of their particular 
relevance  to or importance  for  women.  These  include  eating  disorders,  which mostly 
afflict teenage and young women; lllV and AIDS, which traditionally has been considered 
a_  male .disease,  but  to  which women have  been shown to  be  more ·vulnerable;  heart 
disease, which also is largely seen as a man's disease in spite of  the significant mortality it 
causes to· women;  and  ost~porosis which is  much more frequent  among  women than 
among men. In addition to these issues, family planning and abortion, as well as violence 
against women, should be added to this list of  important women's health issues. 
There  is  a  notable  lack  of data on the · incidence  and  prevalence  of eating  disorders 
(bulimia  and  anorexia nervosa),  although the perception is  that  it  has  been increasing 
.  throughout  the  EC  during  the  past  two  decades.  Mortality  in  anorexia  sufferers  is 
estimated at 6%, double that for those with bulimia.  .  · 
With the ageing of society, the incidence of osteoporosis is  increasing.  Because of the 
sigirificant morbidity and mortality assOciated with this disease, osteoporosis is becoming 
a  growing  concern for  many  Member  States.  Hormo!le  replacement  therapy  (HRT) 
contributes to preventing osteoporosis, but its use is still debated by health care providerS. 
Furthermore,  women seem to  feel  less  than  adequately  .informed  about the  costs and 
benefits of  this type of  therapy (according to results of  the 1996 Eurobarometer survey). 
8. Conclusions 
This report has sought to provide as comprehensive an overview of  women's health issues 
as possible, given the available data. It is clear that while women live long lives and report 
feeling quite healthy, they a.lsc:> have significant disability due to chronic illness. Health, as 
8 measured by a  variety of indicators,  typically  varies  across  Member  States  as  well as 
across age-groups. Not surprisingly, elderly women are in poorer health. 
The report has 3Iso pointed to a number of  policy initiatives which could help reduce the 
premature mortality among women in the EC. 
9 1.  INTRODUCTION 
1.1  Background 
This report provides an overview of the health of women in the European Community 
(EC), highlighting both differences and similarities within and between the Member States. 
It examines the main causes of  mortality and morbidity as well as a· num~r  of individual 
and social determinants which influence women's health within the context of evolving 
demographic and social trends. This approach helps to highlight those health issues that 
are more prevalent among women (e.g.,  eating disorders,  breast cancer,  osteoporosis, 
·sexual abuse, and consequences of  domestic violence), those problems that are unique to 
women (e.g., reproductive health, cervical and ovarian cancer, and menopause), and those 
which appear to affect women differently from men (e.g.,  cardiovascular diseases  and 
HIV/AIDS). 
Women's  health  has  improved  significantly  during  this  century,  as  evidenced  by  a 
considerable increase in life expectancy and a decrease in premature mortality, including 
maternal and child mortality. Women in the EC have a higher life.expectancy than men, on 
average  between 5 to  7  years.  Yet  the  last  two  decades  have  seen a  reappraisal  of 
women's health and the health policies and services directed towards them, based on the  . 
growing recognition that women's health needs and concerns are different from those of 
men. A recent survey (Eurobarometer 44.3/1996)a asked women in the EC whether they 
thought that women's health isSues  received sufficient attention in their country., More 
than  one  out  of three  responded  negatively  (or were  uncertain)  (Figure  1.1).  Not 
surprisingly,  the distnbution of responses  (Figure 1.2)  varied. across  the  15  Member 
States with almost 50% of  Irish women indicating that insufficient attention was given to 
women's health issues (Table 1.1), compared to· only about 12% of  Danish women. These 
results are interesting considering that Danish and Irish women have among the lowest life 
expectancies in the EC (see Section 3.1). Apparently,  other f&.-tors  influence women's 
perceptions of  this issue. It should be noted that the Irish government recently has issued a 
special health policy for women, the first of  its kind in the EC~.  ·· 
The  stronger  focus  on women's  health  has  taken place  within  a  broader  context  of 
profound  societal· and  demographic  changes.  These  include  the  post-industrial 
development of Western Europe,  women's increased  participation in the  labour force 
since  the  1960s,  and  changing  gender  relations  within  both  private  and  public  life. 
Demographic trends highlight the ageing of society (including the feminizationb  of the 
older  age-group),  declining  fertility  rates,  decreasing  fainily  sizes,  older  ages  for  first 
marriages, and increasing divorce rates. These features have dramatically changed the face 
of  Western society and the pOSition of  women and men alike. 
1.2  Women's Health 
Although data on women's health are still incomplete, a clearer picture of their health in 
comparison to men's is emerging.  Women experience higher rates of chronic illness and 
a  See Section 1.4 for further details concerning the Eurobarometer su..-vey. 
b  Feminisation of  older age refers to the fact that due to differing mortality rates, the elderly population 
is predominantly made up ofwomen. See Section 2.1 for further details.  · 
10 disability than men,  which cannot solely be ascribed to their longevity.  They also  have  a 
more negative perception of  their health than do men.  Increasingly, evidence indicates that 
much biomedical knowledge of ill health - with the exception of biological health issues 
unique  to women  - is  derived.  from  research  based  on the  male  prototype.  This  has 
overlooked  the  influences  of gender  differences  in  diagnoses,  treatments,  and  health 
outcomes. Women's patterns of  disease and mortality are changing as well.  Lung cancer, 
for example,  is  increasingly becoming a cause of female  mortality,  influenced by  higher 
rates of smoking, especially among younger women. 
Women make greater use of  health services than do men (both on their own behalf and in 
their role as carers for children and elderly parents), and their participation in the labour 
force  of the  health  sector  greatly  exceeds  that  of men.  However,  they  are  under-· 
represented in the higher managerial and medical echelons which limits their influence on 
health  policy  development.  Women  are  also  more  involved  in  and  spend  more  time 
delivering unpaid carefor the family, the elderly, and the community. 
Despite their growing paid labour force participation, women continue to spend more time 
cariying out household tasks and have less leisure time than men.  Furthermore, women's 
economic  and  social  status  is  generally  worse  than  that  of men,  and  they  experience 
poverty more often and  are more f,requently  financially  dependent on men and/.or  social 
welfare  provisions.  These  conditions  constrain  their  choices  in  life,  including  healthy 
lifestyles.  The influence of these features on women's health and vice versa is,  however, 
not adequately understood. 
Awareness  of these  issues  has  contributed  to  a  growing  focus  on  women's  health, 
characterised  by  many  efforts to prioritise  women's health  on  the  political,  social  and 
biomedical agenda in the last two decades. The United Nation's (UN) Decade for Women 
(1976-1985)  helped  to.  highlight  women's  health.  Similarly,  the  World  Health 
Organization's  (WHO)  1978  targets  for  Health  for  all  by  the  Year  2000  included  a 
specific health target for women.  Mort1 recer.tly, the UN's Fourth World Conference on 
Women, in Beijing in 1995, continued this emphasis, adopting an action programme which 
included an  objective'~ to give priority to educational programmes aimed at, among other 
things, helping women make their own decisions and take responsibility for their health 
and fertility. 
At the Community level a number of activities have been injtiated recently related to the 
improvement  and  protection of women's  health~ for  example  adcption  of the  Council 
Direetive on maternity leavel, the priority given to elderly women within the strategy on 
the elderly" 
3
,  and the network on breast cancer screening of  the 'Europe Against Cancer' 
Progra.ffim.e
4
• 
1.3  Indicators and Determinants of Women's Health 
Effective  health  policies  and  progra..'T.rnes  (and  their  evaluation)  increasingly  rely  on 
objective measures to describe the health status of  populations and variations in health. 
a 
b 
This objective is consistent with the major objectives of the European Union before, during, and after 
the Beijing conference. 
. 
See, for example, European Year of  the Older People, in 1993 and the forthcoming year of the United 
Nations International Year of  Older People in 1999
3
. 
11 Comparisons between ·(sub)populations and  natio.ns  are  also  increasingly undertaken  in 
order to assess the prevalence of various diseases, to understand the underlying causes, 
and to evaluate the impact of  preventive health strategies. 
While  efforts  towards  standardising  data  to  enable  European  and  international 
comparisons have been initiated, truly comparable data are still scarce. This report, which 
utilises existing and new health data and indicators at the EC level, is therefore necessarily 
limited in its choic.e of  topics. It is also limited to women aged 1  5 years and older because 
most  gender~specific health data _at  the EC level focus on this age-group. Finally,  in  the 
interest of saving space, comparisons between men and women's health status are made 
only when they are of particular interest. 
1.4  Information Sources 
This  report  has  drawn  upon  many  eXIstmg  health  and  health-related  primary  and 
secondary information sources.  The level  of aggregation varies,  ranging  from  regional, 
national,  to  Community  and  international  levels.  Although  the  focus  has  been  on 
quantifiable  and  comparable  health  indicators  and  determinants  for  women,  qualitative 
information has.also. been used. References to the specific information sources are cited at 
the end" of  each section as well as in the bibliography at the end of  the report. 
The main data sources include the Health for All (HFA) Database (WHO,  1996)
5
,  various 
reports  and  data  published  by  the  Statisticcil · Office  of the  European  Communities 
(Eurostat), as well as data from the first (1994) wave ofEurostat's European Community 
·Household Panel (ECHP) survey, The World Women's 1970-1990 statistics
6 published by 
the UN,  and  data  provided  by  different  monitqring  centres,  such  as  the  International 
Agency  of Research  on  Cancer  (!ARC)  in  Lyon,  and  the  European  Centre  for  the 
Epidemiological Monitoring of  AIDS in Paris. Finally, an important source of data for this 
report is an EC-wide Eurobarometer survey carried out in early 1996. This survey asked a 
representative sample of  non-institutionalised persons (about ·1 000) in each Member Statea 
a  number  of questions  on  i1ealth,  including  attitudinal  questions,  self-reported  health 
status, and preventive health services received in the past year. 
Despite continuing improvements in the availability and comparability of health indicators 
and determinants, many constraints remain. They include the lack of data on· many issues 
of importance  to  women's  health,  for  example,  menopause  and  eating  disorders  (see 
Section 7),  and/or specific groups, e.g., migrant womeri.  There are also many gaps with 
regard  to morbidity  and  survival  statistics,  and  life  style  determinants  both  overall  and 
gender-related. In addition, there are insufficient health-related data by gender, needed to 
study, for example, the relation between employment, stress, and health. 
Where  possible,  information  has  been obtained for  all  the  15  Member  States.  In  these 
cases results have generally been reported both for the Member States and the EC  as  a 
whole. Data for Germany before 1990 usually refer to· the Federal Republic of Germany, 
and after 1990 to the Federal Republic, including the acceding territories, unless otherwise 
stated.  There  is,  however,  · one  important  exception:  the  Eurobarpmeter  results 
differentiate  between the  former  German  Democratic Republic  and  the  pre-unification 
Federal Republic of Germany.  This differentiation has been retained because the results 
a  For the former German Democratic Republic and the pre-unification Federal Republic of Gennany 
the sample size was 1000 persons each. 
12 -. 
reflect  important  continuing  differences  in  certain  health  and  health-related  indicators 
produced by the many years of  separate statehood. 
In all instances, the most recent data available have been used.  In  some cases, these data 
are several years old (e.g., the WHO mortality data are from  1992) while in  others they 
are current (e.g., the 1996 Eurobarometer data). 
1.5  Structure of the Report 
This report is divided into 8 sections. Section 1 describes the aims, background, methods, 
and structure of  the report, while Section 2 summarises the social and demographic trends 
of importance to women at different stages of  their lives.  Section 3 outlines a number of 
selected  heaith  indicators  of relevance  to  women,  including  life  expectancy,  infant 
mortality,  and  self-perceived  health  status.  Supplementing  this  information,  Section  4 
describes selected morbidity measures, including disability due to long-term illness, short-
term restricted activity measures, and hospitalisations.  Section 5 reviews causes of  death 
for  women · of different  ages.  Section  6  contains  a  discussion  of  various  health 
determinants,  e.g.,  factors  such  as  smoking  and  drinking  as  well  as  various  screening 
programmes.  Section 7 analyses a number of issues of particular concern for women at 
different  stages of their  life.  Section  8  concludes  the  report.  The  Annexes  contain  a 
glossaryoftechnical terms, a list of  tables and figures, as well as the bibliography.  .. 
Throughout the report,  numbered  references are  presented  at  the  end  of each  section, 
while lettered footnotes appear at the bottom of each page.  Figures and tables follow the 
references at the end of  each section. 
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14 Figure 1.1 
Sufficient Attention for Women's Health 1996 (*) 
Women 15+ Years, EU 15 
Agree strongly 
(25.00 %) 
Agree slightly 
(41.00 %) 
Disagree strongly 
(4.70 %)  Disagree slightly 
(13.60 %) 
Uncertain 
(15.70%) 
Source  Eurobarometre 44 31l996 
(*) :  Distribution  of responses of rating  of the  extent to  which  the  respondent  agreed/disagreed  with  the  following 
statement: "In (country) sufficient attention is giver to  women's health issues, such as breast and cervical cancer" 
Figure 1.2 
Sufficient Attention Given To Women's Health, 1996 (*) 
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(*) :  Distribution  of responses  of rating of the  extent  to  which  the  respondent  agreed/disagreed  with  the  following 
stat~ment : "In (country) sufficient attention is giver to women's health issues, such as breast and cervical cancer" 
15 Denmark 
The Netherlands 
Finland 
France 
Luxembourg 
Belgium 
Austria 
Italy 
GermanyE 
EU 15 
Sweden 
United Kingdom 
Spain 
GermanyW 
Greece 
Portugal 
Ireland 
Table 1.1 
Sufficient Attention Given To Women's Health, 1996(*) 
Women 15+ Years 
disagree  disagree  agree 
strongly  slightly  uncertain  slightly 
' 
%  %  %  % 
3.8  8.7  2.0  33.Ji 
4.3  6.1  5.6  33.5 
1.7  11.0  4.5  53.3 
1.4  12.6  11.2  54.4 
1.6  8.4  17.4  48.7 
2.5  8.8  16.9  50.3 
1..2  8.2  21.6  36.2 
5.1  5.6  21.0  . 26.2 
2.6  11.1  20.3  49.5 
4.6  13.6  16.4  42.9 
4.8  20.9  11.6  42.6 
10.1  21.6  7.1  45.0' 
3.3  17.0  21.6  40.5 
1.7  14.9  26.5  41.2 
4.6  14.7  25.8  . 31.5 
5.0  19.9  23.8  45.2 
20.7  27.4  14.4  27.2 
agree 
strongly 
0/o 
52.2 
50.5 
29.6 
20.4 
23.9 
21.5 
32.8 
42.1 
16.5 
22.5 
20.1 
16.2 
17.6 
15.6 
23.4 
6.2 
10.4 
(•) :  Respondents were asked to rate the extent to which they agreed (disagreed) With the followmg statement : "In (country), 
sufficient attention is given to women's health issues, such as breast and cervical cancer" (Eurobarometer44.3/1996) 
16 2.  SOCIAL AND DEMOGRAPIDC TRENDS 
This Section provides background information about demographic and social trends that 
concern women. Information about life expectancy and infant mortality, often defined as 
part of  demographic statistics, is presented in Section 3 which focuses on selected health 
indicators. 
2.1  Population Size and Structure 
When the European Community admitted three new Member States,  (Austria, Finland, 
and  Sweden), on 1 January 1995, the overall population increased from approx.  350 to 
372 million  (6.3%).  Women accounted for just over half (50.~/o) of this increase, their 
number  growing  from  179  to  190  million.  Thus,  as  before  the  expansion,  women 
constitute 51.2% ofthe population in the EC. This percentage is remarkably stable across 
the Member States, varying slightly from a low of 50.4% in Ireland to a high of 51.8% in 
Portugal (see Table 2.1). 
However, women make up varying proportions of the population at different ages.  The 
under 20 age-group comprises 95 women for every 100 men. This over-representation of 
men in the population continues through age 39. In the 40 to 59 age-group, there are 100 
women for every 100 men, but from there on the over-representation of  women increases 
drastically to reach about 221 women for every 100 men among 80-year-olds. (see Figure 
2.1). 
This so-called feminization ratio is virtually identical, for the under 20 year-olds across the 
Member States, but varies considerably in the 60 years and older age-group. Germany and 
Austria have the highest feminization ratio while Greece and Ireland have the lowest (see 
Figure 2.2). 
The high feminization ratio in the older age-group is in part the result of  the difference in 
life expectancy between men and women. On average, women in the EC live more than 6 
years longer than men with the result that they are over  -represented in  the higher age-
groups (for further details on life expectancy see Section 3). 
This  tendency  for  women  to  live  longer  than  men  is  also  apparent  from  the  age 
distribution of  the two sexes.  As shown in  Table 2.2, 23.6% of women are 60 years or 
older, while the corresponding percentage for men is only  17.8%. This relationship may 
change  over time  as  the  population  ages,  because  as  also  shown  in  Table  2.2,  the 
percentage of  men over 60 years is increasing faster than the percentage of women over 
60 years. From 1991  to 19Q6, the percentage of men over 60 years grew by 5.5%, while 
the corresponding increase for women was 2. 7%. 
2.2  Family Life 
At the same time as the population is ageing, changes are also taking place in  relation to 
family  life.  Most noteworthy is  the significant  decline  in  the  marriage  rate,  which  has 
declined by almost one third, between 1960 and  1995, from about 8 to 5.1  marriages per 
17 1000  population.  This  decline  has  occurred fairly  uniformly  across  all  Member  States, 
with Germany experiencing the greatest decline and Greece the smallest (see Table 2.3). 
Concomitant with the decline in the marriage rate has been an increase in the age of first 
marriage from 24 to just over 26 years (see Table 2.3). Here Denmark and Sweden are 
notable  in  the EC  for  having  the  highest  age  at  first  marriage  (28.1  and  28.5  years, 
respectively in 1994) as well as highest increase since 1960 in the age offirst marriage. 
Despite the decline in the marriage rate and the increase in the age of first marriage, the 
divorce rate has more than tripled since 1960, from 0.54 to 1.8 per 1000 population.  As 
was the case with the marriage rate,  the EC  average obscures considerable differences 
across the Member States.  Ireland  stands  out from  the  rest because divorce  is  illegal". 
Southern Member States like Greece, Italy, and Spain have lower divorce rates, while the 
Nordic countries - Denmark, Finland, and Sweden, and the United Kingdom (UK) - top 
the list. 
The results of these trends can be  seen in  Figure 2.3  which shows a  large increase in 
single-person households as well as  single-parent families between 1960 and  1995.  Also 
shown in this figure  is  the large increase in  the percentage of births occurring  outside 
marriage, a trend that along with the increasing divorce rates; contributed to the increase 
in single-parent households. 
The increase in bearing children out of wedlock was not the only change to occur during 
this period. Women
1S total fertility rate declined by  45%, from 2.59 to 1.43  children per 
woman.  As a result,  the total number of births fell  by more than  I. 7 million,  or almost 
31% to just under 4 million births per year (see Figure 2.3 and Table 2.4). 
While there has been an overall decline in the total fertility rate in all Member States since 
1960, the timing of  this decline has varied greatly. As can be seen in Figure 2.4, Ireland in 
particular, has experienced this decline only in the 1990s, while most··ofthe other Member 
States experienced the greatest declines in the 1960s or 1970s.  It is  also interesting that 
the Nordic countries which for a while had the lowest total fertility rates now have the 
highest.  This is particularly curious because, as  \.\ill be seen below, these countries have 
the  highest  labour  force  participation  rat~s,  something  which  traditionally  has  been 
associated with lower total fertility. 
It is also not possible to attribute this increase in fertility rates in the Nordic countries to 
low levels of contraceptive use, which might have been one of the reason for Ireland
1s 
relatively recent fertility decline because, as Table 2.5 shows, a greater share of  Nordic 
women report using contraception compared to women in the other Member States. 
Table 2.5 also shows the age of first  birth, which increased slightly (0.5  years) to 28:7 
years between 1990 and  1994,  probably  as  a  result  of the  increase in the  age  of first 
marriage. Finally, the table shows the percentage of  live births to teenage mothers, which 
varies considerably across the Member States, with the Netherlands reporting the lowest 
percentage (1.38%) and Portugal the highest (7.48%) (see also Section 7.3). 
a  Legislation to allow divorce under certain circumstances has been introduced in the Irish legislature 
following a referendum in 1995.  -
18 2.3  Working Life 
Changes have also been occurring in the working life of women, both those with children 
and  those without.  Some Member  States,  notably the Nordic countries,  saw increased 
labour force participation rates as early as the 1960s, while others experienced such trends 
only in the 1970s and 1980s. As shown in Table 2.6, female employment has continued to 
grow into the 1990s, although two countries (Finland and Sweden) with very high rates of 
female labour force participation have actually experienced a decline since the mid-1980s. 
Women  are  also  becoming  increasingly  active  in  starting  up  and  running  their  own 
businesses: up to 30% of  all enterprises across the Member States are managed by women 
and approximately a third of  all new enterprises are started by women 
1
. 
In spite of the increases in employment (and labour force participation), large differences 
continue to exist between the Member States. :rhe Nordic countries- Denmark, Finland, 
and Sweden- have by far the highest labour force participation rates, (more than 70% of 
women are in the labour force), while Greece, Ireland, Italy, Luxembourg, and Spain have 
the lowest rates (around 40-45%). 
These differences are even greater for part-time employment. As shown in Table 2.7, the 
vast majority (70-90%) of part-time work is undertaken by women. When considered as a 
proportion of  total employment, it is clear that the Netherlands far exceeds the rest of  the 
EC, with more than 60% of employed women in part-time work.  Other countries with a 
large proportion ofwomen in part-time work include the UK (45.2%), Sweden (41.4%) 
and Denmark (36.7%). Greece, Finland, Italy, Portugal, and Spain have the lowest rates 
(less than 15%). 
Figure 2.5 shows the overall increase in  part-time work for women (and men) between 
1975 and 1991. During this period, women's part-time work increased from just over 20% 
to about 28%. This figure also shows the development in unemployment and temporary 
work,  both  of  which  roughly  doubled  between  1975-1991.  With  respect  tr 
unemployment, women have been much harder hit than men. 
Table 2.8 shows the development in  unemployment rates between 1983  and  1993  in  all 
the Member States. Only five countries report female unemployment rates in 1993 of  less 
than 7% (Austria,  Luxembourg, Portugal,  Sweden and  the UK).  Others tend  to hover 
around the 10-15% mark, with the notable exception of Spain, where the rate is  almost 
30%.  In comparison to men,  women  have  higher  unemployment  rates  in  all  but three 
Member States (Finland, Ireland, and Sweden). 
The situation of"young women (under 25  years of age)  is  worse in  the sense  that the 
absolute te·vel  of unemployment  is  considerably higher than that for  the overall  female 
labour force.  This is  also clear from Figure 2.6 which .shows the distribution of activity 
across all the age-groups of  the population in 1994. 
2.4  Gender-Related Development Indices 
Existing gender differences among Member States (except  Germany) and their relative 
ranking  world-wide,  based  on  selected  indices  from  the  Human  Development  Report 
1995~, are illustrated in Table 2.9. 
19 The  Human  Development  Index  (HDI)  is  a  way  of assessing  and  ranking  countries 
according to a number of selected  social  and  economic  indicators  (health,  income  and 
education). Canada, the USA, ·and Japan are the three highest ranking countries, with two 
Member States, the Netherlands and Finland, in fourth and fifth place. 
When  the  HDI  is  adjusted  for  gender  using  the  Gender  Development  Index  (GDI), 
however, a different ·picture emerges.  The Nordic Member States,  Sweden and  Finland, 
top  the  list  both  within  the  Community  and  world-wide.  The  Netherlands  drops 
dramatically on the GDI to ninth place within the Community, thus indicating a relatively 
high level of  gender inequality.  · 
The  Gender  Empowerment  Measure  (GEM),  another  gender-based  index,  indicates 
disparities related to economic and political decision-making. The Nordic Member States 
are  again  positioned  at  the top.  However,  the GEM does  not  mirrQr  the  GDI  for  all 
Member  States.  France,  for  example,  ranking  fourth  on  the  GDI  scale  within  the 
Community,  occupies the lowest  place on the GEM index.  This  represents the  highest 
discrepancy within  the  Community  between women  and  men ·with  regard  to  women's 
parliamentary representation, their level of  professionalisatio~ and their .earning power. 
Gender equality is highest in the Nordic Member States and is attributable to high female 
educational enrolment rates since the 1970s and relatively low disparity between women 
and men with regard to the percentage of  shared earned income. 
Although these indices are not flawless, they do indicate that gender inequality continues 
to exist both within and between the Member States, despite the progress made during the 
second half of  this century. These inequalities appear less pronounced in relation to basic 
health and education, but are more strongly visible in the area of  income distribution and 
economic and political representation.  It should be noted that gender equality does not 
depend  on income (GDP), because,  as  shown in  Table 2.9, Luxembourg,  which  ranks 
highest with respect to basic ourchasing power (real GDP per capita), ranks lowest in the 
Community with respect to GDI. 
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21 Table 2.1 
Wou1en in the Total Population 
·of the European Union 1996 (EU 15) 
Country·  Total  Number of  Women 
Population  Women  in% 
EU15  3 72,653,590  190,739,240  51.18 
Portugal  9,920,760  . 5,143,280  51.84 
Austria  8,054,800  '  4,147,630  51.49 
Italy  57,333,000  29,515,580  51.48 
Germany  81,817,500  41,992,680  51.32 
France  58,255,880  29,891,710  ~1.31 
"  Finland  5,116,830  2,625,130  51.30 
Belgium  10,143,050  5,184,260  51.11 
Spain  39,241,930  20,037,940  51.06 
United Kingdom  58,693,970  29,908,290  50.96 
Luxembourg  412,800  210,200  50.92 
Greece  10,465,060  5,300,110  50.65 
Denmark  5,251,030  2,658,800  50.63 
Sweden  8,837,500  4,471;430  50.60 
Netherlands  15,493,890  7,831,600  50.55 
Ireland  3,615,600  1,820,600  50.35 
Source: Eurostat 1997 
Note :  The countries are in descending order of% women in the ROpulation. 
Figure 2.1 
Feminisation Ratio, 1996 (EU 15) 
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Figure 2.2 
Feminisation Ratio in the 0-19 Years and 60+ Years 
Age-Groups, 1996 (EUlS) 
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Table 2.2 
Female and Male Population in the EU (15) 
Women  Men 
0/o 
0/o 
Age-Group  1991  I  1996  1991  I 1996 
0-19 years  23.9  22.6  26.4  24.9 
20-39 years  29.2  29.2  .  31.6  31.6 
40-59 years  23.9  24.6  25.0  25.7 
60 and over  23.0  23.6  16.9  17.8 
Total  100  100  100  100 
Source : Eurostat 1997 
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:.  0-19 Table 2.3 
Marriages and Divorces in the EU (15), 1960-1995 
Country  Marriages  Average age at First 
Number  Difference 
in  1995  since 
1960 (%) 
EU 15  1,901,000'  -24.1 
Austria 
Belgium 
Denmark 
Finland 
France 
·Germany 
Gre~ce 
Ireland 
Italy 
Luxembourg. 
Netherlands 
Portugal 
Spain 
Sweden 
United Kingdom 
Source: Eurostat 1997 
'provisional data · 
l  1993 
2 1992 
• estimate 
42,900  -26.6 
51,500  -21.0 
34,700  - 3.2 
23,700  -27.7 
254,000'  -20.6 
430,500  -37.5 
64,000  10.0 
15,600  1.0 
283,000'  -27.0 
2,100  - 7.2 
81,500  -8.6 
65,800  - 5.3 
196,900'  -16.9 
33,600  -32.9 
321,000 p  -18.4 
Single-parent families 
(%) 
Numberofchildren per 
woman 
Crude divorce rate (per 
1000 pop.) 
Live binhs outs ide 
marriage(%) 
Single-persons 
',  Marriage (women) 
Rate in  Difference  in  1994  Difference  Number 
1995  since 1960  since 1960  in 1995 
(oloo)  (%)  (years) 
5.1  p  -54.4  26.1 1•  2.0  677,500• 
5.3  -55.6  25.8  1.8  18,200 
5.1  -40.7  25.2  2.4  35,000
2 
6.6  -18.0  28.9  6.1  13,000 
4.6  -59.5  26.7  2.9  14,000 
4.4•  -60.3  26.7  n  117,000• 
5.3  -79.8  26.3  2.9  169,400 
6.1  -14.2  25.6  0.4  11,000 
4.4  -25.2  27.0
2  -0.6  -
4.9 p  -57.4  26.1
1  1.3  27,000 
5.1  -40.7  26.3  - 700 
5.3  -47.2  27.0  2.8  34,200 
6.6  -18.2  24.6  -0.2  12,300 
5.0 p  -53.9  26.2
1  0.1  33, I 00• 
3.8  -75.9  28.5  4.6  22,500 
5.5 p  -37.1  25.8
1  - 170,100• 
Figure 2.3 
Families Past and Present, EU 15 
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Difference 
since 1960 
(%) 
237.7 
99.0 
586.0 
70.0 
232.8 
204.1 
105.9 
255.0 
-
-
264.1 
345.4 
1369.5 
-
113.1 
489.0 Country 
EU 15 
Austria 
Belgium 
Denmark 
Finland 
France 
Germany 
Greece 
Ireland 
Italy 
Luxembourg 
Netherlands 
Portugal 
Spain 
Sweden 
United Kingdom 
Source: Eurostat 1997 
'  provisional data 
• estimates 
I  1994 
Table 2.4 
Births and Fertility in the EU (15}, 1960-1995 
Births  Percentage of births  Fertility 
outside marriage 
~,Number in 1995  Difference  in  1995  Difference  Rate in  1995  Difference 
since  since  since 
1960 (%)  1960 (%)  1960 (%) 
3,999,000,  -30.9  23.4*  354.5  1.43•  -44.9 
88,700  -29.6  27.4  110.2  1.40  -48.0 
114,700'  -25.9  15.0•  624.6  1.55'  -39.5 
69,800  -8.3  46.5  494.2  1.80  -29.1 
63,100  -23.2  33.1  719.8  1.81  -33.5 
727,800,  -10.8  36.1
1  491.8  1.70P  -37.7 
765,200  -39.3  16.1  112.4  1.25  -47.3 
101,500  -35.5  3.0  145.2  1.32  -42.1 
48,500  -20.1  23.0  1347.2  1.87P  -50.3 
521,300,  -42.7  8.1  ,  233.1  1.17•  -51.5 
5,400  8.0  13.1  314.2  1.69  -25.9 
190,500  -20.3  15.5  1049.6  1.53  -51.0 
107,200  -49.9  18.7  97.6  1.40  -54.8 
359,900P  -45.5  10.8
1  365.8  1.18.  -58.7 
103,400  1.2  53.0  369.5  1.73  -21.4 
732,000  -20.3  33.6  543.1  1.71'  -37.3 
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Trends in the economic indicator of fertility 
over the past 40 years 
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< Table 2.5 
Contraception Usage and Fertility (EU 15) 
Country  Women using  Average Age of Women  at 
contraception  Childbirth 
1986-93 (%) 
1990  I  1994 
EU 15  - 28.2  28.7 
Austria  71  26.7  27.5 
Belgium  79  27.9  28.2* 
Denmark  78  28.5  29.1 
Finland  80  28.9  29.1 
France  81  28.3  28.8P 
Germany.  75  27.6  28.2 
Greece  n/a  27.2  28.0 
Ireland  n/a  30.1  30.3 p 
Italy  78  29.0  29.6• 
Luxembourg  n/a  27.9  28.8 
Netherlands  76  29.3  29.9 
Portugal  66  27.3  27.9 
Spain  59  28.9  29.5• 
Sweden  78  28.6  29.2 
United Kingdom  81  27.7  28.1 
Source: Human Development Report 1995: HFA  1996: and Eurostat /997 
P provisional data 
"estimate 
I  1994 
%  Live Births to 
mothers under 20 
1995 
3.84 
4.39 
2.40 
1.99 
2.48 
2.35" 
3.48" 
4.74 
5.11 
2.51
1 
2.12 
1.38 
7.48 
3.55
1 
2.07 
6.38
1 
Table 2.6 
Employment EU 15, (1993) 
Women 15-64 years 
f  Thousands  1  Change  Female part1c1pat1on rate• 
i  Country  1993  since 1983  j1983  1993  %change 
I  %  %  % 
I 
'A0SIRIA
1  3,724  13.1  49.7  58.0  16.70 
I  BELGIUM
1
' 
4  4,237  2.8  48.7  54.1  11.09 
fDENMARK  2,893  5.9  74.2  78.3  5.53 
I  FINLAND  2,508  1.9  72.7  i  70.0  -3.71 
FRANCE  25,213  6.3  54.3  59.0  8.66 
I  GERMANY
1
' 
3  i  38,682  8.1  52.5  61.3  16.76 
I  GREECE  4,118  7.2  40.4  43.6  7.92 
.IRELAND
2  1,334  4.9  37.8  39.9  5.56 
IITALY
1  22,787  1.2  40.3  46.5  15.38 
ILUXEMBOUR~  165  3.1  41.7  44.7  7.19 
i  NETHERLANDS
1  . 7,084  40.3  55.5  37.72 
I  PORTUGAL  4,537  0.4  56.7  59.4  4.76 
jSPAIN  15,564  12.4  33.2  42.8  28.92 
!SWEDEN  4,320  1.3  76.6  75.8  -1.04 
!  UNITED KINGDOM  '  28,179  5.9  I  57.2  64.8  13.29 
1 1992 
2 1991 
3FRG to 1990 
4 1992  1982 
5 1991  1981 
• defined as female labour-force of all ages divided by female population aged 15-64 (in%) 
27 Table 2. 7 
Part-Time E_mployment as% ofTotal Employment 
EU 15, (1993) 
,,.ft  ........ 
AUSTRIA 1 
BELGIUM 1 
DENMARK 1 
FINLAND 
FRANCE 3 
GERMANY 1, 3 
GREECE 1 
IRELAND 2 
ITALY 1 
LUXEMBOURG 1 
NETHERLANDS 
1 
PORTUGAL~ 
SPAIN 5 
SWEDEN 
,,.,,.,.,.n 
11992 
21991 
3FRG to 1990 
4 1986  • 
Source - OECD 19941 1995 
lldhs  .... 
1Qin  1QM. 
8.4  9.1 
8.1  12.4 
23.8  22.5 
8.3  8.6 
9.6  13.7 
12.6  14.1 
6.5  4.8 
6.6  8.4 
4.6  5.9 
6.3  6.9 
21.4  32.8 
6.0  7.3 
5.8  6.3 
24.8  24.9 
1 
"' 
~., n 
Femlllo  -
1!111:!  1!1!13  1!1113 
20.0  20.5  1.5 
19.7  28.1  2.0 
44.7  36.7  6.6 
12.5  11.2  4.5 
20.1  26.3  2.5 
30.0  30.7  1.7 
12.1  8.4  3.7 
15.5  17.8  2.7 
9.4  11.5  2.4 
17.0  16.5  1.0 
50.1  62.9  7.2 
10.0  11.2  3.4 
13.9'  14.3  2.4 
45.9  41.4  6.3 
·~  ·~ 
~ 
Figure 2.5 
Changes in Employment (EU) 
0  5  10  15 
Source -COM (96) 60  final 
28 
&1991 
01975 
20  25  30 
-·pst-t~  ...  .......,.,_, 
as  11  '% ot ratl!lll  pcwtoodrm  .......,.,_.. 
tll!l:l  _illll3.  _illll3 
1.6  88.4  89.1 
2.1  84.0  -
10.1  84.7  75.8 
6.2  71.7  63.1 
4.1  84.3  83.3 
2.2  91.9  91.0 
2.8  61.2  61.3 
3.6  71.6  71.6 
2.9  64.8  68.5 
1.3  88.9  88.5 
13.4  77.3  75.0 
4.3  65.9  67.3 
2.3  71.5  .75.9 
9.1  86.6  81.3 
~  QQ  0~ BothMie:!l 
%of  total labour force 
Country  1983  1993 
AUSTRIA  4.1  4.2 
BELGIUM
1  13.2  IO.J 
DENMARK  11.4  10.7 
FINLAND  5.4  17.7 
FRANCE  8.3  11.6 
GER..~  7.9  8.8 
GREECE  7.9  9.7 
IRELAND  14.0  15.1 
ITALY  9.J  10.8 
LUXEMBOURG
1  16.0  1.2 
NETHERL\NDS
1  11.8  6.7 
PORTUGAL  7.8  5.5 
SPAIN  17.0  22.4 
SWEDEN  3.5  8.2 
UNITED KINGDOM
1  11.2  10.2 
Source • OECD 199-m  995 
1National definition 
11992 
11991 
4FR.Gto  1990 
c 
0 
....... 
ra 
:::::1  a. 
0  a. 
ra  ....... 
0  .....  - 0 
'$ 
-4.5  3 
Table 2.8 
Unemployme;nt Rates 
EU 15, (1993) 
Fem.Je  Male 
%of  total fcm&le  % of  total male labour 
labour force  force 
Youth Unemployment rata 
(Under 2') % ofyoutb labour force 
Female  Male 
1983  1993  1983  1993  1983  1993  1983  1993 
5.1  4.5  3.5  4.0 
18.3  14.2  10.0  . 
12.J  11.1  10.7  10.3 
5.2  15.6  5.6  19.5 
11.2  13.7  6.3  9.8 
8.8  10.4  7.3  7.7 
11.8  15.3  5.8  6.4 
11.1 
112.1  1D 
117.3 
15.3  IS. I  6.2  8.3 
1.7  2.0  1.0  1.1 
14.0  8.8  10.6  5.3  . 
12.2  6.5  4.7  4.6 
20.3  28.9  15.6  18.6 
3.5  6.6  3.4  9.8 
8.0  5.4  13.3  13.9 
Figure 2.6 
Present Demographic Structure and 
Structure of the Active Population 
1.5  a 
1994 
90+ 
85-89 
8()-M 
75-79 
7G-74 
65-69 
6(H)4 
55-59 
50-54 
45-49 
4G-44 
35-40 
3G-34 
25-29 
2G-24 
15-19 
1Q-14 
5-9 
()-1 
2~ 
a  1.5 
.  . 
28.5  19.7 
19.3  14.6 
10.8  11.3 
25.5  28.4 
11.1  7.6 
30.0  38.6 
16.6  20.9 
36.5  35.6 
7.4  3.8 
18:8  6.8 
24.6  14.9 
43.7  47.4 
8.3  14.9 
17.3  13.4 
3 
I 
I 
I 
I 
. 
19.1 
17.8 
10.J 
IS.O 
10.2 
17.1 
22.9 
25.5 
6.2 
22.6 
13.2 
33.7 
7.8 
22.2 
. 
17.4 
14.3 
15.4 
21.5 
7.4 
20.1 
24.9 
26.7 
4.2 
6.8 
9.8 
39.9 
21.6 
20.8 
0  Non-active 
II  Unemployed 
•  In  employment 
4.  .:l Country*  Gender-related 
development 
a 
index (GDD 
' 
Sweden  0.919  (l) 
Finland  0.918  (2) 
Denmark  0.904  (4) 
France  0.898  (7) 
Austria~  0.882  (10) 
United Kingdom  0.862  {13) 
Italy  0.861  (14) 
Bel~ium  0.852  (18) 
Netherlands  0.851  (20) 
Portugal  0.832  (25) 
Greece·  0.852  (27) 
Ireland  0.813  (30) 
Spain  0.795  {34) 
Luxembourg  0.790  (35) 
Source: Human Development Report, 1995 
•No data for Germany. 
Table 2.9 
Gender Related Development Indices 
Real GDP per  Share of  earned  Combined  Gender 
b  primary,  '  capita  income(%)  empowernment 
(PPP$)  secondary and  measure 
1992  tertiary  c 
education gross 
(GEM) 
enrolment 
ratio 
(%} 1992  • 
Female  Male  Female  Male 
18,320  41.6  58.4  79.3  76.7  0.757  (I) 
16,270  40.6  59.4  100.0  90.6  0.722  (3) 
19,080  39.8  60.2  85.6  82.3  0.683  (4)' 
19,510  35.7  64.3  87.5  83.5  0.433  (31) 
18,710  33.6  66.4  82.0  85.9  0.610  (9) 
17,160  30.8  69.2  77.4  76.1  0.483  (19) 
18,090  27.6  72.4  70.3  69.0  0.585  (10) 
18,630  27.3  72.7  84.3  84.1  0.479  (21) 
17,780  25.2  74.8  86.5  89.4  0.625  (7) 
9,850  29.9  70.1  84.3  70.2  0.435  (30) 
8,310  22.2  77.8  77.6  77.4  -
12,830  22.2  77.8  84.6  80.6  0.469 .(24) 
13,400  18.6  81.4  88.7  83.0  0.452  (26) 
21,520  23.1  76.9  57.4  55.6  0.542  (13) 
• The figure between brackets relates to the overall GDI ranking. GDI measures development but adjusts for gender. 
b Latest available year.  . 
<GEM measures gender disparity related to economic and political decision making. 
d HDI measures national development according to social and economic indicators. 
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27 3.  SELECTED HEALTH INDICATORS 
The  previous  chapter  provided  an  overview  of social  and  demographic  trends  of 
importance to the situation of  women within the EC. This section profiles selected health 
indicators,  including life  expectancy,  infant  mortality,  maternal mortality,  self-perceived 
health  status,  and  height.  These  indicators  are  unfortunately  the  only  ones  currently 
available on a EC-wide basis. They do, however, indicate important differences across the 
Member States which are likely to reflect differences in underlying health status. 
3.1  Life Expectancy 
Life  expectancy  (at  birth)  has  increased  significantly  in  recent  decades  in  virtually  all 
Member States.  Between 1970 and  1995  the EC average life  expectancy for  women at 
birth increased by 5 1/2 years (for men the corresponding increase was almost 5 years).  As 
a result, a girl born in  1995 may expect to live well over 80 years, while a boy may expect 
to live well over 73  1/2 years. 
There has been considerable variation within the EC in the degree to which life expectancy 
(at birth) has increased as shown in Figure 3.1.  Typically,  the countries with the lowest 
life  expectancy  in  1970  experienced  the  greatest  increase.  This  is  particularly  true  for 
Portugal. Furthermore, the increase in some countries (e.g., Spain) was so great that they 
now  rank  towards  the  top  of the  distribution  of life  expectancy.  Other  countries 
experienced much smaller increases, in  particular Denmark, where life  expectancy went 
from bemg among the highest in  1970 to one of the lowest in the EC today due to a 
virtual stagnation in life expectancy since the mid-1970s.  One reason for Denmark's low 
(and stagnating) life  expectancy is  its high premature mortality among women under 65 
years  of agea 
1
.  As  shown  in  Figure 3.2,  Denmark  had  the  highest  reduction  in life 
expectancy due to premature death, while Spain and Greece had the lowest. 
In every Member State women live longer than men as Figure 3.3 shows. ·On  average, 
women live 6.4 years longer than men (see Table 3.1) but this ranges from  8.1  years in 
France to 5.1 years in Denmark. With a few exceptions, the gender gap has been relatively 
stable over time. Exceptions include Denmark, the Netherlands, and the UK where it has 
narrowed since the 1980s, and Spain where it has widened
2
. 
Life  expectancy  is  not  limited  to  being  measured  at  birth.  Tables  3.2-3.4  show  life 
expectancy at  ages  15,  45, and  65.  The  same patterns of variation across the Member 
States  (and  between  men  and  women)  persist  across  all  age-groups,  although  the 
difference between average life expectancy of  women and men decreases with age. 
3.2  Infant Mortality 
Infant mortality (before the age of 1 yearY is another widely reported health indicator. As 
shown in Figure 3.4, infant mortality has declined significantly in recent decades. In 1970, 
female  infant  mortality in the EC  was 21·. 9 per 1000 live births, whereas in  1992 it was 
only 6.9, a decline of 68%.  This decrease has been accompanied by  a narrowing of the 
a  ExplanationS for the  high rate of premature  mortality in Denmark include excessive smoking and 
drinking, and high unemploymene. 
31 range of rates.  In  1971,  Portugal, which had the highest  infant  mortality rate,  reported 
almost 50 deaths per 1000 live births, while  Sweden (in 1970) reported the lowest rate, 
(11  deaths per 1000 live births), a difference of almost 40 deaths per 1000 live births. In 
1992, the highest (female) infant mortality rate, still that of Portugal, was 9.29 whereas 
the lowest rates were found in Sweden and Finland, just above 5 per., 1000 live births. The 
difference was only 4.13 deaths per 1000 live births, a small fraction of  the difference 22 
years earlier.  · 
The reasons for this important decline in  infant mortality are related to improved health 
status  of mothers,  higher  quality  of ante- and  neonatal  care
3
,  and  general  social  and 
· economic improvements over the last three decades. 
3.3  Maternal Mortality 
While there are many  maternal  deaths  in  developing  countries,  there are relatively  few_ 
such deaths in developed countries because of their better health care delivery  systems. 
Nevertheless even the EC has experienced a relatively large decline in maternal mortality 
· during  recent  decades.  As  shown  in  Figure 3.5, maternal  mortality  has  declined  from 
approximately 35  per 100,000 live births in  1970 to just over 7 per 100,000 in  1992, a 
_  79% decline  during· this  period.  In absolute terms,  maternal  deaths  in  the EC deplined 
froml,493 in 1970to 178 in 1992. 
As with infant mortality, the decline in maternal mortality rates has been accompanied by a 
large  decline  in  both  range . and  variation.  In  1971  the  highest  maternal  mortality, 
· experienced  by  Luxembourg,  was  67.5  per  100,000  while  the  lowest  was  found  in 
Denmark,  8.47  per  100,000.  In 1992,  France  had  the highest  maternal  mortality  with 
12.91 per 100,000 whereas Sweden and Luxembourg had no maternal deaths. 
As ·shown in Figure 3.5 the greatest rates of decline were experienced by  Sweden .and 
Luxembourg (100%) while DenmarJr had the smallest decline (12.9%), one reason being 
that it had already an extremely low rate in 1970. 
3.4  Self-Perceived Health Statu5; 
While life expectancy provides one measure of a population's health status, it  says little 
about how its citizens rate their health. Figure 3.6 shows how a random sample of  women 
in_ the E.C  rated their own health at the beginning of 1996a.  (See Tables 3.5-3.7 for the 
distribution of responses for all women and elderly women). Generally, women in the EC 
perceive themselves as being in quite good health.  About 62% report being in good or 
very  good health  during  the  past  year.  This  percentage  is  naturally  lower for  elderly 
women. On average, only about 40% of  women aged 65 to 74 years report being in good 
or very  good  health  (Table 3.6).  Not  surprisingly,  women  aged  75  years  and  more 
typically report lower levels of self-perceived health status rJsee  Figure 3.  7), although in 
Austria, Luxembourg, Spain, and Portugal women aged 75 years and older report being in 
better health than women aged 65-74 yearsb. 
a  Respondents were asked to rate their own health ·during the past 12 months on a 5-point scale: very 
good, good, fair, bad, very bad 
b  The relatively small sample size may account for this somewhat anomalous result. 
32 As with life  expectanC"J,  the EC average belies  the large differences  between Member 
· States. As shown in Table 3.5, the percentage of  women in each country reporting being 
in very good health varies from  45.~/o in Irel8nd to 6.9% in Portugal (see also Figure 
3.6). The combined percentage (ofwomen in good and very good health) varies as much, 
ranging from 75.8% in Ireland to 34.7% in PortugaL It should be noted, however, that 
Portuguese women report a considerably lower percentage in good or very good health 
than do Finnish women who have the next lowest percentage (54.~/o). Portugal's results 
are consistent with the relatively high level of disability due to long-term illness reported 
in Section 4 .1. 
3.5  Height 
It is  well known that the ~verage height of the world's population hru;  been increasing 
over the last century, but this has particularly been-the case during: the past few decades. 
Height in developed cmmtries increasingly has come to be seen as a measure of  the health 
status of the population.  To capture this  dimension of health status, a  question about 
height has includ~ in the 1996 Eurobarometer survey. 
On average,  Eurcpean women are  163.5  em tall  but this  average  varies  considerably 
across the Me:-nber States. As can be 5een in Fig-Ore 3.8 and Table 3.8, the Netherlands 
and Dcnmuk have the tallest female population in the EC, with average heights of 167.9 
and  166.3  em,  respectively,  while  Spain and  Portugal have  the shortest with average 
heights of  161.0 and 159.n em, respectively. Thus, the difference between the shortest and 
the tallest population i.t1 the EC is more than 8 em. 
While average height differs considerably within the EC, all countries have experienced an 
increase in  the height of  the female population.  As shown in Figure 3.9 ana Table 3.8, 
older cohorts (i.e.,  women 60 years and older)  are ·considerably  shoa1er  than· younger 
cohorts (i.e., women aged 18-29 years), which confirms the increasing height over timt:. 
This is even more apparent when lc'Jking at the distribution of  the average height across 
the entire age-span, as depicted in Figure 3.10. Average height of  EC womP.&1 decreases 
unifor.mly  from the youngest cohorts (aged 18-29 years) to the oldest ;x)hort (aged 60 
years and older), with the youngest age-group being alroost 5 em taller than the oldest 
age-group. 
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Table 3.1 
Life Expectancy at Birth (in Years). 
Country 
EU AVERAGE 
FRANCE 
SPAIN 
FINLAND 
PORTUGAL 
LUXEMBOURG 
BELGIUM 
ITALY 
AUSTRIA 
GERMANY 
NETHERLANDS 
IRELAND 
SWEDEN 
UNiTED KINGDOM 
GREECE 
DENMARK 
*Estlmate 
"ranked by difference 
Source: Eurostal 1997 
-
EU 15 (1995) 
Males·  Females 
73.70*  80.10* 
73.80*  81.90* 
73.20*  81.20* 
72.80  80.20 
71.30  78.60 
73.00  80.20 
73.40  80.20 
74.90*  81.40* 
73.60  80.10 
73.30  79.70 
74.60  80.40 
73.00  78.60 
76.20  81.40 
74.00  79.20 
75.00  80.30 
72.70  77.80 
.  36 
80 
!oremales i 
18Males  1 
82 
Dilference • 
6.40 
8.10 
8.00 
7.40 
7.30 
' 
7.30 
6.80 
6.50· 
6.50 
6.50 
5.80 
5.60. 
5·.30 
5.20 
5.20 
5.10 Table 3.2 
Life Expectancy at 15 Years (in Years) 
EU 15 (1995) 
Country 
EUAVERAGE 
FRANCE 
FINLAND 
PORTUGAL 
LUXEMBOURG 
SPAIN 
BELGIUM 
GERMANY 
AUSTRIA 
ITALY 
NETHERLANDS 
IRELAND 
SWEDEN 
UNITED KINGDOM 
GREECE 
DENMARK 
ranked by d1fference 
Source- Eurostnt /997 
Males  Females 
59.40  65.60 
59.50  67.50 
58.30  65.60 
57.30  64.40 
58.60  65.70 
60.00  67.10 
59.20  65.80 
58.90'  65.30 
59.20  65.60 
60.20  66.50 
60.30  65.90 
58.70  64.20 
61.70  66;80 
59.70  64.80 
60.90  66.00 
58.40  63.30 
Table3.3 
Difference • 
6.20 
8.00 
7.30 
7.10 
7.10 
7.10 
6.60 
6.40 
6.40 
6.30 
5.60 
5.50 
5.10 
5.10 
5.10 
4.90 
Life Expectancy at 45 Years (in Years) 
EU 15 (1995) 
Country 
EUAVERAGE 
FRANCE 
LUXEMBOURG 
FINLAND 
SPAIN 
BELGIUM 
GERMANY 
ITALY 
NETHERLANDS 
AUSTRIA 
PORTUGAL 
IRELAND 
SWEDEN 
UNITED KINGDOM 
DENMARK 
GREECE 
ranked by difference 
Source- Eurostat /997 
Males 
31.30 
31.90 
30.50 
30.40 
32.30 
31.10 
30.70 
32.00 
31.60 
31.20 
30.30 
30.30 
33.00 
31.20 
30.20 
32.70 
. Females  Difference • 
36.50  5.20 
38.50  6.60 
36.90  6.40 
36.50  6.10 
38.00  5.70 
36.80  5.70 
36.20  5.50 
37.30  5.30 
36.80  5.20 
36.40  5.20 
35.50  5.20 
35.00  4.70 
37.50  4.50 
35.60  4.40 
34.30  4.10 
36.80  4.10 
37 Table 3.4 
Life Expectancy at 65 Years (in Years) 
EU 15 (1995) 
Country  Males  Females  Difference • 
EUAVERAGE 
LUXEMBOURG 
NETHERLANDS 
FRANCE 
BELGIUM 
FINLAND 
GERMANY 
ITALY 
SPAIN 
IRELAND 
SWEDEN 
AUSTRIA 
UNITED KINGDOM 
PORTUGAL 
DENMARK 
GREECE 
ran ked by dtfference 
Source- Eurostat 1997 
15.00  18.80  3.80 
14.70  19.20  4.50 
14.70  19.10  4.40 
16.20  20.60·  4.40 
14.80  19.10  4.30 
14.50  18.60  4.10 
14.70  18.50  3.80 
15.50  19.30  3.80 
16.00.  19.80  3.80 
13.70  17.40  3.70 
I6.00  19.70  3.70 
15.20  18.70  3.50 
14.60  18;10  3.50 
14.30  17.70  3.40 
14.10  17.50  3.40 
16.10  18.40  2.30 
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Table 3.5 
Self-Perceived Health Status, 1996 
Women 15+ Years, EU 15 
Very  Good  Fair 
Good 
%  %  % 
45.9  29.9  18.3 
35:3  38.3  20.0 
45.4  27.4  19.4 
20.7  48.4  22.7 
27.2  41.2  22.8 
24.8  41.0  27.4 
30.8  32.9  19.8 
20.6  41.0  25.0 
19.8  41.7  28.5 
16.5  44.7  29.6 
31.9  28.9  27.3 
23.1  37.5  27.0 
15.6  44.8  27.8 
25.5  32.1  31.2 
18.8  36.1  36.3 
14.4  40.7  37.9 
6.9  27.8  37.6 
Source: Eurobarometer 44.3/1996 
40 
EU 
.average 
80%  100% 
Bad  Very 
Bad 
0/o  % 
4.5  1.4 
5.3  0.7 
5.4  2.2 
5.8  '2.4 
7.5  1.3 
5.8  1.0 
14.3  2.2 
10.6  2.8 
9.1  9.0 
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Tablf/3.6 
Health Assessment, 1996 
Women 65-74 Years, EU 15 
Very  Good  Fair 
Good 
o;o  %  o;o 
21.6  25.5  47.1 
15.9  28.6  41.3 
31.7  33.3  20.0 
25.0  40.0  30.0 
16.0  46.0  30.0 
8.8  32.4  44.1 
9.0  29.9  22.4 
6.4  27.7  36.2 
6.0  34.3  50.7 
4.7  34.4  51.6 
21.0  30.6  33.9 
9.7  29.2  43.3 
6.9  25.0  37.5 
17.6  24.4  41.2 
7.4  23.5  56.8 
4.2  28.4  54.7 
0.0  4.3  52.9 
Table 3. 7 
Health Assessment, 1996 
Women 75+ Years, EU 15 
Very  Good  Fair 
Good 
o;o  %  % 
5.0  30.0  45.0 
17.9  39.3  32.1 
19.2  23.1  50.0 
30.8  23.1  23.1 
12.2  28.6  42.9 
5.9  52.9  17.6 
0.0  23.5  11.8 
5.3'  26.3  47.4 
9.1  15.2  48.5 
0.0  .  20.8  62.5 
14.8  18.5  55.6 
8.6  23.7  43.5 
9.5  28.6  38.1 
15.2  24.2  45.5 
0.0  28.6  42.9 
7.9  21.1  44.7 
3.7  7.4  18.5 
41 
Bad  Very 
Bad 
%  o;o 
5.9  0.0 
9.5  3.2 
5.0  10.0 
0.0  5.0 
4.0  4.0 
11.8  2.9 
37.3  1.5 
19.1  .  10.6 
7.5  1.5 
4.7  4.7 
14.5  0.0 
14.1  3.7 
25.0  5.6 
15.3  1.2 
6.2  4.9 
12.6  0.0 
34.3  8.6 
Bad  Very 
Bad 
o;o  o;o 
15.0  5.0 
10.7  0.0 
7.7  0.0 
23.1  0.0 
14.3  2.0 
11.8  11.8 
58.8  5.9 
15.8  5.3 
27.3  0.0 
16.7  0.0 
7.4  3.7 
19.2  5.1 
19.0  4.8 
6.1  9.1 
19.0  9.5 
21:1  5.3 
51.9  18.5 Figure3.7 
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42 Table 3.8 
Average Height (in em) 
Women 18 +Years by Age-Group, EU 15 (1996) 
AGE-GROUP 
18-29  ,30-44  45-59  60 +Years  Total 
Years  Years  Years  18+ Years 
THE NETHERLANDS 
DENMARK 
GERMANYW 
SWEDEN 
AUSTRIA 
GERMANYE 
LUXEMBOURG 
BELGIUM 
EU 15 
FINLAND 
IRELAND 
FRANCE 
GREECE 
UNITED KINGDOM 
ITALY 
SPAIN 
PORTUGAL 
Source: Eurobarometer 44.311996 
169.7.  168.6  167.0 
167.8 
168.3 
166.8 
166.7 
165.7 
166.0 
165.8 
165.4 
165.6 
164.8 
164.6 
164.8 
163.6 
164.1 
164.4 
161.6 
. 167.8  165.6 
167.5  165.6 
166.4  165.6 
166.2  165.8 
166.5  165.3 
165.0  165.7 
165.3  162.8 
164.3  162.9 
164.6  163.7 
163.5  162.9 
163.9  162.1 
163.3  162.4 
162.1  162.4 
162.9  161.0 
160.9  159.7 
160.7  158.4 
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44 4.  MORBIDITY 
The previous chapter described various health indicators such as  life  expectancy,  infant 
mortality,  and  height.  This  chapter  provides  a  brief overview  of various  morbidity 
measures.  Because disease-specific  morbidity  indicators  at  the EC  level  do  not  exist, 
indirect measures, such as self-reported disability, both short-term and long-term, and use 
of  health services,· such as doctor consultations ·On the past 2 weeks) and hospitalisations 
(in the past year) aie used instead.  The data for these measures come from the  1996 
Eurobarometer  survey  and  the  1994  European  Community  Household  Panel  survey 
(ECHP). Because the latter survey was undertaken when the EC had  only  12  Member 
States, the ECHP data are limited to those countries. 
4.1  Activity Limitations Due to Chronic Conditions 
As shown in Figure 4.1 and Table 4.2, almost one out of four women in the EC reports 
being limited in their daily activities to some extent (17.3%) or severely (6.3%) because of 
long-standing illness. This average ranges from a high of  30% in Finland and Portugal to a 
low of 15% in Luxembourg. While this measure may to some extent be influenced by each 
Member State's criteria for obtaining disability pensions,  it  is likely  that it  dces reflect 
some  underlying  differences  in  the  prevalence  of disability  in  the  female  population. 
Certainly, the high percentage of Portuguese women reporting being hampered in their 
daily activities by long-standing illness corresponds well with the high percentage of  them 
reporting being in poor health (see Section 3.4). 
Not surprisingly, the incidence of disability due to long-term illness increases uniformly 
with age.  As shown in-Figure 4.2, the percentage of  women reporting being disabled to 
some extent or severely rises from 10.2% among 15-29 year-old women "to  54.3% among 
women aged 75 years or older. The percentage women under 30 years who report being 
severely disabled is  1.5% while it is just over 20% for women aged 75  years and older 
(Table 4.2). 
When looking at older women only, i.e., those aged 65  years and older, it is noticeable 
that about half report being hampered to some extent (36.4%) or severely (12.3%) in their 
daily activities because oflong-standing illness (see Table 4.3). Moreover, the ranking of 
disability among elderly women (aged 65  and over) differs from that among the  entire 
population of  women. This is shown in Figure 4.3, in which the Member States appear  in 
the same order as in Figure 4.1, but that no longer corresponds to their relative ranking. 
For example, Greek women are ranked 1Oth on an overall population basis, just above the 
EC  average,  but  Greece  has  the  second  highest  percentage  of elderly  women  with 
disability due to long-term illness. Thus, elderly Greek women are relatively more disabled 
than are younger Greek women.  Similarly, Irish women have the third lowest percentage 
of  disabled women overall, but the third highest among elderly women. 
4.2  Short-Term Activity Limitations 
Short-term activity limitations due to illness and injury are considerably less frequent than 
activity limitations due to chronic conditions.  On average,  13.8% of EC womena  report 
a  Owing to data problems, only 11 of  the then 12 Member States are included in this analysis. 
45 having had to cut down on their usual activities in  the past two weeks because of an 
illness or injury, but the range is considerable: only 5.6% of  Italian women report having 
to cut down on their usual  daily activities compared to almost  20% of Dutch women 
(Figure 4.4 and Table 4.4). 
\ 
Not  surprisingly~ the percentage of women who report short-teiT'l activity limitations is 
much greater among  elderly .  women, with  an average of almost  25% reporting  such 
activity limitation due to illness and injury, and a range from a low in Italy of 12.00/o to a 
high in Germany of31.5%. It is remarkable that Italian women (aged 65 years and oldet:) 
report the low~st frequency of short-term disability when they report one of the highest 
prevalences  of disability  due  to  chronic  conditions.  Apparently,  these  two  measures 
capture different dimensions of  disability (Figure 4.5 and Table 4.5). 
The last disability  indica~or to be reported here is  short:.term activity restrictions (in the 
past two weeks) because of  emotional or mental health problems. As shown in Figure 4.6 
and Table 4.6, only about 3% of  women in the EC report having had to reduce their daily 
.activities due to a..-.. emotioMl or mental health problem. This ranges from a low in Italy of 
approximately 1% to a high of  almost 90/o in the Netherlands. 
When looking only at elderly women (aged 65 years and over), the pattern is the same but 
the level of  activity restriction is higher.  Thus, Italy reports the lowest incidence (2.8%) 
and  the Netherlands reports the highest  (11.2%), while  the EU average  is  5.0%  (see 
Figure 4.  7 and Table 4.  7). Thus, the reported incidence of short-terln restricted activity 
even among elderly women in the EC is quite low, both absolutely and relative to other 
· types of  activity restrictions. 
4.3  Doctor Consultations 
. While restricted activity days are likely to result in a decline in quality of life, they do not 
. necessarily give rise to medical consultations. In view of the cost implications, the 1996 
Eurobarometer survey asked its respondents whether they had consulted a physician in the 
past two weeks (either in person or on the telephone). The results are given in Figure 4.8 
and "I:able 4.8. On average, about one. in three women had consulted a doctor in the past 
two weeks, with some variation between Member States. In Ireland and the Netherlands 
only 25% of  women reported doing so, while 38% reported doing so in Spain. 
Not surprisingly,  the percentage of women consulting a  doctor (during the previous  2 
weeks) increases with age. While a siZeable proportion - almost one in four - seek medical 
help under the age of 30 years, this proportion increases uniformly with age until more 
than two out of  five women seek medical help among the 75 and over group (Figure 4.9 
and Table 4.9). 
4.4  Hospitalisations 
Hospital  stays  (in  a  one-year  period)  provide  another  measure  of morbidity  in  a  · 
population. As periods in hospital are only necessary for the most severe illnesses, they are · 
relatively infrequent, even on an annual basis.  As shown in Figure 4.10 and Table 4.10, 
only about 10% of  EC women report having been hospitalised. However, hospitalisations 
vary considerably within the EC, only 3.8% of the Danish women asked reported having 
46 been hospitalised in the previous year compared to nearly  13% in France and Finland
3
• 
These differences  may  to some extent reflect  differences  in  the availability  of hospital 
beds, which also varies considerably within the EC
1
.  . 
When looking at age-group differences,  it is  apparent that the increasing disability with 
older age also results in increasing hospitalisation. As shown in Figure 4.11 only 6.3% of 
women aged 15-29 years report having been hospitalised in the previous year, compared 
to 18% of  women aged 75 years or over (Table 4.11). 
' 
Figure 4.12 shows the average number of nights spent in the hospital for those women 
who had at least one non-birth hospitalisation. On average, women spent about 1  0 nights 
in the hospital in a 12-month period. Again, there were considerable variations across the 
Member States,  with the former  Gerinan  Democratic  Republic  and  the pre-unification 
Federal Republic of  Germany reporting the highest number of  night~ in ihe hospital (14.9 
arid  13.5, respectively) and Spain reporting the lowest (5.9) (see also Table 4.12).  Care 
should be taken when interpreting these numbers, because of differences in the types of 
hospitals  that  exist  in  the various  Member  States  and  the  relatively  small  number  of 
hospitalisations that form the basis for these estimates. 
Referencti!S 
1  Eurostat  (1996),  Soci(l/  Portrait of Europe,  L&..l(embourg:  Office  for  Official  Publications  of the 
European Comm.·nities. 
a  Corresponding data from the 1994 ECHP survey yield slightly different results, probably becauSe of 
different  sampling methods and sizes.  In particular,  15% of women  in Luxembourg and 12% of 
women in Denmark report a hospitalisation in the previous year. 
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Table 4.1 
Percent with Disability Due to Long-Standing Illness* 
Women 15+ Years, EU 15 (1996) 
no  yes,some  yes,severe  dk/refuse 
0/o  % 
0/o  % 
.69.8  20.1  9.5  . 0.6 
69.9  17.2  12.4  0.5 
71.2  19.2  9.1  0.4 
72.4  18.4  8.6  0.6 
74.0  20.1  5.6  0.3 
72.1  16.9  8.5  2.6 
74.9  17.1  8.0  0.0 
73.8  17.7  7.2  1.3 
75.4  18.1  6.0  0.6 
75.7  17.3  6.3  0.8 
75.0  18.8  4:4  1.8 
78.4  15.8  4.8  1.0 
78.8  13.6  6.9  0.7 
80.5  15.6  3.5  0.4 
80.1  16.5  2.6  0.8 
82.4  14.6  2.8  0.2 
83.9  10.6  4.2  1.3 
Source: Eurobarometer 44.311996 
• Distribution ofreponses to the following question :"Do you have any  long~standing illness, health problem or handicap that 
limits, to some extent or severely, your work or daily activities? This includes all types of  health problems as well as those due 
to old age. If yes, to some extent or severely?" 
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Figure4.2 
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Iable4.2 
Percent with Disability Due to Long-Standing Illness* 
By Age-:.Group~ EU 15 (1996) 
some + severe  severe only 
0/o  % 
10.2  1.5 
15.0  4.1 
27.4  8.1 
43.5  11.6 
54.3  20.3 
Source: Eurobarometer 44.311996 
* Distribution of reponses to the following question : "Do you have an·y long-standing illness, health problem or handicap that 
limits; to some extent or severely, your work or daily activities? This includes all  types of  health problems as well as those due 
to old age. If yes, to some extent or severely?" 
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Table 4.3 
Percent with Disability Due to Long-Standing Illness* 
Women 65+ Years, EU 15 (1996) 
no  yes, some  yes, severe  dk/refuse 
0/o  % 
0/o  % 
48.7  31.9  19.3  0.0 
44.3  -24.7  29.9  1.0 
57.0  26.7  15.1  1.2 
27.3  54.5  18.2  0.0 
55.1  34.7  10.2  0.0 
46.6  34.1  17.0  2.3 
59.6  28.1  12.4  0.0 
57.0  :51.0  10.0  2.0 
34.5  48.8  15.5  1.2 
50.7  36.4  12.3  0.6 
45.1  40.7  12.1  2.2 
44.1  40.9  15.1  0.0 
81.8  12.1  6.1  0.0 
61.9  29.9  8.2  0.0 
42.3  45.1  11.3  1.4 
60.3  33.6  6.0  0.0 
68.6  17.6  13.7  0.0 
Source: Eurobarometer 44.311996 
•  Distribution of reponses to the following question : "Do you have any long-standing illness, health problem or handicap that 
limits, to some extent or severely, your work or daily activities? This includes all types of health problems as well as those due 
to old age. If yes, to some ex_tent or severely?" 
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Table 4.4 
Percent with Restricted Activity in Past 2 Weeks 
Due to Illness or Injury 
Women 16-r Years, EU u* (1994) 
Percent 
'13.8 
5.6 
9.4 
10.9 
11.4 
13.6 
14.6 
14.9 
14.9 
18.6 
19.0 
19.9 
Source: European Commrmity Household Panel/994 
"'  Excluding F  ranee 
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Table4.5 
Percent with· Restricted Activity in Past 2 Weeks 
Due to Illness or Injury 
Women 65+ Years, EU 11" (1994) 
Percent 
24.4 
12.0 
21.6 
19.4 
18.8 
27.7 
29.0 
23.4 
22.7 
31.5 
27.0 
27.8 
Source : European Community Household Panel I 994 
• Excluding France 
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Table4.6 
Percent with Restricted Activity in Past 2 Weeks 
Due to Emotional or Mental Health Problem 
Women 16+ Years, EU 12 (1994) 
Percent 
3.2 
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Table 4.7 
Percent with Restricted Activity in Past 2 Weeks 
Due to Emotional or Mental Health Problem 
Women 65+ Years, EU 12 (1994) 
Percent 
5.0 
2.8 
4.1 
5.2 
6.8 
5.8 
4.7 
7.5 
3.2 
6.5 
7.8 
11.2 
4.2 
Source: European Community Household Panel 1994 
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Women 15+ Years, EU 15 (1996) 
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Table4.8 
Percent Women with Doctor Consultation(s) in Past 2 Weeks 
Women 15+ Years, EU lS (1996) 
Consultation  No Consultation 
%  % 
Spain  37.8  62.2 
Italy  36.4  63.~ 
·Portugal  34~8  65.2 
France  33.3  66.7 
UE15  31.7  68.3 
B~lgium  31.5  68.5 
Greece  31.0  69.0 
GermanyW  30.9  69.1 
Finland  29.7  70.3 
Denmark  29.7.  70.3 
Luxembourg  28.9  71.1 
Germany E  28.4  71.6 
Austria  26.7  73.3 
United Kingdom  26.7  73.3 
Sweden  ·26.3  73.7 
Ireland  24.6  75.4 
The Netherlands  24.6  75.4 
Source: Eurobarometer 44.311996 
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Percent Women with Doctor Co~ultation(s) in .Past 2 Weeks 
By Age-Group, EU 15 (1996) 
% 
23.9 
25.7 
32.1 
39.2 
41.8 
Source: Eurobarometer 44.311996 
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Percentage with Non-Birth Hospitalisation(s) in Past Year 
Women 16+ Years, EU 15 (1996) 
No Hospitalisation  Hospitalisation 
%  % 
87.3  12:7 
87.3  12.7 
88.9  11.1 
89.5  10.5 
89.6  10.4 
90.2  9.8 
90.5  9.5 
90.5  9.5 
90.5  9.5 
91.5  8.5 
92.1  7.9 
92:2  7.8 
92.3  7.7 
92.5  7.5 
93.0  7.0 
95.4  4.6 
96.2  3.8 
Source: Eurobarometer 44.311996 
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Figure 4.11 
Percentage with Non-Birth Hospitalisation(s) in Past Year 
By Age-Group, EU 15 (1996) 
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Table 4.11 
Percentage with Non-Birth Hospitalisation(s) in Past Year 
By Age-Group, EU 15 (1996) 
No Hospitalisation 
% 
93.7 
92.8 
90.8 
87.4 
82.0 
Hospitalisation 
0/o 
6.3 
7.2 
9.2 
12.6 
l8.o· 
Source: Eurobarometer 44.31!996 
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Table 4.12 
Average Number ofNigths in the Hospital" in Past Year 
Women 15+ Yean, EU 15 (!996) 
GermanyE 
GermanyW 
Austria 
The Netherlands 
Greece 
Luxembourg 
France 
Italy 
EU 15 
Denmark 
Portugal 
Ireland 
Finland 
Belgium 
United Kingdom 
Sweden 
Spain 
Source: Eurobarometer44.3/J996 
Number 
nights*"" 
14.9 
13.5 
12.8 
11.1 
10.7 
10.2 
10.0 
9.8 
9.8 
9.3 
9.2 
9.1 
8.9 
8.8 
6.2 
6.0 
5.9 
• For those women with at least one (non-birth) hospitalisation in the past year. 
** N= 729; 8 cases (outliers) are excluded (those above 60 days). 5.  CAUSES OF DEATH AND TRENDS IN FEMALE 
MORTALITY 
While  the  previous  section  focused  on different  measures  of morbidity,  this  section 
concentrates on the main causes of  death for women in the EC. It also describes the trends 
during the past two to three decades as well as the main risk factors associated with the 
diseases  (and  conditions) that are the main  cause of female  mortality in  the EC (e.g., 
smoking and drinking). As will become a,pparent, much of  the current premature mortality 
(i.e., deaths among women under 65 years) may be prevented through primary prevention 
(changes in life style) or secondary prevention (early detection of  disease). 
The main causes of  female mortality (across all age-groups) are illustrated in Figure 5  .1. 
The two largest Ca.uses  of death among women are diseases of the circulatory system, 
which account for 43% of  all deaths, and cancer which accounts for. 26%. However, the 
major causes of death vary with age.  Motor vehicle  accidents  are the  main  cause of 
mortality for women under 30 years, while suicide is the main  cause for the 30-34 age-
group. Cancer,  specifically  'female cancers', such as breast and  cervical  cancer, is the 
main  cause of death for  women aged  35-64 years.  For elderly women (65  years  and 
older), it is diseases of  the circulatory system that account for most deaths, approximately 
half of  all deaths in this age-group 
1
.  , 
5.1  Motor Vehicle Accidents 
Approximately  50,000  people  are  killed  annually  in  the  EU  on  the  roads  either  as 
occupants of  motor yehicles or pedestrians. Alcohol abuse is a significant cause of motor 
vehicle accidents. While such accidents are still  an important cause of female  mortality 
(see Figure 5.1), the rate of mort;ility has been declining. As Can be seen in Figure 5.2, 
women's average mortality from motor vehicle accidents declined by  nearly 40% from 
1970 to 1992, to 6.42 deaths per  100,000. The rates range considerably, from a high in 
Luxembourg of 11.39 per 100,000 to a low of  4.14 per 100,000 in the UK. The rates of 
change  since  1970  vary  to an even  greater extent,  with  all  but  three Member States 
reporting  declining  rates  of between  25%  (in  Italy)  to  64%  (in  the  Netherlands• 
2
). 
However, Greece reports an increase of almost 62%, while Luxembourg, Portugal, and 
Spain report smaller increases (4-14%). 
5.2  Suicide and Self-Inflicted Injury 
More than 40,000 people in the EU commit suicide each year. While men are more likely 
than women to commit suicide, the so-called parasuicide (attempted suicide) rate is higher 
for women
4
,  perhaps because women tend to use  less violent methods  than  do  men
5
. 
Overall female mortality from suicide has decreased by 24% since 1970, 6.24 deaths per 
100,000 (see Figure 5.3). Suicide rates vary considerably'within the EC, with a tendency 
toward higher rates in the North. Luxembourg has the highest suicide rate with 14.30 per 
a  The educational programme implemented by the Traffic Safety Foundation in the Netherlands may 
have contnbuted to· the decrease there
2
• 
61 100,000, followed by Denmark with a rate of 13.67• 
6
. Both rates are over twice the EC 
average. Greece has the lowest rate with 1.21 deaths per 100,000. 
Risk  factors  for  suicide  and  parasuicide  include  alcoholism, · depression,  and  Socio-
economic problems. Women with eating disorders, such as anorexia anc\ bulimia, are also 
at  higher risk of committing  suicide  and  parasuicide
7
.  Furthermore, women who  have 
attempted suicide are much more likely to try again.  Several studies estimates the risk of 
suicide within one to two years after a suicide attempt as several times higher than that for 
the average population
8
•  .  ·  .  . 
5.3  Cancer as a Cause of Female Mortality 
Cancer is the second leading cause of death for women in the EC after diseAses  of the · 
circulatory system,  cal.asing  26% of all  female  deaths in  the Community  in  1992  (see 
Figure 5.1). Furthermore, it is the primary cause of  death for women 35-64 years of  age. 
Figures ,5.4 and  5.5 show women's mortality rates from  cancer in the Member States  .. 
The.EC average for women under 65 years was 69.74 per 100,000 in  1992~ and  150.30 
for women of  all ages, indicating that most cancer mortality occurs among elderly women 
(over 65 years of  age). 
Cancer mortality for women under 65 years has declined by  13% since 1970, while it has 
declined by only 5% for all  women combined.  Among Member States there is  a clear 
North-South division, with the Northern Member States generally reporting higher rates. 
However, both Sweden and Finland are below the EC average; with Finland having one of 
the lowest cancer rates in the EC.  Conversely, Denmark has the highest rates in the EC 
(102.23 per 100,000 among women under 65 years, and 203.73 per 100,000 for all ages). 
Moreover, Derimark is the only Member State to report a (slight) increase (0.28%) since 
1970 among women under 65  years,  and  one of only four Member States to  see  an 
increase in cancer mortality across all ages. 
The so-called 'female' cancers (b.c:ast, cervix, and uterus) account for more than 23% of 
all  cancer deaths.  By comparison cancer of the digestive organs accounts for 3  2% artd 
cancer of the respiratory system (trachea, .bronchus, and lung) for  <)0/o  (see Figure 5.6). 
Importantly, the latter group of cancers have been rising among women but generally 
falling among menb 
9
,  probably because smoking r~es have been rising among women and 
falling among men (see Section 6.1). All tllese cancers are to a high degree related to life 
style  and  environment  and  therefore  to a  large  extent  preventable.  They  account for 
considerable premature mortality among women (under 65 years). 
5.3.1  Breast Cancer 
Breast cancer is one of the most common types of cancer ·among women in the EC, as 
well  as  iri  other industrialised  countries,  such as the United  States and  Canada.  Breast 
cancer was responsible for around 21% of  all female caricer deaths in the EC in 1992 (see 
Figure 5.6). It is also the main cause of death for women aged 35-64 years
10
. It has been 
a  A Danish study concluded that women there had a greater tendency to use violent methods, which 
may partly explain their relatively greater rates of 'success'
6
• 
b  Cancer of  the trachea, bronchus, and lung has declined since 1970 by almost 200/o among men. while 
it has increased by almost 700/o among women in the E~. 
~ estimated that a woman in the EC has a 2-3% chance of developing breast cancer during 
her lifetime 
11
.  ' 
The incidence of breast cancer is  still  rising  in  many  Member States, though this  may 
partly be due to the increased level of detection through screening programmes.  Survival 
rates are improving because of earlier detection and more effective therapies,  although 
survival rates are better for women under 50 years (60% survival after 5 years) than for 
older  women  (only  40%  survival  after  5  years)
12
.  Survival  rates  also  vary  markedly 
according to whether the cancer is localised or has spread at the point of diagnosis.  The 
rate of survival is over 90% when the cancer is localised within the breast, 75% when it 
has  s~read to adjoining areas, but below 200/o when the cancer has reached other distant 
sites
1 
.  . 
Figures 5.  7 and 5.8 detail the EC breast cancer mortality rates in  1992. The average for 
women of all  ages was 31.25 deaths per 100,000 (a 16% decline since  1970), while for 
women under 65 years, the mortality rate was 19.80 per 100,000 (a fall of9.27%). These 
rates vary considerably across the Member States. For all  ages Denmark has the highest 
rate (40.56 per 100,000) followed by the UK (39.23 per 100,000), while Greece has the 
lowest rate (21.32 per 100,000). The Greek rate, however, has risen by nearly 57% since 
1970, a rise that is second only to the 73% increase of  Spain. 
Among women under 65 years Ireland has the highest rate (25.80 per 100,000), followed 
by Denmark (24.77 per 100,000). The Irish rate increased by 17% since  1970, while the 
Danish rate remained virtually unchanged.  As was the case for the mortality rate for all 
ages, Greece has the lowest rate. among women under 65 years (14.58 per 100,000), but 
has seen an increase of 45% over the rate in  1970.  Spain also reports an increased rate 
··(almost 62%).  Figure  5.9, which  shows  how the  rates  in  six  EC  countries  changed 
between 1970 and 1992, clearly demonstrates the rising trend in Spaln. 
There is  insufficient  knowledge  about  the  causes  and  relevant  risk  factors  for  breast 
cancer.  Approximately  80%  of wo~nen who  develop  it  have  none  of the  known risk 
factors
14
.  The most important known parameters include age (the risk increases with age, 
and 2/3 of  cases are in women over 50 years of age), and having a mother and/or a sister 
with breast cancer.  Less important risk factors include  early  menarche  (under  11 ),  late 
menopause (over 54 years), being over 30 y~s  at first  full  term pregnancy,  and never 
having had any children. Other risk factors include having had certain breast diseases and 
a  history  of ovarian  and/or  endometrial  cancer.  It has  been  suggested  that  living  in 
urbanised societies, the consumption of a diet high ir..  animal fat  and protein, and having 
high economic status may also be linked with breast cancer. Recent evidence suggests that 
alcohol consumption may also be a risk factor for breast cancer
15
.  . 
Given the inadequate knowledge about the causes and  associated risk factors  of breast 
cancer,  secondary  prevention  through  early  detection  by  self-examination,  clinical 
examination  and mammography is  very important. ·Further research  into  the  causes of 
breast  cancer  is  needed  to  establish  how  far  it  might  be  preventable.  International  · 
differences in incidence and studies on the development of breast cancer among different 
generations of immigrants support the idea that exposure to certain risk factors plays a 
key role
16
. 
63 5. 3. 2  Cervical Cancer 
Caricer of the cervix is  the second most common of the 'female'  cancers in  the EC, 
responsible for around 2% of  all cancer deaths (see Figure 5.6). Cervical cancer develops 
very slowly and, if the cancer is  detected while still  localised (pre-invasive),  the 5-year 
relative survival rate is high, around 88%. However, if  the cancer is detected in the later, 
invasive stages the survival rate falls to 13%
17
. 
·Figures 5.10 .and 5.11 show that mortality rates for cervical cancer have fallen in most 
Member States since 1970  .. The EC average mortality rate for women under' 65 years has 
decreased to 2.28 per 100,000, corresponding to a decline of  nearly 48% (Figure 5.10). 
For women of  all ages mortality due to cervical cancer has declined ;y  more than 40% , to 
3.28 per 100,000 (Figure 5.11). Denmark has the highest mortality rate among women 
under 65  years of age (4.64 per 100,000) but has experienced a fall of more than 55% 
since 1970. Only in Spain
8  18  and Greece has the rate been rising, but it is still relatively 
low in these countries.  Greece .. has the third lowest rate in the EC (1.31  per 100,000) 
while Spain has the fourth lowest (1.66 per 100,000). Italy has the lowest rate at 0.75 per 
100,000.  .  . 
The picture for all ages closely mirrors that of  the under 65 age-group. Denmark has the 
highest rate, while Italy has the lowest rate, and Spain and Greece are the only Member 
States to report increases in mortality since 1970 (see Figure 5.11). 
The general  reduction  in  mortality  may 
1 partly  be  attributable  to  effective  screening 
programmes.  It  is  now  widely  accepted  that  cervical  cahcer  occurs  after  sexual 
transmission  of a  carcinogen.  The  principal  known  risk factor  for  cervical  cancer  is 
infection with the human papilloma virus (HPV16 and HPV18) and, to a lesser degree, 
with  other  sexually  transmitted  diseases  (STDs),  such  as  herpes,  gonorrhoea,  and 
chlamydia.  Strong  risk  factors· for  this  type  of cancer  are,  therefore,  'unsafe'  sex  in 
general, early age at first intercourse (under 16 years), multiple sexual partners, and a past 
(or present) sexual partner infected with HPV or other STD(s). Other risk factors include 
active and/or passive smoking, infection with IITV, and poor nutrition
19
. 
5. 3. 3  Cancer of  the Respiratory System  · 
As can be seen from Figure 5.6, 9% of  deaths from cancer 3.mong women are attributable 
to lung  cancer  b.  The  EC  average  mortality  rate  for  women  of under  65  years  has 
increased since  1970 by almost 45% to 66.3  per 100,000 (see Figure 5.13), while the 
corresponding rate for all  women has increased by almost 70% since 1970, to 14.05 per 
100,000 (see Figure 5.14). The rate of increase since 1970 has been most marked in the 
Netherlands and Denmark (for all ages as well as for the under 65 year-olds), while Spain 
has actually experienced a decli.'le in lung cancer mortality among women (for all ages as 
well as for the 4nder 65 year-olds). France has also seen a decline in lung cancer mortality 
but only among women less than 65 years old.  · 
a  Research  in  Spain  to  determine  causes  for  increased  mortality  from  cervical  cancer  found  a 
connection  with  increased  sexual  activitv  associated  with  increased  tourism  and  a  low  level  of 
education 
18
•  • 
b  In this section we refer to lung cancer for the sake of brevity, but this includes other cancers of the 
respiratory system, such as cancer of  the trachea and bronchus. 
64 Within the EC, Denmark stands out as having by far the highest female mortality rates d~;e 
to lung cancer, followed by the UK, Ireland, and the Netherlands. The Danish mortality 
rate is more than three times the EC average among women under 65 years,  and more 
than twice the EC average for all ages. In contrast, the Mediterranean CO\llltries tend to 
have lower lung cancer mortality rates (see Figures 5.13 and 5.14).  These results are 
consistent with the lower levels of  smoking among women in the Mediterranean countries 
during the past decades and the high level of smoking among Danish women during the 
past forty years or more
20
• 
Given the high increases in lung cancer mortality among women, it is not surprising that 
there is considerably uncertainty in the general population (of women) in the EC about 
which gender is more affected by lung cancer. As shown in Figure 5.15 and Table 5.1, 
about half of  all women asked in the 1996 Eurobarometer survey, thought that men were 
more  affected  by  lung  cancer than women,  but  more  than  one  third  did  not  know. 
Responses varied  considerably  within the EC.  In  particular,  in  Finland,  80% of those 
asked thought men had a higher incidence oflung cancer, whereas in Sweden 48% did not 
know. This striking difference between neighbouring countries may be partly explained by 
the higher female lung cancer mortality rates in Sweden (above the EC average) than in 
Finland which is below the EC average (see Figures 5.13 and 5.14). 
Lung cancer is typically caused by inhalation of carcinogenic materials,  such as tobacco 
smoke  and  asbestos,  and  by  exposure  to  ionising  radiation
21
.  In  particular,  tobacco 
smoking is associated with greatly elevated risk of  lung cancer. One study estimates that 
the risk of lung cancer is more than 12 times higher among women smokers than among 
non-smokers,  and  25  times  as  great  among  male  smokers  as  among  non-smokers, 
corresponding to about 85 to 90% of  all lung cancers being caused by smoking
22
. Passive 
smokin~  has also been shown to increase the ris~ of  lung cancer although to a much lower 
degree  . Other risk factors include environmental pollution, poor nutrition, overcrowded 
housing, and low socio-economic status
24
.  · 
5.4  Diseases of the Circulatory System (Cardiovascular Diseases) 
Diseases  of  the  circulatory  system  (particularly  ischaemic  heart  diseasea  and 
cerebrovascular diseases, or stroke) are disorders of  the heart and blood vessels. They are 
· the main cause of  mortality (as well as morbidity and disability) among women generally 
in  the EC (see Figure 5.1)  and  the second  most important  cause of premature death 
(under 65 years of  age) after cancer. 
These diseases are characteristic of developed Western societies and life  style.  They are 
also related to social class
25
. Thus, to a great extent these diseases are preventable through 
life style changes, such as not smoking and eating a diet low in saturated fats,  sugar and 
sale
6
. Women appear to be differently affected by these diseases than men:  They develop 
them more often,  but at a  later age,  and  particularly  after the  age of 65  years,  when 
incidence and mortality increases rapidly.  Another difference  is  that women have more 
strokes while men have more heart attacks. 
a  Ischaemic heart disease is frequently used synonymously with coronary heart disease,  however,  the 
two are not strictly identical. because it is possible to have coronary heart disease without ischaemia 
(poor oxygen flow to the heart). Because death is caused by a lack of oxygen flow to the heart (i.e., by 
ischaemia), ischaemic heart disease is the term used in this report. 
65 Death rates  for  circulatory  diseases  lptve  decreased  in  all  Member  States  since  1970 
among women under 65 years of age. The EC average mortality rate for this age-group 
has dropped more than 500/o since 1970, to 31.56 per 100,000 (Figure 5.1), with a range 
going from 64%decline in Finland to 32% decline in Denmark and Greece. The story is 
similar for women of  all ages, except that in this case, the overall decline (since 1970) in 
mortality  due  to diseases  of the  circulatory  system  was  only  3  7%.  Furthermore,  the 
overall mortality rate is  much higher (248.44 per 100,000).  Again,  the Member States 
vary in the extent to which their mortality rates have declined. In particular, Greece stands 
out because it reports an overall increase (7.54%) in mortality since 1970 (Figure 5.17). 
5.5  Ischaemic Heart Disease 
Ischaemic heart disease is the largest single cause of  female mortality in the EC.  Despite 
this, it is often perceived by the public and media as a 'male' disease.  As shown in Figure 
5.18 and Table 5.2, almost 60% of the women asked  during the  1996  Eurobarometer 
survey,  indicated  that  they  thought  that  heart  disease  affected  many  more  men  than 
women. Over the last years some Member States have implemented prevention campaigns 
specifically  addressed  to  women,  for  example,  the campaign  organised  by  the British 
Heart Foundation which referred to heart disease as 'Britain's no.  1 !ady killer'
27 28
. 
Heart disease follows a different pattern for women than for men. Typically men begin to 
develop ischaemic heart disease at an earlier age, often in their 40s and 50s, while women 
tend to be in  their 60s,  i.e.,  after menopause.  This  difference is  assumed  to be  caused 
partly by the protective characteristics of  the female oestrogen hormone, but may also be 
the result of lower iron stores in  pre-menopausal women
29
.  Data about coronary heart 
disease in women are generally insufficient, in part because many studies are carried out 
on  men.  Further  investigation  is  required  into  claims  that  women  more  often  have 
unrecognised symptoms, different symptoms, and different survival rates than do men
30  31 
32 
While there are significant variations in mortality from ischaemic heart disease, rates ha·.  ~ 
generally been declining since 1970. Among women under 65  years of age, the mortality 
rate has declined by just over one third  since  1970,  to about  12  per 100,000 (Figure 
5.19). The mortality rate varies from a high of24.31 per 100,000 in Ireland to 4.51  per 
100,000 in France. The rate ofdecline also varies, from a high of6,0% in Finland to a low 
of  about 2% in Greece.  · 
As already noted, mortality rates are much higher among older women, accounting for the 
much higher rates when this group \s included. As shown in Figure 5.20, the EC average 
mortality rate for ischaemic heart disease among women of all ages is 84.75 per 100,000. 
The range varies from  a high  of 149.75  per  100,000 in Finland to a low of 36.94 per 
100,000 in  France.  All  but  three Member States (Greece,  Spain,  and  Germany)  report 
declines in overall mortality, ranging from 20% (in Portugal) to 46% (in Sweden). 
The  decrease  in  mortality  rates  is  linked  with  changes  in  diet,  notably  a  decrease  in 
saturated fat  intake,  and  declining  smoking rates in  certain groups and  Member States. 
Notwithstanding  its  decline,  ischaemic  heart  disease  continues  to  be  one  of the  main 
causes of premature and overall mortality for women in the EC.  Moreover, decreases in 
mortality rates may hide increased rates of morbidity, specifically among elderly women. 
Furthermore, ischaemic  heart  disease  is  linked  with  chronic  disability,  high  health  care 
66 expenditures and other economic costs, such as  loss of working days, and often with a 
decline in quality of  life. 
There  are  many  risk  factors  for  heart  disease.  Some,  such  as  ageing  and  genetic 
disposition,  can  not be  altered,  but  the  three  most  important  risk  factors  - smoking, 
hypertension, and high levels of  blood cholesterol - may be influenced either by life style 
changes or through medication. 
Smoking is the single most important risk factor.  The risk increases with the number of 
cigarettes  smoked,  in  particular,  for  women  over  35  years  of age,  who  take  oral 
contraceptives.  Women are particularly vulnerable to developing hypertension  after the 
age of 50 years. Furthermore, blood cholesterol levels also increase with age.  Other risk 
factors for ischaemic heart disease include being  overweight (see Section 6.3), diabetic, 
having a sedentary life  style, and  drinking e.xcessively.  Lower socio-economic status and 
occupational  stress  have  also  been  associated  with  increased  risk  of ischaemic ·heart 
disease
33
. 
Interestingly,  stress  is  often  perceived  by  the  general  public  as  a  key  risk  factor  for 
developing heart disease, even though  medical evidence to support this notion is lacking, 
except as  regards occupational stress.  As shown in Figure 5.21  and Table 5.3,  almost 
20% of  the women asked during the 1996 Eurobarometer survey, rated stress as the main 
risk factor for heart disease.  In Greece,  Sweden, and the Netherlands over 30% regarded 
stress as  a principal risk.  In comparison with other (known) risk factors,  stress was the 
second  most  frequently  mentioned  main  risk  factor,  after  smoking  but  ahead  of an 
unhealthy diet,  overweight, lack of exercise and  excessive alcohol  consumption (in that 
order). These results indicate that there is significant ignorance throughout the EC among 
women as to the main risk factors for heart disease.  This points to an area where public 
health interventions might be targeted. 
5.6  Cerebrovascular Disease (Stroke) 
Another major disease of the circulatory system is cerebrovascular disease (stroke). The 
risk of this disease for women increases with age, especially· after 65, in part  be~ause of 
increased  rates  of high  blood  pressure  among  older  women.  As  with  ischaemic  heart 
disease,  the  mortality· rates  for  stroke  for  women  under  65  years  have  declined 
significantly since 1970, dropping almost 43% to an average of 8.73  deaths per 100,000. 
All Member States have experienced declines, ranging from a high of  69% in Ireland to a 
low of 2% in Luxembourg (see Figure 5.22).  Among women under 65  y~ars, Portugal 
has the highest mortality rate (18.42 per 100,000) while France has the lowest (5.80 per 
100,000). 
As already mentioned, the highest mortality from stroke occurs among elderly women. As 
a result,  the mortality rates for all  ages, which include this age-group, are much higher 
than those  shown in  Figure 5.22.  As  shown in  Figure 5.23,  the average mortality  for 
women of all ages in the EC is 75.93 per 100,000. This rate varies from a high of 175.63 
per 100,000 in  Portugal to a low of 44.11  per 100,000 in France, which has the lowest 
rate in  the EC of both ischaemic heart disease and  cerebrovascular disease.  As was the 
case for younger women, mortality rates for all age-groups combined have declined since 
1970,  by  alm<?st  43%  at  the  EC  level.  However,  rates  have  actually  increased  in 
67 Luxembourg (10%) and in Greece (1%). In the other Member States, mortality rates have 
declined between 26% (in Portugal) and 60% (in France).  · 
The main risk factor for cerebrovascular disease is high blood pressure. Other risk factors 
include previous heart disease and/or stroke, diabetes, and excessive alcohol consumption. 
Smoking has also been linked with cerebrovascular disease,  although to a lesser extent 
than  with  ischaemic  heart  disease
34
.  As  with  that  disease,  healthy  life  styles  and 
appropriate health care can contribute to a reduction in female deaths, particularly among 
women under 65. 
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Table 5.1 
Perceptions of  which Gender Lung Cancer Affects More 
Women 15+ Years, EU 15 (1996) 
Yes  No  OK 
·A>  %  "'o 
82.9  7.8  9.3 
60.7  8.9  30.4 
58.8  8.8  32.4 
58.3  9.1  32.6 
56.8  8.6  34.7 
SS.4  11.0  33.6 
.54.0  10  .  .5  3.5 .  .5. 
53.9  12.2  33.9 
50.7  8.1  41.2 
50.3  13.4  36.3 
47.1  20.3  32.6 
45.4  11.7  42.9 
40.6  12.6  46.8 
36.8  17.1  46.1 
36.3'  29.8  33.9 
32.5  26.6  40.8 
22.6  28.9  48.5 
Source: Eurobarometer 44.311996 
*  Respondents were asked to indicate the exlent to which they agreed or disagreed with the following st.atement : "In {country) hmg canoec affe~U 
many more mc:u than women". Y  cs indicates that they agreed, no that they  disagreed. 
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Perceptions of which Gender is More Affected by He~  at n;sease* 
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• Respondents were asked to indicate the extent to which they agreed or disagreed with the following statement : "In 
(country) heart disease affects manv more men than women". Yes indicates that they agreed, no that they disagreed. 
Table 5.2 
Perceptions of which Gender  1is More Affected by Heart Disease* 
EU 15 All Women (1996) 
Yes*  No*  DK 
%  %  % 
81.2  9.1  . 9.7 
66.5  11.9  21.6 
66.1  7.9  26.0 
63.5  10.2  26.3 
60.7  5.6  33.6 
59.6  10.4  29.9 
58.8  17.1  24.0 
57.9  10.6  . 31.5 
57.8  11.9  30.2 
5.7.7  8.8  33.5 
57.5  8.3  34.2 
56.8  14.0  29.2 
55.8  20.0  24.2 
51.8  13.3  34.9 
51.0  9.7  39.4 
48.8  11.9  39.4 
43.8  13.8  42.4  . 
Source: Eurobarometer 44.311996  \ 
* Respondents were asked to indicate the extent to which they agreed or disagreed with the following statement : "In (country) heart disease affects many 
more men than women". Yes indicates that they agreed, no that they disagreed. 
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Table 5.3 
Perceived Main Risk Factors for Heart Disease (1996)* 
All Women, EU 15 
unhealthy  lack of  excessive 
smoking  diet  exercise  alcohol  stress  overweight 
OJo  OJo  OJo  %  OJo  % 
Portugal  52.5  15.6  3.0  7.6  8.3  8.7 
Spain  51.5  I 3 1  4.1  7.1  11.0  8.7 
France  51.2  12.4  5.2  10  12.6  7.6 
Ireland  45.1  13.0  6.7  3.0  15.0  14.2 
Greece  43.3  9.3  4.4  2.6  35.7  4.4 
Belgium  42.9  8.4  4.0  5.2  22.6  12.3 
EU 15  42.7  13.3  6.3  6.3  18.5  10.4 
Luxembourg  42.6  12.3  6.8  4.5  22.9  7.4 
Italy  42.3  13.4  3.3  5.6  24.6  9.3 
United Kingdom  41.9  17.6  6.2  2.4  12.1  14.0 
Germany W  38.7  10.9  9.6  7.4  19.2  11.9 
Germany E  38.1  7.5  9.2  8.5  25.2  10.1 
Sweden  35.5  9.8  8.2  2.8  30.7  11.6 
The Netherlands  32.4  16.9  8.4  7.0  30.9  9.1 
Austria  31.6  18.6  10.1  7.1  21.3  7.3 
Denmark  28.4  14.1  12.5  2.0  24.6  16.7 
Finland  22.3  30.0  7.4  7.6  14.5  15.1 
Source: Eurobarometer 44.3/1996 
•  Respondents were asked to indicated the main and the second risk factors for heart disease. 
82 
DK 
% 
4.3 
4.4 
1.0 
3.1 
4.0 
4.6 
2.8 
3.5 
. 1.4 
5.7 
2.3 
1.5 
1.6 
1.5 
4.1 
1.8 
3.0 Figure 5.22 
Cerebrovascular Disease Mortality (1992) 
Women 0-64 Years, EU 15 
SDR cerebrovascular diseases, 0-64 per 100,000 
Females 
SDR cerebrovascular diseases, 0-&4 .per 100,000 
Femakt 
Rar*ed by 1992 SCR 
·  W15 i 
POR11JGAL (I) t 
LUXEMBOURG (I) 
GA£ECE 
Fr-LAP«:: 
UNITI3)KNGOOM 
OEI'.NARK 
I:'  RS.AP«:: 
1! 
il  BELGI.AI(2) 
<J 
ITALY (3) 
AUS'TRIA 
GERMANY (4) 
I'EIHERLA NOS 
1  1971 
'1989 
'1991 
SPAN 
SWEDe; 
FRANCE 
• FRGb 1990 
~  -
Source- HFA  1996 
10 
= 
!~ 
i:.l9921 
~5  20  25  30  35 
...... 
Country 
EU 15 
PORTUGAL' 
LUXEMBOURG ' 
GREECE 
FINLAND 
UNITED KINGDOM 
DENMARK 
IRELAND 
BELGIUM' 
ITALY' 
AUSTRIA 
GERMANY• 
NETHERLANDS 
SPAJN 
SWEDEN 
FRANCE 
1 1971 
'lll69 
J  ~991 
• FRGt>1900 
Source- HFA  1996 
Figure 5.23 
Cerebrovascular Disease Mortality (1992) 
All Women, EU 15 
11192  %change 
sfnce 11:7 
1.7l  ·54.05 
18.42  ·30.25 
12.98  ·2.41 
12.12  ·32.85 
11.29  -64.11 
10.88  -55.70 
10.82  ·18.85 
9.77  -89.08 
8.92  -53.22 
8.88  -57.14 
8.41  -57.22 
8.17  -50.24 
8.08  ...-s_., 
7.30  -63.37 
6.97  ·49.82 
5.80  -84.81 
SDR C!!l :brovascular diseases, All ages, 
p<~r 100.~00. Female 
SDR cerebrovascular diseases.·.A.II ages. per 100,000 
Female 
RriB:lbyi99Zs::R 
EUIS ~  ••.. 
IU'!lU>AL (I) c 
GRf£CE 
LU<EM301..RG (I) 
FN..Af-1) 
ITALY (3) 
AUSTRA 
, 1971 
'191!9 
'11&1 
REI..A~ 
SPAN 
BELGI  •  .t.\{2) 
~RK 
/'£Tl'ERLANDS 
Swe::e.t 
FRANCE 
• FRGtJ 199) 
Source- HFA  /996 
so  100  150  200 
R;l1e 
0 197ol 
;.  1992 i 
250 
83 
Country 
EU 15 
PORTUGAL' 
GREECE 
LUXEMBOURG' 
FINLAND 
ITALY' 
AUSTRIA 
UNITED KINGDOM 
GERMANY' 
IRELAND 
SPAIN 
BELGIUM' 
DENMARK 
NETHERLANDS 
SWEDEN 
FRANCE 
1 1971 
2 1989 
] 1991 
'FRG to 1990 
Source- HFA  /996 
I 
1992  %  chanpe 
since 1970 
75.93  ·42.94 
175.63  ·26.34 
125.75  1.35 
101.82  9.85 
82.71  -51.54 
81.27  -35.24 
80.33  -49.92 
79.53  -45.16 
78.80  -49.33 
77.96  -51.26 
75.2:i  -41  39 
66.46  -52.30 
65.41  -33.57 
62.75  -42.36 
61.34  -30.30 
44.11  -59.68 6. · HEALTH DETERMINANTS AND HEALTH PROMOTION 
The major  causes of mortality  in  women were outlined  in  the previous  chapter  .. This 
chapter describes the major health determinants of  the diseases that affect women, which 
include risk factors, such as smoking, drinking, diet and weight, and physical inactivity. It 
· also discusses health promotion and disease prevention activities, such as cancer screening 
programmes. 
6.1  Smoking 
Tobacco smoking is one of  the leading causes of  morbidity and mortality in the European 
Conuriunity
1
.  It is  the major causative factor in an 'estimated 30% of cancers
2
,  including 
lung  cancer (85% of which  is  estimated to be caused by  smoking),  cancer of the  oral 
cavity (lips, mouth, tongue, throat), cancer of  the pharynx, larynx,  oesophagus, bladder, 
and the kidneys. Respiratory diseases, such as chronic bronchitis, emphysema, and asthma, 
are also attributable to and/or exacerbated by  smoking. Furthermore, smoking is a major 
contributor to cardiovascular disease, the risk of  developing ischaemic heart disease being 
approximately twice as high among smokers as among non-smokers
3
.  Passive smoking is 
also -considered a risk factor for a number of  diseases, in particular lung cancer. 
Besides the generic _risks  associated  with  smoking,  women  smokers  face  a number of 
additional  gender-specific  health  risks  because  smoking  can  influence  their  hormonal 
balance. Specifically, smoking may contribute to a reduction in fertility
4  5 and increase the 
risk  of early  menopause.  Furthermore,  it  is  a  contributory  factor  to  calcium  loss  and 
consequent osteoporosis in post-menopausal women.  Smoking when combined with. oral · 
contraceptive  use  may  also  appreciably  increase  the  risk  of developing  cardiovascular 
disease
6
.  Smoking  during  -pregnancy  has  been  associated  with  increased  risk  of 
spontaneous  abortion,  complications  of pregnancy  (e.g.,  bleeding,  placenta  praevia) 
stillbirth, premature delivery,  low birth-weight, and 'neonatal death.  It also increases the 
risk of sudden infant  death and· is  associated with  a number of other long-term  health 
consequences for the offspring (e.g., reduced lung capacity, increased infection rates)
7
. 
Traditionally,  a greater proportion of .nen than women  smoke.  The percentage of men 
who smoke (43%) in  the EC has  long been higher than the percentage of women who 
smoke  (28%)
8
.  How~ver, significantly  greater rates  of smoking  cessation  and  different 
patterns of smoking initiation among men have narrowed the gap between the two sexes 
in a riumber of  Member States (e.g., Finland, the Netherlands, Spain, Germany, Portugal, 
Italy, anJ Denrnark)
9 with the result that if current trends continue, female smokers could 
in a few years outnumber male smokers
10
. 
As can be seen from Figure 6.1 and Table 6.1, the percentage of women who smoke in 
most Member States is. around 25%. Denmark and Portugal are exceptions to this pattern 
with Danish women reporting a much greater percentage of smokers (42%) and Portugal 
a much smaller percentage (12%)
11
.  · 
Smoking typically is most frequent among women of  lower socio-economic status (except 
in  Portugal), among unemployed women,  and those with lower. educational attainment . 
. Smoking among adolescents is a matter of particular concern because evidence suggests 
84 that in this age-group the proportion of  daily smokers amongst women is approaching that 
ofmen
12
. Indeed in Denmark, more women than men smoke in the younger age-groups. 
Since tobacco-related diseases usually develop after smoking for 15-20 years or more, the 
results of  increasing smoking rates among EC women are only just beginning to be seen. 
Evidence  suggests  that  female  mortality  from  smoking-related  cancers  during  the  past 
decade  has  increased  in  all  Member  States,  except  Portugal  and  Ireland,  with  the 
Netherlands  having  the  highest  increase  (87%)  and  Belgium,  Denmark,  Germany  and 
France showing increases of over 40%
13
.  According to a calculation based on national 
vital  statistics,  the  highest  rate  of female  tobacC4)-related  mortality  is  in  Ireland  and 
Denmark, where it  was found  that in  1990,  16.2 and  15.3%,  respectively,  of deaths in 
women aged 35 years and older were attributable to smoking (see Figure 6.2 and Table 
6.2). This is more than 3-1/2 times the average EU rate (5.1%), but at least in Denmark's 
case this rate is· consistent with the.high rates of smoking among Danish women during 
the past four or five decades
14
. On the other hand, the same calculations found that France 
had very few  such  deaths,  and  Luxembourg,  Portugal and  Spain  had  none.  The latter 
result  is,  of course,  rather  unlikely  but  is  probably  an  artefact  of the  extremely 
conservative methods used to calculate smoking attributable death rates
15
. 
' 
6.2  Alcohol Consumption 
The relation between alcohol consumption and health is complicated.  Evidence suggests 
that there is  not a  straightforward linear relation, but rather that low levels  of alcohol 
consumption are associated with lower mortality while higher levels are associated with 
excess mortality  .. Alcohol abuse has been linked  to a variety of diseases  and  ~nditions 
resulting in increased mortality.  These include cirrhosis of the liver
16
,  aloohol  psychosis 
and alcohol poisoning
17
. It is also associated with raised blood pressure, stroke and heart 
disease
18  19
. 
In addition, alcohol consumption is also a risk faotor in a number of cancers, e.g., breast 
cancer
0
,  cancer of  the oral cavity, pharynx, l~  oesophagus, and pancreas
21
.  In several 
of these, there is a synergistic effect between alcohol consumption and tobacco smoking. 
Furthermore, alcohol abuse is  associated with threatening b'ehaviour,  domestic violence, 
occupational  and  road  accidents,  as  well  as  depression,  suicide,  and  parasuicide
22  23
. 
Finally, excessive alcohol intake by pregnant women may lead to foetal alcohol syndrome 
which can result in physical and mental abnormalities in their children
24
. 
Recent  evidence  suggests  that  the  health  risks  associated  with  alcohol  abuse  may  be 
greater for women than  for  men,  partly  because of differences  in  how they metabolise 
alcohoe
5
.  Despite  the  potential  importance  of alcohol  consumption  for  women,  there 
currently  exist  no  gender-specific  data  on  alcohol  consumption  at  EC  level.  Various 
studies provide some information,  but these are neither comprehensive nor comparabfe. 
Available evidence suggests that alcohol consumption among women has been risifig  in 
Finland,  Sweden,  Denmark,  ill(, and  the  Netherlands
26
.  Ir.  Denmark and  the  UK  this 
increase in alcohol consumption among women has  been accompanied by an increase in 
death rate from liver diseases (see Figure 6.3). 
Women still consume less alcohol than do men and they tend to drink less beer and spirits. 
However, some Member States, e.g., Sweden
27
,  have noted an increase in consumption of 
spirits by  wom~n. In addition, alcohol consumption by young women (aged 12-24 years) 
is also of concern in some Member States. For example, in the Netherlands women in the 
85 16-19 age-group constituted the highest percentage of heavy drinkers in  1993-1994
28
• 
Since the 1980s, Sweden, has reported a  significant increase in  alcohol consumption by 
women in the 12-24 age group
29
;  and them<. has set targets to reduce excessive alcohol 
consumption for those aged 15-16
30
• 
Public health initiatives in the Member States involve education policies on the effects of 
alcohol, the setting of safe consumption levels in units per week (typically 21  units per 
week for men and  14 per week for women)• 
31
,  and promotion of low-alcohol drinks. 
Recent EC legislation  on  alcohol  relate  to advertising  and  minimum  rates  of alcohol 
·  taxation
32
• 
6.3  Diet and Weight 
_ A  nutritious diet is fundamental  to good healtlt  In industrialised countries diet-related 
health problems tend to be caused by over-eating or earing the wrong types of  food. Over-
eating can lead to obesity whi~h in women is associated with increased risk of diabetes, 
. hypertension, ischaemic heart disease, cardiovascular disease, as well as increased risk of 
certain  cancers (including  cancer of the colon and  rectum, ·and,  for  women,  breast
33
, 
cervical, and ovarian cancer  )
34
• 
Figure 6.4 and Table 6.3 show the distribution of  underweight and overweight women in 
the EC according to body mass index (BMI)b. WHO defines women as beirig underweight 
when their BMI is between 18 and 20 and as being severely underweight when it is below 
18.  Women are defined as overweight with a BMI between .27  and 30 and as severely 
overweight with a BMI of 30 or more.  Thus, women of normal weight have BMis of 
between 20 and 27. Health risks increase considerably when the actual weight exceeds the 
desirable weight by more than 20% (or when BMI exceeds 27) and inr.rease rapidly with 
a BMI of 30 and ove?s. The average B~  for women in the EC, which is  2~, therefore 
· falis  within the -normal  range.  However, a  significant  proportion of women (20%) are 
overweight. A smaller proportion (15%) are underweight. 
Considerable differences exist within the EC. Greece and Portugal have the highest rates 
of obesity  (33.2  and  28.5% respectively),  while  France,  Denmark,  the  pre-unification 
Federal Republic of Germany, and Ireland have the lowest rates (15.5,  16.5,  16.5, and 
16.91'/o respectively). The BMI of  women from the former German Democratic Republic is 
higher than that of  women from the pre-unification Federal Republic of  Germany, as is the 
proportion of  overweight women (20 and 16.5% respectively). 
E-.ting the wrong types of  food may result in a number of  different health problems. A diet 
high·in saturated fat is associated with increased cardiovascular disease
36
,  wlile one low in 
fresh  fruit  and vegetables is  associated with increased  risk  of a  number of cancers,  in 
particular cancer of  the stomach, colon, rectum, and the intestines
37  38
• 
Probably owing to different agricultural and cultural traditions, eating patterns in the EC 
are characterised by a  north-south divide.  The ·northern EC countries have traditionally 
consumed higher quantities of animal protein and fat, while southern (Mediterranean) EC 
countries have had a diet high(er) in natural fibres due to higher proportions of  vegetables, 
a  The UK recently increased its recommended limits to 21 for women and 28 for men
31 
• 
b  BMI is calculated by dividing a person's weight (in kilograms) by her height (in meters)  squared 
(thus, BMI=kglm
2
), thereby creating a weight measure that controls for height. 
86 fruits, cereals, and polyunsaturated fats. However, these eating patterns are becoming less 
delineated with the greater flow of  food products within the EC resulting from the internal 
market. Sweden, for example, has adopted a more Mediterranean sty!e diet on a national 
level,  consuming  higher  proportions  of fruit,  vegetables,  cereals,  and ·low  fat  dairy 
products
39
• 
Although there are no recent (post-1970) gender-specific data at the EC level on dietary 
habits,  most Member States report that women eat more vegetables and fruits  than do 
men. 
Public health initiatives within the Eca include the highlighting of  the connection between 
healthy  diet  and  disease  prevention,  including  the  importance  of screening  tests  for 
cholesterol and diabetes for identified risk groups. In this context, it is surprising that, on 
an EC level, only 1  7% of  women recognised an  unhealthy diet as the second main (life-
style-related)  risk  factor  linked  to  heart  disease,  while  approximately  1  in  2  women 
recognised smoking as the main (life-style-related) risk factor. 
6. 4  Exercise 
Regular physical exercise is important for mental and physical well-being. Physical fitness 
reduces death rates from both heart disease and cancerw because of its ,lbility to reduce 
the effect of stress, maintain an optimum body weight, strengthen the heart and lungs, and 
reduce  the  risk  of heart  disease
41
•  Furthermore,  load-bearing  exercise  (e.g.,  waUcing, 
running) is particularly important for pre-menopausal women in order to minintise the risk 
of  osteoporosis in later life. 
J Jthough no gender-specific data on physical exercise e;-:ist at the EC level, it is generally 
accepted  that  women,  in  particular  elderly  women,  exercise  less  than  men  and  in 
insufficient amounts for optimal health benefits
42
. 
6.5  Health Promotion and Dtsease Prevention 
As already aoted, Article 129 of  the Treaty specifies that the EC is to ensure a high level 
of health protection by· means of health promotion and disease prevention.  A number of 
questions were included in t!1e  1996 Eurobarometer survey concerning the preventive and 
health promotion services that people receive. This survey also included s0me attitudinal 
questions to shed light on topics of frequent  debate,  such as  mammography screening. 
The  results  show wide  divergence between the  Member  States.  As  the  data  are  self-
reported, the results should be interpreted with care. 
6.5.1  Heart Check-Up 
As  discussed  in  Sections  5. 7  and  5. 8,  heart  disease  is  one  of the  major  sources  of 
morbidity  and  mortality  in  women,  and  early  detection  can  play  a  major  role  in  its 
prevention.  The Eurobarometer  survey  included  a  question  on  heart  check-ups  .. The 
results shown in Figure 6.5 and Table 6.4 indicate that about 22% of  women in the EC 
had  a  heart check-up in the past year.  Not surprisingly, the rate of heart  check-ups is 
highly age-dependent, with older women reporting more check-ups; 44% of  women aged 
a  Programmes on cancer and health promotion. 
87 I 
I 
65 and over had a heart check-up in the previous year, compared to only 10% of  women 
under 35.  · 
Considerable variation exists within the EC.  The highest  proportion of heart check-ups 
reported was in  Germany (both the former German Democratic  Repu~lic and  the pre-
unification  Federal  Republic  of  Germany)  and  Portugal  (35.3,  31.5,  and  32.6% 
respectively) while the lowest rates were reported in the Netherlands and Sweden (9. 7 and 
12.8% respectively). 
6.5.2  Cholesterol Testing 
Although  controversy  surrounds  the  issue  of the  desirability  of mass  screening  for 
cholesterol, 1 in 4 women in the EC repoits having had their cholesterol checked duting 
the previous year.  As in  the  case of heart  check-ups,  cholesterol  testing  is  very  age- · 
dependent, with almost 43% of  women aged 65 ·or over reporting having had a test in the 
previous year (see Figure 6.6 and Table 6.5). 
These results show large variation across the Member States, with Greece reporting the 
highest percentage (38.1%) of  women having had a cholesterol test in_ the previous year, 
and Denmark reporting the towest  level  (7.5%).  The variation is  even  greater among 
women  aged 65  and over where 67.9% of Greek women.report having had such a test 
compared with only 12.8% of  Danish women.  · 
6.5. 3  Diabetes Testing 
The incidence of non-insulin dependent diabetes mellitus (normally referred to as diabetes 
type IJ) has been increasing for the past several  decades
43
.  Women over age 40 are at. 
particular risk of the disease,  perhaps because of their higher rates of obesity following· 
menopause. Evidence suggests that approximately half of  all persons with diabetes type II 
are undiagnos~d  resuaing in  ~onsiderable preventable morbidity and mortality
44
. 
Figure 6. 7 and Table 6.6 show that just over 1 in 5 women in the EC had been tested for 
diabetes in the past year. While the rate is age-dependent, it is surprising that only 25% of 
women aged 40-64 years and 37% of  women 'aged 65  years and older have b'een tested  · 
for  diabetes.  As  obese  women  over  the  age  of 40  years  are  particularly ·at  risk  of 
developing diabetes type II, the rate of  diabetes testing in this group· was calculated. The 
results indicate that about 3go1o  of overweight women and 44% of severely overweight 
· women underwent testing for diabetes in the previous year. These results suggest a need, 
to increase diabetes testing in middle-age and older women, particularly among those who · 
are overweight. 
As was the case with cholesterol testing, significant variation exists across the Member. 
States. The former German Democratic Republic and the pre-:-unification Federal Republic 
of  Germany report the highest rates of  testing overall (3 8.1 and 3  3. 0% respectively), while 
Ireland and  Sweden report the lowest overall rates (7.9 and  11.2% respectively) (Table 
6.6). 
88 6.5.4  Osteoporosis Testing 
Age-related osteoporosis occurs more frequently  in women than in men  and  results in 
both  significant  morbidity  and  mortality.  Data from  the  1996  Eurobarometer  survey 
indicate that 17% of  women over the age of 50 years have had a tesr for osteoporosis in 
the past year. This percentage varies from a high of28% and 27%, respectively, in Austria 
and the pre-unification Federal Republic of Germany to a low of 5%  and 4% in Ireland 
and Finland, respectively (see Figure 6.8 and Table 6. 7). 
6. 5. 5  Cancer Screening 
. 
The  third  EC  action  plan  against  cancer  (1996-2000)  has  assigned  priority  to  early 
detection  and  screening of cancer.  The  objective is  to help  improve  and  increase  the 
possibilities of  early detection, in particular through the development and dissemination of 
effective  screening  programmes  and  appropriate  practices
45
•  For women,  two  specific 
cancer sites (breast and cervix)  have  been  subject to  screening practice for  almost two 
decades and proven effective when adequately set up (see below). 
Screening  services  are  only  as  effective  as  the  quality  of  the  service  itself 
Misinterpretation of: for example, cervical smear tests  has resulted in the need for recall 
of women for further assessment.  Indeed, the fact  tnat cancer screening results in some 
percentage of false  positive and  false  negative results  is  for  some  people an  important 
argument against such screening programmes. 
In the screening  programmes that  do  exist  effectiveness  is  strongly  influenced  by  the 
participation rate of  the targeted population.  A 60% participation rate \s acceptable, but 
75% (or graater) is desirable. Desirable rates are t;ypically only achieved in countries with 
sy:;tematic  scr~ni."lg  programmes  with  personalised  invitations.  Reasons  for  non-
participaticn include lack of access to screening facilities,  either because of geographic 
isolation or because of(low) socio-economic status, lack of  information, or lack of  female 
physicians
46  47
.  On this latter ;>aint,  results from the 1996 Eurobarometer su!Vey indicate 
that just over 36% of women in  the EC  prefer a doctor of the  same  sex.  Rates vary 
considerably across the Member States, with Dani-:;h, Finnish, and Irish women expressing 
the most preference for a female doctor and Sweden, Luxembourg, and the Netherlands 
expressing the least preference for a female doctor (see Figure 6.9 and Table 6.8}. 
6.5.5. r  Cervical Cancer Screening 
Cervical cancer may be detected by a Papanicolaou smear test available to women through 
outlets  such  as  GPs,  family  planning  clinics,  hospitals,  and  special  women's  clinics. · 
Assessment of  organised screening programmes shows a significant reduction in mortality 
from  cervical  cancer.  For  example,  studies  from  Finland  report  possible  mortality 
reductions of 50-80%
48
,  while Sweden reports actual  reductions of 34%
49
•  Overall,  the 
reduction in incidence of  and mortality from cervical cancer is estimated to be sufficient to 
justify mass screening programmes  5°. 
a  These data should be  interpreted with care because "osteoporosis examination" was not specificalJy 
defined in the survey. As a result, there is no guarantee that respondents' replies are entirely accurate. 
89  . . While facilities for smear testing exist in  all Member States, not all  of them have mass 
screening programmes• s
1
•  Cervical cancer screening is  organised on a national  level  in 
Denmark,  Finland,  Sweden,  the  Netherlands,  and  the  UK,  albeit  with  different 
recommended time inteiVals
52
. Denmark and Sweden, for example, call women for a test 
every three years, while Finland  and the Netherlands use five-year  inteiVals.  In the UK 
women can opt for either three- or five-year inteiVals. The statutory age for screening also 
varies between Member States with the lower age limit ranging from 18-30 years and the 
upper limit from 59-75 years.  Participation rates in these programmes range from  70 to 
83% of  the target population. 
On  an EC level  about 400/o of  all women aged 15  and over report having had a cervical 
· smear in the pr~ous  year (Eurobarometer, 1996). This varies from 16.5% among women 
aged 65  and over to about 4~%  among women aged 35-64 (see Figure 6.10 and Table 
6.9).  Considerable variation may  be obseiVed  across the Member  States as  well,  with 
Danish  and  German  (both  the  former  German  Democratic  Republic .  and  the  pre-
unification Federal Republic of Germany) women reporting the  highest  overan  rates of 
screening  (63.5,  53.2, and  52.3% respectively).  Ireland  and  Portugal report the lowest 
rates (15.8 and 22.3% respectively).  ·  · 
6.5.5.2  Breast Cancer Screening 
Breast cancer screening may be performed by physical examination of the breast or by a 
dedicated  x-ray  machine  (mammography).  For  decades  physical  examination  of the 
breasts, either by a doctor or other health worker (palpation) ·or by women themselves, 
has been promoted as a method of early  det~on. Palpation is  carried out fairly  often 
either as a separate examination or as part of a general medical  ~tion.  However, 
results have been disappointing with not ~y  additional tumours being detected at an 
early stage. Furthermore, because many younger women have benign breast lumps, many 
women  end  up  being  unnecessarily  referred  for  further  tests.  or  biopsies.  Studies 
concerning  the  effectiveness  of self-examination  have  been  equivoc3ls~.  Nevertheless, 
almost 40% of  all women in the EC report having performed a breast sdf-examinatior_ :,j  · 
the previous year (Eurobarometer,  1996).  The rates vary slightly across the age-groups, 
ranging from 29.8% among women aged 60 and over to 48.4% among women aged 50-
59 years (see Figure 6.11 and Table 6.10). Within the EC, the rates range frum a high of 
61.5% in the former GeWlan Detaocratic Republic to_ a low of 15.6% in Ireland. 
Breast car.cers detected through well organised screening among 50-69 year-old women  . 
are,  on  aver~ge,  identified  four  years  earlier  thar..  clinical  appearance,  re.rulting  in 
(gradually)  reduced  death  rates.  A!thcug.i.  screening  programmes  with  full  (100%) 
participation  can  almost  cut  in  half the  risk  of dying  .from  breast  cancer,  obseiVed 
participation rates of  around 70 percent reduce the risk of  dying by one third
54
.  As breast 
cancer is  detected  earlier  in  more  women  and  life  expectancy  increases  through  early 
treatment,  the . number  of follow-up  checks  for  cancer  will  necessarily  increase. 
Furthermore, as the breast cancer death rate drops there should be fewer  patients with 
distant metastases to be treated.  · 
a  Some of the autonomous communities in Spain have screening programmes and in Ireland a national 
programme is in preparation.  In  Germany women with health insurance are entitled to an annual 
check-up
51
. While screening has been shown to be effective in reducing mortality from breast cancer in 
50-69  year-old  women,  there  is  currently  insufficient  evidence  to  recommend  mass 
screening of  women aged 40-49 years
55
• 
More and  more  countries are debating the desirability of breast cancer mass  screening 
programmes.  Those countries with a national screening programme justify their decision 
by arguing that the expense of  the screening and the stress caused by false positive results 
or the knowledge that the disease is present are outweighed by the benefits of  reduction in 
advanced treatment and mortality due to tJlls disease. 
Much of  the debate about the so-calied mcdicalisation of  women has taken place without 
actual knowledge about women's feelings about mammography screening. In view of  this, 
the 1996 Eurobarometer survey asked women to indicate the extent to which they agreed 
or disagreed with the following statement:  · 
"Mammography screening, that is breast x-ray,  should be offered free  of 
charge to all women from a certain age because it may help reduce deaths 
from breast cancer."  · 
The results, shown in Figure 6.12 and Table 6.11, are unequivocally in favour of mass 
screeniug. Over 90% of  women in the EC agree (slightly or strongly) with this statement. 
Furthermore, and contrary to all the other questions asked in the Eurobarometer survey, 
there is only very limited variation in the range of responses between Member States and 
age-groups. 
Notwithstanding this consensus among women in favour of mammography screening, the 
situation  in  the  Member  States  varies  greatly.  Currently,  Finland,  the  Netherlands, 
Luxembourg  (for  women  on  social  security),  Sweden,  and  the  UK  have  national 
mammography  (mass)  screening  programmes.  Denmark,  France,  and  Spain  have 
mammography  screening  prograrn.lnes  in  some  areas.  In Germany,  women  with  health 
insurance are offered an  ~~1i.ial screening which, however, does not necessarily involve a 
mammogram. 
Participation rates in national screening programmes vary.  The Netherlands reports 79% 
participation, FiPland 89%, Sweden 70-85%, and the UK 72%
56
. 
Although many Member States do not have national screening programmes, this does not 
mean  that  women  in  those  countries  do  not  receive  mammograms  when  needed.  As 
shown in Figure 6.13 and Table 6.12, 38% of all  women aged 50-59 years and 28% of 
women aged 60-69 years report having had  a mammogram in  the previous  12  months. 
Given the variation in  national screening programmes, it  is  not  surprising that there are 
considerable differences between Member States in  the  percentage of women reporting 
having had a mammogram in the previous year. Sweden and Luxembourg- both countries 
'vith mass screer.lng programmes - report 71% and 64%, respectively, while Greece and 
Ireland report the lowest rates of mammography screening with rates of 3 1%  and  2%, 
respectively (for the 50-59 years old). 
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Table 6.2 
Smoking Attributable Mortality * (1990) 
Women 35+ Years, EU 15 
Total Mortality*  Percent 
Ireland  2.3/  14.2  16.2 
Denmark  4.41  28.8  15.3 
United Kingdom  48.0 I  320.0  15.0 
Austria  2.1/  43.3  4.9 
Netherlands  2.11  60.0  4.5 
Sweden  2.0 I  45.5  4.4 
Italy  10.11  256.0  4.0 
Germany  16.21  487.0  3.3 
Greece  1.31  43.2  3.0 
Finland  0.7 I  24.9  2.8 
Belgium  1.31  50.0  2.6 
France  2.21  246.0  0.9 
Luxembourg  0.0 I  1.8  0.0 
Portugal  0.0 I  47.0  0.0 
Spain  0.0 I  151.0  0.0 
EU total (15)  9.3/  1817.9  5.1 
Source: PetoR. Lopez AD. BorehamJ, ThunM, Heath C. Mortality from smoking in developed counm·es. 1950-2000 
Indirect estimates  from vital statistics. Oxford Medical Publications. Oxford, New York, T okyo,l994. 
•  Smoking related deaths over total deaths (in thousands) and in percentages;  data were calculated (see source) for two 
age-groups: 35-69 and 70+ years of  age and then added. (Estimates were computed for the year 1990). 
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Percent Reporting a Diabetes Tesfin Past Year 
Woinen 15+ Years, EU 15 (1996) 
age <40  age 40-64  ·age 65+  Total 
years  years  years 
Gernumy E  23.7  42.2  62.5  38.1 
GennanyW  14.2  41.7  58.0  33.0 
Portugal  17.2  39.5  48,5.  31.4 
Greece  12.8  33.3  47.6  26.8 
Luxembourg  24.7  30.5  45.1  30.0 
Austria  20.2  29.5  44.0  ~  27.3 
Finland  16.1  29.5  37;8  26.1 
EUlS  12.5  25.1  36.6  21.6 
Italy  7.5  22.2  34.5  18.5 
France  15.2  1'9.8  34.9  19,6 
Spain  7.3  19.2  30.1  15.4 
Belg~urn  10.7  19.9  23.2  1~.3 
Denmark  10.4  14.6  24.4  14.5 
United Kingdom  13.3  15.8  19.5  15.4 
Sweden  5.8  12.1  21.4  11.2 
The Netherlands  10.4  13.4  15.2  11.9 
Ireland  5.8  7.8  15.5  7.9 
Source: Eurobarometer 44.3/1996. 
Figure 6.8 
Percent Reporting an Osteoporosis Examination in Past Year 
Women 50+ Years, EU 15 (1996) 
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Percent Reporting an Osteoporosis Test in Past Year 
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Women 50+ Years, EU 15 (1996) 
50+  50-64  65+  Total 
yean  years  yean 
27.5  28.9  25.9 
26.7  27.0  26.4 
22.8  18.8  29.5 
19.7  18.2  21.7 
•, 
19.5  24.5  14.3 
19.2  19.2  19.4 
18.5  20.7  16.2 
16.8  16.7  17.2 
1·+.1  11.0  18.3 
12.6  10.5  14.9 
12.3  19.4  7.1 
11.6  12.2  10.6 
10.3  8.5  15.6 
5.7  5.3  6.1 
5.5  3.5  8.0 
4.5  4.7  4.2 
4.4  2.7  6.1 
Figure 6.9 
Pucent Preferring Women Doctors* 
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• Respondents were asked to rate the extent to which they agreed/disagreed with the following st.atanart :" I would prefer to coosult a 
doctor of  my awn sex for my hearth problems" The  tables shows the distribution of  responses to this statement  · 
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Percent Preferring Women Doctors* 
Women 15+ Years, EU 15 (1996) 
disagree  disagree  agree  agree  agr£:e 
strongly  slightly.  uncertain  slightly  strongly 
Denmark  16.1  21.8  2.0  25.1  . 34.9 
Finland  8.6  21.4  18.8  30.0  21;2 
Ireland  10.0  22.8  18.7  21.7  26.8 
GermanyW  10.8  24.3  22.2  27.7.  15.0 
Italy  21.7  . 6.2  . 31.2  21.1  19.9 
Gennany E  12.6  26.8  21.1  23.1  16.5 
United Kingdom  12.5  29.7  18.8  21.0  17.9 
Greece  15.7  16.5  30.2  23.6  14.1 
Austria  17.4  20.9  25.2  20.7  15:8 
EU15  16.7  22.3  25.4  21.0  14.6 
Spain  9.7  30.1  25.7  23.9  10.6 
Portugal  10.5  26.2  33.3  21.3  8.7 
france  24.0  21.6  31.4  14.2  8.8 
Belgium  15.9  34.4  27.6  15.0  7.1 
The Netherlands  45.8  15.3  17.9  8.9  12.1  . 
Luxembourg  19.7  31.0  29.7  13.2  6.5 
Sweden  15.7  25.3  39A  13.1  6.4 
Source: Eurobarometer  44.311996 
•  Respondents .were asked to rate the extent to which they agreed/disagreed with the following statement:" I would prefer to. 
consult a doctor of  my own sex for my hearth problems" iThe tables shows the distribution of  responses to this statement. 
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. Percent Reporting a Cervical Sme.ar Test in Past Year 
Women 15+ Years, EU 15 (1996) 
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Percent Reporting a Cervical Smear Test in Past Year 
Women 15+ Years, EU 15 (1996) 
5-34  35-64  65+  Total 
years  years  years 
Denmark  51.8  73.2  58.1  63.5 
Austria  49.3  60.9  22.0  50.2 
France  55.2  60.4  21.2  53.2 
GennanyE  55.7  58.1  27.3  52.3 
Finland  38.0  55.1  12.8  40.6 
GermanyW  38.0  53.2  18.0  41.4 
Luxembourg  42.5  52.2  18.0  42.8 
Belgium  41.6  49.4  20.1  41.0 
EU IS  37.3  45.9  16.5  37.7 
Greece  24.4  43.0  15.5  31.9 
Italy  22.2  40.3  15.5  29.1 
United Kingdom  41.6  38.0  8.6  33.3 
Sweden  26.7  36.8  11.2  28.8 
The Netherlands  20.1  32.2  15.2  26.4 
Spain  29.3  31.3  12.9  27.2 
Portugal  23.2  27.3  7.2  22.3 
Ireland  14.4  21.5  1.4  15.8 
Source: Eurobarometer  44.311996 
Figure 6,11 
Percent Reporting a Breast Examination by Hand in Past Year 
Women 15+ Years, EU 15 (1996) 
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Percent Reporting a  Breast Examination by Hand in Past Year 
Women 15+ Years, EU 15 (1996) 
15-34  35-49  50-59  60+  Total 
years  years  years  years 
GennanyE  5402  71.5  .  7405  5008  61.5 
Denmark  41.1  51.5  64o7  6208  5208 
Austria  55.4  5907  6207  3205  5207 
Luxembourg  4508  6603  7607  2703  . 5203 
. GennanyW  4806  6403  6301  38.4  5200 
France  4203  5009  5802  39.4  4608 
Belgium  3603  5807  5000  2700  4102 
EUlS  32.4  47.0  48.4  29.8  37.9  ° 
Finland  2401  .  4806  5408  3306  3706 
Sweden  20.4  '  3807  4403  3709  3302 
Spain  2708  3806  3602  21.0  29.9 
·Italy  2001  38.4  3,707  23.2  2800 
The Netherlands  16.3  39.4  33.3  2600  2709. 
United Kingdom  2008  34.3  3707  18.8  2508 
Portugal  1903  3508  3405  1800  2408 
Greece  1509  2906  36o5  1105  21.4 
Ireland  11.9  2208  2202  905  1506 
Source: Eurobarometer 440311996 
Figure 6.12 
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Finland 
Sweden 
France 
The Netherlands 
Spain 
Italy 
Greece 
EU 15 
Ireland 
Luxembourg 
Denmark 
Germany E 
Portugal 
Belgium  , 
Austria 
Germany W 
0% 
ranked by age 15+ 
Women 15+ Years, EU 15 (1996) 
20%'  40%  60%  80%  100% 
age 15+ 
D 
age 50-59 
EU 
average 
Source: Eurobarometer 44.3/1996 
106 Xab.le. 6..ll 
Percent Favouring Mammography Screening 
Women 15+ Years, EU 15 (1996) 
15-34  35-49  50-59  60+ 
years  years  years  years 
Finland  97.6  98.6  98.6  97.5 
Sweden  97.i  96.8  98.9  93.1 
France  95.4  93.0  96.9  95.7 
The Netherlands  92.8  97.0  91.2  98.6 
United Kingdom  94.8  96.6  94.3  94.0 
Spain  96.5  96.1  98.6  88.7 
Italy  93.8  91.1  93.5  86.8 
Greece  92.1  96.2  93.2  82.0 
EU 15  91.3  91.7  93.0  87.4 
Ireland  91.6  89.7  90.9  84.8 
Luxembourg  90.9  89.1  90.3  82.5 
Denmark  88.1  89.1  90.6  85.8 
GermanyE  86.4  85.7  90.4  90.3 
Portugal  91.3  90.0  79.3  86.0 
Belgium  87.9  87.2  87.1  86.9 
Austria  82.3  88.3  90.7  71.7 
GermanyW  81.1  85.0  88.2  73.2 
Source: Eurobarometer 44.311996 
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Percent Reporting a Mammography in the Past Year 
Women 15+ Years, EU 15 (1996) 
<40  40-49  50-59  60-69  70+  Total 
years  years  years  years  years 
Sweden  2.4  30.3  70.5  57.4  22.4  27.9 
Denmark  11.0  34.4  51.2  57.4  45.5  3I.I 
The Netherlands  6.1  16.5  50.9  55.6  15.8  18.4' 
Luxembourg  13.9  47.0  64.3  36.4  20.0  28.3 
Finland  2.4  11.8  58.3  33.7  9.1  17.8 
Austria  19.1  41.1  57.3  27.1  19.3  '  28.9 
United Kingdom  2.6  10.5  40.0  32.5  3.2  12.9 
France  6.0  23.9  34.4  32.8  22.9  18.4 
EU15  8.1  24.6  38.0.  28.4  11.9  18.1. 
GermanyW  14.8  30.4  37.4  26.1  ll.8  21.8 
Portugal  10.7  21.7  35.6  22.5  10.2  . 18.0 ·. 
Spain  12.6  32.5  .  31.9  24.3  3.9  18.8 
Germany E  14.2  25.5  31.2  22.8  16.0  20.7 
Italy  3.4  27.0  . 36.0  . 19.0  9.4  15.1 
Belgium  11.0  31.2  32.2  16.7  10.5  17.2 
Greece  3.2  19.3  30.6  14.8  . 5.1  12.0 
Ireland  2.7  10.1  1.9  6.8  4.4  4.6 
Source: Eurobarometer 44.311996 
108 7.  SPECIAL ISSUES IN WOMEN'S HEALTH 
This chapter describes selected issues in women's health of importance to public health 
endeavours at both Community and Member State level. They have been chosen to reflect 
health  concerns for  women  at  different  stages of their  lives.  Thus,  for  young women 
eating disorders and IDV/  AIDS are discussed. For women of  childbearing age the focus is 
on  family  planning  and  abortion  issues,  and  for  elderly  women  menopause  and 
menopause-related  health  issues  (e.g.,  osteoporosis and  hormone  replacement  therapy 
(HRT)). In addition to these issues, violence against women is  discussed because of its 
importance to women of  all ages. 
It should be pointed out that despite the importance of  these issues, national statistics are 
scarce. Furthermore, existing data are of  limited comparability because of differences in 
definitions and/or data collection methods.  This chapter should therefore be seen as an 
attempt  to  highlight  important,  emerging  health  issues  for  women,  rather  than  as  a 
comparison of  these aspects of  the state of  women's health in the EC . 
7.1  Eating Disorders 
The  eating  disorders  bulimia  and  anorexia  nervosa,  which  occur  primarily  in  young 
women, are associated with considerable morbidity and even mortality. There is currently 
no  national  public  health  policy  on these issues  anywhere  in  the EC,  and  no  national 
statistical data are available on their incidence and prevalence.  Various estimates of the 
incidence  of bulimia/anorexia  nervosa  indicate  that  they  are  increasing  in  the  EC. 
However, with the greater media attention given to them,  it  is  impossible to determine 
whether  the apparent  increase  is  real  or only  the  result  of greater  awareness  of the 
problem.  An additional  difficulty  in  obtaining  reliable  data on the incidence of eating 
disorders is that the victims often tty to hide their disorder(s). 
Estimated  incidence  rates  for  these  eating  disorders  vary  considerably.  One  source
1 
estimates the incidence of anorexia nervosa in western countries to be nearly 1% among 
women aged  14-29.  However,  other studies  have  reported much  lower rates,  ranging 
from 0.45-per 100,000 in Sweden
2 to 8.1  per 100,000 in the Netherlandsa 
3
,  with the UK 
reporting rates of 0.66-3.77 per 100,000
4
.  Needless to  say it is  impossible to determine 
which  estimate  is  the  most  accurate.  With  respect  to  bulimia  nervosa,  estimates  for 
Western countries put the incidence at 1-2% ofwomen aged 14-45 years
5
.  Estimates from 
individual studies vary considerably from a low of 11.4 per 100,000 in the Netherlandsb 
6 
to a high of3-4% in Sweden and Germany' 
8
. 
As already noted, anorexia and bulimia nervosa are associated with significant morbidity 
and mortality. In particular suicide and suicide attempts are frequent. Unfortunately, there 
is little information about the actual rates of  morbidity and mortality from these disorders, 
because  other conditions are  often listed  as  the direet  cause of death (or illness).  For 
example,  suicide from depression,  or heart failure,  both frequent  sequellae of anorexia 
nervosa, are often given as the cause of  death when anorexia nervosa would be equally (or 
more) correct. One study estimates a mortality rate of 6% for anorexia nervosa and 3.1% 
a  In this study, 8.3% of  the sample population were men. 
b  In this study, 3.5% of  the sample population were men. 
100 for  bulimia  nervos~t In 'addition,  many  women  suffer  from  partial  anorexia/bulimia 
syndrome  or other abnormal  eating  styles,  which  pose a  health  risk- and  put  them  at · 
elevated risk for full eating disorders.  ·  · 
.  . 
·The causes of  eating disorders are unclear, although some blame, at least:· in part, society's. 
obsession with body weight and appearance. Research.suggests that teenagers and young 
women are particularly concerned about their weight and this may be  a reason for the 
higher incidence. of eating disorders in these age-groups. For example, a 'Belgian study
10 
found adolescent schoolgirls to be preoccupied with body weight, even when they had  .. an 
ideal  body  mass  index,  cau~ing them  to  adopt  a  restricted . eating  style  which  was 
considered· a risk factor for developing eating disorders.  Similarly,  a Dutch ~dy  found · 
that 41% of  the sample's schoolgirls considered themselyes too heavy, 33% were dieting,  . 
· 11% were suffering from  some form of  eating disorder, and  1.5% were suffering from 
bulimia/anorexia nervosa 
11
'.  .  .  . 
The .  findings  from these and  similar  studies 
12  are confirmed ·by the results of the· 1996 
Eurobarometer survey. As indicated in Figure 7.1 and Table 7.1, about 1/3 ofEC women 
ag'ed  15-24 report dissatisfaction with their body weight,  and about ·25% report having 
been on a diet in the previous year (see Figure 7.2 and Table 7.2). Considerable variation 
exists  between the Member  States,  With  Greek .woinen  reporting the  highest  level  of, 
dissatisfaction-with their weight and Irish women reporting_the lowest, perhaps reflecting, 
at least in part, differing body mass distributions (see Section 6.3). As shown in Figure 
7.3,  satisfaction  with  one's  weight  is  highly  correlated  with  body  mass.  Women 
considered severely overweight (i.e:, those with BMI of  30 and over) are far more likely · 
to report being unhappy with their weight than severely underweight women (i.e., those 
with a BMI ofless than 18).  · · 
Treatment  for  eating  disorders  includes  nutritional  counselling,  psychotherapy,  family 
. therapy (recommended for anorexia nervosa),  and  cognitive therapy (recommended for 
bulimia  nervosa).  MedicaVpsychiatric  help  is  usually  obtained  through· hospitals  with 
specialist  out-patient  programmes~ in-patient  care being  limited to instances where the 
disorder is life-threatenmg
13
•  Specialist  clinics  have  been  established  in  some ·Member 
· States (e.g., Sweden, Finland, Belgium, UK) but demand for treatment exceeds supply. 
7.2  HIV/AIDS and Women's Health 
Infection with Human Immunodeficiency Virus (HIV) and. Acquired Immune Deficiency 
Syndrome (AIDS) is an important health issue for young women. Since the identification 
ofthe first AIDS cases in the EC in the early 1980s, the prevention ofiDV has become an 
important- public  health  concern.  However,  because  AIDS . first  became  wide-spread 
.  among gay and bi-sexual men, AIDS has. only recently come to be seen as a pmblem for 
women as well. By 30 September 1996, 167,021 persons had contracted AIDS in the 'EC, 
of whom 27,355  (17%) were women (see Tables 7.3 and 7  .4•)
14
.  Among women, the 
majority (52%) were intravenous (IV) drug users.  While the incidence of AIDS  among 
gay  and  ·bi-sexual  men  appears  to  be  stabilising,  the  rate  of transmission  in  the 
heterosexual population (both male and femate) is still increasing. Evidence suggests that 
a  The total in the two tables are not identical although they come from tJ;le  same source
14
•  While no · 
explanation is provided, the discrepancy is likely to be due to missing data on the sex of the reported 
ca5e(s) in Table 7.3.-
110 in the EC the majority of  cases of heterosexually acquired IDV have resulted from unsafe 
sex with HIV-positive IV drug users
15
,  and that the majority of  babies born IDV-positive 
have  acquired the virus  through perinatal  (vertical)  transmission  (i.e.,  from  mother to 
child) from an IV drug-using mother or a mother with a partner at risk. 
It should be noted, however,  that· the main transmission routes of mv in women vary 
somewhat between Member States (see Figure 7.4). In Spain, Italy, Portugal, and Ireland, 
for example, IV drug users account for the largest share of  AIDS cases, while in Belgium 
heterosexual transmission is the main route. 
Owing to the higher prevalence of  HIV  I  AIDS among men, knowledge about the natural 
history of ffiV in women is  relatively limited.  It is  clear,  however,  that they  are more 
vulnerable to the virus (as well as to other sexually transmitted diseases) than are men. In 
other words, it is  easier to transmit the mv virus from men to women than vice versa. 
Furthermore, women are frequently diagnosed at a later stage, because of a general lack 
of recognition of their symptoms.  Sexually-transmitted reproductive tract infections have 
also been identified· as associated risk factors for the spread of  HIV 
16
. 
In ad.dition, women have other difficulties in safeguarding themselves from infection. They 
are in  a weaker position to ensure safer sex,  whether in  stable,  casual,  or commercial 
sexual relationships, than are men.  At the same time, it is often assumed that they should 
take  the ·responsibility  for  using  condoms.  Trends  show  that  women  and  men  have 
changed  their  sexual  behaviour;  they  use  condoms more often and  have  reduced  their 
number of partners.  However, unsafe  sex practices continue.  Prostitutes face  particular 
risks of infection, though contrary to public perception, prostitution does not appear to 
have p!ayed a significant role in the transmission ofHIV in the EC
17
,  indicating the use of 
safer sex practices  in that group, encouraged by preventive interventions. 
Notwithstanding the risks faced by women, preventive interventions aimed at women have 
in  general been limited.  Either women have been targeted indirectly  as  part of general 
campaigns for  the whole  population,  or there have  been particular actions targeted  at 
certain  groups,  notably  IV  drug  users  and  sex  workers.  More  efforts  are  needed 
specifically tailored to women, and particularly young women who have, or are likely to 
become part of  the group with, the highest mv  incidence. 
7~3 Family Planning 
One uf the most important questions for women during their reproductive years is family 
planning. Most women feel that in order to have control over their lives, they must be able 
to control their fertility with regard to the number and spacing of their children, and they 
must be able to express their sexuality without fear of unwanted pregnancy and sexually 
transmitted  diseases  (STDs).  Availability  of contraceptives  and  abortion  are  therefore 
important issues. 
Widespread  availability  of effective  contraceptives  have  contributed  to  rapidly  falling 
fertility  rates in  the EC.  Since  1970, fertility ·has  declined  in  all  Member States,  except 
Finland and Sweden where fertility rates have increased slightly (see Table 7.5). Data on 
contraceptive use are  not  available  in  Greece,  Ireland,  and  Luxembourg,  however,  the 
majority ofMember States report contraceptive use rates between 71  and 81%. Portugal 
and Spain report rather iower rates, 66 and 59%, respectively. 
111 There are no data on contraceptive use among teenagers, but it  is known that teenagers 
are less likely than the adult population to use contraception for a variety of  reasons. They 
may be inhibited by ignorance, by fear of  parental discovery of  their sexual activity, and by 
a  lack of access to contraceptives, etc.  These factors  contribute to the relatively  high 
teenage birth rates, which despite recent declines, continue in the EC (see Table 7.5). 
The following methods of  contraception are available in the EC: natural methods (e.g., the 
rhythm· method,  coitus  interruptus/withdrawal),  hocmonal  (e.g.,  birth  control  pills,. 
injectable/transdermal  absorption),  barrier  methods  (e.g.,  male  and  female  condoms, 
diaphragm, cervical cap, intra-uterine devices (IUDs)), surgical techniques (e.g., male and 
female sterilisation), and post-coital contraception (i.e., the morning-after pill).  The most 
widely used contraceptivesare birth control pills, followed by conc\Pms. Use of  condoms 
has increased as a result of  efforts to prevent the spread oflllV
18  19
. 
Choice of  contraceptive method is likely to be influenced by availability, cost, and access, 
national  policies,  physical  access,  culturai  and  religious  considerations,  health  status, 
partner preferences, and socio-economic status. Another factor influencing choice are the 
health  risks  and/or  side:..effeets ·associated  with  a  contraceptive method.  For example, 
·  hypertension and increased thrombosis risk associated with some birth control pills,  and 
increased risk of  pelvic inflammatory diseases associated with lUDs, make these methods 
unacceptable to some women. Choice of  method is also likely to change over a woman's 
. fertile life.  Younger women may favour the use of birth control pills or condoms, while 
IUDs and surgical sterilisation may be preferred by older women. 
Family  planning  advice  is  readily  available  in  all  Member States from  doctors,  family 
planning  centres,  maternity  clinics,  and  municipal  health centres,  however,  cost varies 
• considerably. In some Member States (e.g., Finland, Italy, and the UK) contraceptives are 
provided free of charge
20  21
,  while in others (e.g., Ireland, Germany) certain groups, such 
as  the  poo~
2  or the  young
23  are  targeted.  Some Member  States  (e.g.,  Finland,  the 
Netherlands, Sweden, and the UK) provide family planning centres especially for sexually 
active teenagers
24
. 
7.4  Abortion 
Improved family planning programmes have reduced the humber of  unwanted pregnancies 
but  have  not  totally  eliminated  them.  As  a'  result,  the  demand  for  induced  abortion 
persists,  not  least  among teenagers
25
.  Reasons for  seeking  abortions include failure  of 
contraceptive method,  completed family  size,  pregnancy as a  result of rape,  confirmed 
deformation of  the foetus, health risk to the mother, and· socio-economic circumstaJ!ces. 
l 
Abortion  is  permitted,  under varying  criteria/conditions,  in  aU  Member  States  except 
Ireland and Northern Irelanda.  Since 1995 health care professionals in Ireland may inform 
their clients about legal abortion services within the EC, but only within the context of  full 
counselling on all available options and without advocating abortion.  The right for Irish 
women to travel within the EC to procure an abortion was established in 1992.  · 
a  Abortion is not available in Ireland However. it ~hould  be  noted that the Irish Supreme Court has 
ruled that an abortion would be permissible where there was a real and substantial threat to the life of 
the mother which could not be obviateU by aily other means. The Abortion Act of 1967 which applies 
to  England,  Scotland,  and Wales  was  not  extended to  Northern  Ireland where  abortion  is  only 
permitted when the life of the mother is threatened 
112 The criteria for obtaining an abortion differ among the Member States that permit it.  All 
include specific time limits which generally allow abortion to be performed within the first 
trimester, but only to a  limited extent in  the second trimester.  Pre-abortion counselling 
with emphasis on alternative options and a period of  reflection is mandatory. in all Member 
States. Some Member States also specify that a health professional may refuse to perform 
an abortion because of  moral objections. Recently, some Member States (Spain, Germany, 
and France) seem to have been liberalising their abortion policies,  although not without 
controversy, while others (Italy and Belgium) have been trying to tighten theirs
26
• 
Abortion rates per 1000 women vary across the EC (see Table 7.6). The highest rates are 
in Sweden (18.3  per 1000 women), Denmark (14.3 per 1000 women), and France (13.0 
per 1000 women). Italy, the Netherlands, and Spain report substantially lower rates:  8.6, 
6.0, and 5.4 per 1000 women, respectively. Another frequently reported abortion statistic 
is the ratio of  abortion to 1000 live births. Not surprisingly, this ratio also varies within the 
EC, with the highest ratios reported in  Sweden, Italy,  Denmark,  France,  and the UK
27
, 
and the lowest in the Netherlands, Luxembourg, and Spain (see Table 7.6). The ratios in 
the latter countries are only one third of  those in the former group. 
CompFcations  associated with abortions  done under good medical  conditions  are  very 
rare. One study estimates the mortality rate for legal abortions before 8 weeks to be 0. 5 
per  100,000
28
.  This  compares  with  a  maternal  mortality  rate  of 7  per  100,000  for 
childbirth (see Section 3.3). 
Identification of  trends in abortion over time is complicated by a dearth of  data and lack of 
comparability. However, inspection of the data from the UK, the Netherlands, and Spain 
seems to indicate that there may be a typical pattern of  development following legalisation 
of  abortion in a Member State: first the abortion rate increases,  oft~n substantially, then as 
time passes the rate stabilises and may even decrease. 
7.5  Menopause 
Menopause  - literally  the  cessation  of monthly  menstruation  - signifies  the  end  of a 
woman's fertile  period but usually refers to the extended period (20 or more years)  in 
which a woman's body adjusts to a lower hormonal climate, before and after the end of 
menstruation.  The average age at menopause is  50-52 years, thus women in the EC can 
expect to live at least one third of  their lives after menopause. 
The  effect  of menopause  on  women's  health  varies.  Estimates  indicate  that  75%  of 
menopausal  women  experience  some  problems  or discomfort,  but  only  10-20%  seek 
~edical help
29
. Short-term effects of  menopause include vasomotor symptoms (hot flushes 
and night sweats), genito-urinary symptoms, and mood swings.  These symptoms may be 
attributed  to  the  effect  of  declining  hormone  (oestrogen)  levels  associated  with 
menopause. 
The increasing longevity of  women in the EC has intensified the debate about the possible 
long-term consequences of menopause.  Although there is  currently no proof of a causal 
relation between post-menopausal hormone levels and post-menopausal health, morbidity 
statistics reveal increased incidence of cardiovascular disease  and  osteoporosis in  post-
menopausal women. 
113 7. 5.1  Osteoporosis and Cardiovascular Disease 
Age-related osteoporosis occurs in both women and men, but is greater in women because 
of the accelerated bone loss that  occurs in  women during and  after menopause.  Post-
menopausal osteoporosis Is  a cause of concern throughout the EC because of the high 
incidence  of bone  fracture,  especially  hip  and  vertebral  fracture,  which  leads  to 
considerable  mortality,  morbidity,  reduced  mobility,  and  decreased  quality  of life. 
Research suggests that osteoporosis is  increasing.  A Greek study estimated that  90/o  of 
women over 45  years have symptoms of osteoporosis
30
•  A Finnish study calculated that 
women aged 50 and over have nearly 40% chance of sustaining an osteoporotic fracture 
during their life time
31
.  Other studies show that hip  fractures are associated with a 20% 
mortality  during  the  first  year  and  40%  during  the  three  years  after  the  fracture. 
Furthermore, more than half of  those with hip fractures never regain full·mobility
32
. 
Preventive initiatives have focused on ways to maintain quality of  life  into old  age and 
methods to reduce the costs associated with osteoporosis. There are currently no national 
osteoporosis screening programmes in the EC, although local screening facilities exist in 
most  countries.  Further  research  is  needed  to  determine  the  cost-effectiveness  of 
prevention methods,  which include primary prevention involving increased  exercise and 
greater  calcium  consumption  among  teenage  and  pre-menopausal  women;  secondary 
prevention emphasising  early detection  (and treatment) through  screening;  and  tertiary 
prevention,  which  typically  involves  accident  management  an.d  rehabilitation  of 
osteoporotic women. 
Cardiovascular disease has long been regarded as a disease of  men primarily because of  its 
low incidence in pre-menopausal women Among women under 50 the incidence is  only 
one quarter of  that among similarly aged men. However, the risk of  cardiovascular disease 
increases significant as women age.  By the age of 60, ·the incidence has risen to half that 
of  men
33
. When looking at women across their entire lives, cardiovascular disease emerges 
as  the  primary  cause of death.  Furthermore,  with  women's increased  longevitY,  it  is 
rapidly becoming an iniportant sourr.e of  morbidity throughout the EC. 
7.5.2  Prevention and  Symptom Control 
Research into the causes of  and treatments for osteoporosis and cardiovascular disease in 
post-menopausal  women  continues  in. many  Member  States.  Since  the  1980s,  many 
doctors have begun to recommend hormone replacement therapy (HRT) because of its 
potential for  preventing both osteoporosis,  cardiovascular disease,  and,  as  documented 
recently, Alzheimer's disease
34
.  However, the debate about the relative costs and benefits· 
of HRT  is  far  from  ~ettled.  Precise  rates  of HRT  usage  in  Member  States  are  not 
available, but estimates range from 2% in  ltal~
5 , 4% in Spain
36
,  15% in the Netherlands
37
, 
20% in Austria
38 and Sweden
39
, to 56% in Finland
40
. 
Evidence suggests that HRT use is associated with higher socio-economic status and city 
residence
41
.  More  educated  women  are  also  more  likely  to  use  HRT,  suggesting  that 
information  about the  potential  benefits  (and  side effects)  of HR. T  may  be  insufficient 
among  the general  population.  To  address  this  issue,  the  1996  Eurobarometer survey 
asked women whether they felt well (or poorly) informed about HRT. The results appear 
in  Figure 7.5 and Table 7.  7  which  show that  61% feel  insufficiently  informed  about 
HRT. When analysed by age-groups, this conclusion holds although on women aged 50-
64  years  appear  slightly  better  informed  than  women  of other ages.  This  is  perhaps 
114 understandable as this is the age-group for whom HRT is particularly relevant. Figure 7.5 
also reveals considerable variation between Member States. Portugal, Ireland, Spain and 
Greece  report  the  highest  percentage  of poorly  informed  women  while  Finland  and 
Luxembourg  report  the  lowest,  to  some  extent  mirroring  the  usage  rates  in  these 
countries.  Altogether these results clearly point to the need  for more (or better) HRT 
information in the EC. 
7.6  Violence against Women 
Violence against women - defined by the UN General Assembly as "any act of gender-
based .violence that results in,  or is  likely to result in,  physical,  sexual or psychological 
harm  or  suffering  to  women,  including  threats  of such  acts,  coercion  or  arbitrary 
deprivation of liberty,  whether occurring in  public  or in  private  life"
42
- is  an  issue of 
growing concern in the ECa 
43
• Owing to the lack of  national statistics on the subject, it is 
impossible to determine whether the perceived increase in violence against women reflects 
a true increase, or whether it  is  due to a higher level of reporting because of a greater 
awareness and acceptance of  the problem. 
Violence against women, which was initially seen as a human rights concern, has gradually 
been recognised as. a public health issue. Indeed, the European Women's Health Network, 
established in Vienna in 1994, included violence against women as one of 6 major health 
concerns.  Although  violence  against  women  is  known  to cut  across  socio-economic, 
cultural, religious,  and racial boundaries, there is  concern that some groups of women, 
such as the elderly, migrants and poor women, may be especially vulnerable. 
The causes of violence against women arc unclear, but alcohol and drug abuse, poverty, 
and overcrowded conditions are factors known to exacerbate violent attacks on women
44
. 
It has also been suggested that changes in society aimed at improving the status of  women 
(relative to men) may have contributed to increased assaults and sexual violence against. 
them
45
.  • 
7. 6.1  Domestic Violence 
Although data are scarce, it is now recognised in all  Member States that violence against 
women by a male partner is the most endemic form of violence
46  47
.  In general, available 
data differentiate between domestic  and  sexual violence,  although there is  considerable 
overlap since rape within an  intimate relationship  is  also  viewed  as  a form  of domestic 
violence.  Information  on  the  long-term  health  consequences  of domestic  violence  on 
women is very limited.  The few studies that exist tend to focus  on psychological rather 
than physical consequences. For example, it is estimated that battered women are four to 
five  times  more  likely  to  require  psychiatric  treatment  and  five  times  more  likely  to 
attempt suicide than  non-battered women 
48
.  A Danish  study of women who attempted 
suicide found that they had been subjected to a high degree of psychological and physical 
violence
49
. More recently, in a number of Member States studies have been conducted to 
provide base-line data on the number of  women exposed to domestic violence. Estimates 
differ and range from 1 in 5 women in Ireland
50
,  1 in 4 in the UK
51
,  to 1 in 3 in Portugal
52 
and Germany
53
. 
a  The  European  Commission  has  recently  proposed  a  Community  action  programme  tu  fight  the 
trafficking in women for the purposes of sexual e>.:ploitation
44
. 
115 7. 6. 2  Rape and  Sexual Assault 
Rape and  sexual  assault  may  result  in  physical  injury  and  profound  emotional  trauma. 
Furthennore, rape victims are also frequently exposed to a variety of health risks ranging 
from  death/suicide  to  unwanted  pregnancy,  STDs,  including mv,  long-tenn  chronic 
conditions, as well as psychological symptoms, such as depression, anger, guilt,  sleeping 
and eating disturbances,· fear of  sex, and inability to concentrate  5
4
. 
It  is  acknowledged  throughout  the  EC  that  rape  is  a  very  under-reported  crime.  In 
Finland, for example, the average number of  reported rape cases per year in the 1980s was 
345, although the police estimates that the actual number was between 6000 and  10,000 
per y~
5 .  Other reports of the  number  of rapes  per year  vary  from  125  in  Portuga) 
(1992),  1381  in  Sweden (1995),  1599  in  Spain (1992), to 5082 in  UK  (1994).  In  the 
. Netherlands, which reports rape on a population basis, the rate increased from 7 to 1  0 per 
100,000 women between 1980 and 1988
56
. 
7.6.3  .Sexual Harassment and Stalking 
Awareness  of sexual  harassment  - undesired  sexual  advances  - as  well  as  stalking  -
persistent annoyance of someone  - has  been  increasing  throughout  the Member  States 
during  recent  years  Although  national .statistics  are  unavailable,  a  number  of studies 
suggest that the prevalence of sexual harassment of  women is substantial. In Finland, for 
example, one study estimated that among 18-to-24-year-olds, 26% of women (compared 
with 4% of  men) experience sexual harassment
57
.  In the Netherlands reports indicate that 
1 in  3 .  girls  under  the  age  of 16  years  experienced  some  fonn  of unsolicited  sexual 
advance, ranging from sexlial harassment to rape  5
8
. 
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lable. Z.l 
P~rcent  Dissatisfied with Body Weight* 
Women 15+ Years, EU 15 (1996) 
15-24  25-34  35-64  65+  Total 
years  years  years ·  years 
Greece  46.5  35.3  45.9  33.7  42.1 
United Kingdom  45.0  43.6  56.9  47.9  50.4 
France  40.0  41.2  43.7  28.8  40.6 
Finland  39.5  52.3  60.0  45.4  52.2 
The Netherlands  35.7  28.7  38.0  42.4  35.6 
Denmark  33.4  32.7  43.8  31.4  38.0 
EU15  33.3  30.6  40.1  30.7  35.4 
Spain  32.7  31.2  37.8  31.5  34.4 
Sweden  30.5  38.2  49.3  39.3  42.6 
GermanyW  30.2  18.1  33.3  19.4  26.9 
Luxembourg  29.7  . 38.8  42.3  26.5  36.9 
Belgium  28.5  40.5  35.8  28.5  34.3 
Portugal  26.9  27.4  31.0  12.6  26.5 
Italy  24.3  19.1  28.3  26.8  25.8 
Austria  23.0  28.0  33:1  40.7  28.3 
Germany E  20.0  23.9  41.2  22.1  31.7 
Ireland  18.9  27.1  34.2  26.8  28.6. 
Source: Eurobarometer 44.311996 
•  Respondents were asked to rate the extent to which they agreed/disagreed with the following statement: "I am very satisfied 
with my body weight." The table shows the percentage ofrespondents who disagreed (either slightly or strongly) with this 
statement 
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Percent Dieting during the Past Year 
Women 15+ Years, EU 15 (1996) 
15-24  25+  Total 
years  years 
43.7  34.1  35.7 
40.7  34.8  35.8 
39.0  33.7  34.6 
35.8  26.4  27.7 
31.4  23.8  24.8 
23.6  24.7  24.5 
22.5  26.0  25.4 
22.1  24.6  24.1 
20.2  23.7  23.1 
19.2  26.1  24.8 
19.1  17.8  17.9 
18.6  18.5  18.5 
16.7  19.4  19.0 
15.2  18.6  18.1 
14.2  22.7  20.9 
11.7  17.4  16.7 
7.7  22.8  20.0 
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Percent Dissatisfied with Body Weight by Weight Category* 
Women 18+ Years, EU 15 (1996) 
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Cumulative Number of  AIDS Cases* 
by Transmission Group~  Eli 15 (1996) 
Females  Males 
Transmission Group  Cumulative  Cumulative  Cumulative  Cumulative 
Total**  Total** 
N  % 
Homo/bisexual male  - -
Injecting drug user (IDU)  14 049  5L4 
Homo/bisexual IDU  - -
Haemophiliac/Coagulation disorder  71  0.3 
Transfusion recipient***  1 439  5.3 
Heterosexual contact  10 199  37.3 
Other ****/Undetermined  1 597  5.8 
TOTAL  27 355  100 
• Aged 13 years and older 
•• fl'()lll the beginning ofthe epidemic to 30 Sqrtembel' 1996, unadjusted for reporting delays. 
••• Includes recipients of  blood components or tissue  _ 
•••• Includes transsexual subjects 
Total** 
N 
59 260 
51  535 
2 535 
2 806 
1635 
12 869 
6 344 
136 984 
Source : European Centre  for the Epidemiological  Monitoring of  AIDS, Quarterly Report  No. 36, 30 September 1996. 
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Total** 
% 
43.3 
37.6 
1.9 
2.0 
1.2 
9.4 
4.6 
100 Figure 7.4 
Adult/Adolescent* AIDS Cases in the Two Main Transmission Groups 
1985-1995 
Austria 
Number of  c:aseS** by year of  diagnosis 
Women- Femmes 
Cases-Caa 
90 
80 
70 
eo 
50 
40 
30 
20 
10 
92  93  94  95 
Year of diagnosis-Al'lnM de diagnostic 
Belgium 
Number of  cases•• by year of  diagnosis 
I 
Women - Femmes 
Cases-Caa 
120 
100 
80 
60  ....  _,  ....... -.  . 
·'  •'  ., 
....... ·-·""  .... ·  ............. 
40 
20 
85  86  87  88  89  90  91  92  93  94  95 
Year of diaQ'10Sis- Ann6e de diagnostic 
•••••••  IDU-UDI  - • - • Heterosex. J 
*13 years or over 
**Adjusted for reporting delays (1993-1995) 
123 Adult/Adolescent"" AIDS Cases in the Two Main Transmission Groups, 
1985-1995 
Denmark 
Number of cases** by year of diagnosis 
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Netherlands 
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United Kingdom 
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130 Country 
Austria 
Belgium 
Denmark 
Finland 
France 
Germany 
Greece 
Ireland 
Italy 
Luxembourg 
Netherlands 
Portugal 
Spain 
Sweden 
United Kingdom 
Table 7.4 
Cumulative Number of AIDS 
Cases for both Sexes*, EU 15 (1996) 
Country  Cumulative Total* 
30.9.1996 
Austria  1 609 
Belgium  2 203 
Denmark  1 957 
Finland  248 
France  43 451 
Germany  15 308 
Greece  1 422 
,Ireland  549 
Italy  35 949 
Luxembourg  114 
Netherlands  4 199 
Portugal  3 575 
Spain  41  598 
Sweden  1445 
United Kingdom 
/  13 394 
TOTALEC  167 021 
* Smce the begmnmg of the epidemic until 30 September 1996, unadJusted 
for reporting ·delays. 
Source: European Centre for the Epidemiological Monitoring  of  AIDS. 
Quarterly Report No.  36, 30 September 1996. 
Table 7.5  . 
Co~traceptive Use and Fertility Rates among 
Women, EU 15 
Women using  Total fertility rate  %  Live births to 
contraception (%)  mothers under 
1986-93  1970  1993  20 latest 
available year 
71  2.30  1.50  5.76 (1992) 
79  2.20  1.70  3.69 (1986) 
78  1.90  1.70  2.73 (1988) 
80  1.80  1.90  2.70 (1992) 
81  2.50  1.70  2.40 (1991) 
75  2.10  1.30  3.36 (1991) 
n/a  2.30  1.40  5.82 (1992) 
n/a  3.90  2.10  4.35 (1987) 
78  2.40  1.30  3.00 (1994) 
n/a  nla  1.70  2.62 (1989) 
76  2.60  1.60  1.87 (1992) 
66  2.80  1.60  10.35 (1985) 
59  2.80  1.20  5.20 (1989) 
78  1.90  2.10  3.11(1986) 
81  2.40  1.80  8.13 ( 1989) 
Source: Human Beve/opment Report 1995/HFA. 1996. 
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Fertility rate per 1000 
women 15-19 years 
1970  1990 
61.4  21.3 
31.1  12.2 
32.4  9.1 
32.2  12.1 
26.4  9.0 
n/a  n/a 
36.5  26.3 
16.9  16.0 
42.8  10.0 
28.0  11.6 
22.6  8.3 
29.4  26.3 
14.1  16.7 
34.0  12.7 
49.7  33.0 Country  Abortion 
Legislation 
Year 
Austria  1975 
Belgium  1990 
Denmark  -
Finland  1970 
France  1975 
.Germany  1992/1996 
Greece  1986 
Ireland  Illegal 
Italy  1978 
Luxembourg  1979 
Netherlands  1984 
Portugal  1984 
Spain  1985 
Sweden  1938 
United Kingdom  1968 
Table 7,6 
Abortion, EU (15) 
Abortion Rate  Ratio of abortions 
per 1000 women  to 1000 live births 
all ages 
n/a  n/a 
n/a  n/a 
14.3  (I 993)  278.00  (1992) 
7.9  (1994)  157.34  (1993) 
13.0  (1990)  254.00  (1990) 
n/a  146.60  (1992) 
n/a  108.25  (1991) 
n/a  n/a 
8.6  (1994)  287.30  (1991) 
n/a  99.00  (1992) 
6.0  (1994)  98.70  (1992) 
n/a  200.00  '(1994) 
5.38  (1994)  92.70  (1990) 
18.3  (1994)  290.00  (1993) 
12.18  (1994)*  227.48  (1988) 
Source: Human Development Report 1995/HFA, 1996. 
132 
Ratio of abortions to 1000· 
live births under  20 
n/a 
n/a 
.1856.07  (1988) 
961.22  (1991) 
1058.00  (1990) 
n/a 
86.47  (1992) 
n/a 
n/a 
n/a 
,. 
558.50  (1988) 
n!a 
n/a 
1701.40  (1993) 
663.52  (1988) Portugal 
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The Netherlands 
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Sweden 
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Source: Eurobarometer  44.311996 
Figure 7.5 
Percent Not Well Informed about HRT 
Women 35+ Years, EU 15 (1996) 
EU 
average 
. age50-64 
D 
age 35-49 
20%  40%  60%  80%  100% 
%not informed 
Source: Eurobarometer 44.311996 
raflle z, z. : 
Percent Not Well Informed abont HRT 
Women 15+ Years, EU 15 (1996) 
<35  35-49  50-64  65+  Total 
years  years  years  years 
77.3  69.2  67.9  67.0  71.5 
69.8  64.4  67.4  74.7  68.5 
72.7  62.2  67.0  71.0  68.7 
76.7  75.8  65.2  81.0  74.6 
89.7  71.2  61.6  69.0  75.2 
67.9  65.7  50.5  51.5  62.9 
70.1  60.8  50.5  62.7  62.8 
71.7  59.3  47.1  58.5  60.9 
64.5  59.2  42.1  65.9  57.5 
67.2  51.2  40.7  54.0  54.7 
64.7  59.7  39.4  58.2  57.6 
77.0  57.3  36.5  46.1  57.4 
66.0  55.3  28.6  45.5  51.4 
71.4  53.6  26.8  41.9  51.6 
55.8  33.1  26.0  32.3  39.9 
54.6  36.4  15.2  32.8  36.7 
53.7  44.6  10.8  21.6  40.3 
133 8.  CONCLUSION · 
This  report was prepared in order to provide an overview of issues related to women's 
health and women's health ~tus. Its aim is to help clarify women's health issues using the 
most  recent  Co~unity-wide data available  to promote discussion.  The  report  is  not 
intended to form the basis for a new Community action programme on women's health, 
however,  its  findings  will  be  incorporated  into  existing  programmes  where  relevant. 
Although the available data are far  froJTI  ideal,  it has  nonetheless  still  been possible to 
gather _enough  data to_ provide a picture of (some of) the many different  dimensions of 
women's health.  In particular, it is clear that women in the EC are quite healthy, ·both in 
terms of life expectancy, which currently equals 80 years,  and in t'trms of self-perceived 
health status. On average, more than 600/o  of women in the EC report being in good or 
very good health. 
'This situation is the result of  several decades of  improvements in women's health, in part 
as a result of general improv_ements in living conditions throughout the EC, in part as a 
result of improvements in the status of  women in society. Needless to say, the health of 
women varies across the M~mber States, in  part because of different  starting points, in 
· part because of different  rates of progress.  What  is  clear is  that  some  of the Member 
States  with  the  poorest  health  status  twenty  years  ago  have  achieved  the  greatest 
improvements, while other Member States with historically good levels of  health have had 
more modest results. 
In spite of  the improvements seen, there is still cause for concern about women's health. 
Almost one out of  every four women in the EC reports some degree of  disability due to a 
lm1g-term  illness.  Furthermore,  a  large  number  (and  percentage)  of women  report 
unhealthy life  styles (e.g., smoking,  drinking,  sedentary life  styles; and  unhealthy diets). 
Combined, these factors contribute to (much of) the disability, morbidity, and premature 
mortality among women in the EC. 
The main causes of  death for women are cardiovascular disease and cancer. Both of  these 
diseases also result in significant amounts of  premature mortality, which to a considerable 
extent  may  be  prevented  either  through primary  prevention,  improved  life  styles,  or 
secondary  prevention  (early  detection  of disease  through,  for  example,  screening). 
Unfortunately,  there seems to be considerable misconception  among women  about the 
extent to which they are at risk for heart disease and what are the main risk factors for the 
disease. 
Data on health promotion and disease prevention activities indicate large variations across 
the Member States in the extent to which  women receive needed services. In particular, it 
is  noteworthy that less than half of obese women over 40, who  are at elevated risk for 
diabetes type II, have been screened in the previous year  for a disease that is rapidly rising 
and that causes significant mortality and morbidity.  It is  also  notable that most women, 
regardless  of age  feel  insufficiently  informed · about  the  potential  advantages  and 
disadvantages of hormone-replacement therapy.  These  and  other findings  make  it  clear 
that there are a number of important health c,oncems  for women which have  yet to be 
addressed. 
The final part of  the report has attempted to highlight aspects of  emerging health issues of 
importance to women at different stages of  their life cycle. In particular, it is apparent that 
134 HIV and  AIDS  are  no  longer  health  concerns  specific  to (homosexual)  men.  In fact, 
women are more vulnerable to contracting the disease  than are  men,  even if they  still 
represent a minority of  AIDS victims. Efforts to prevent the spread of  this disease should 
therefore also  target women.  Eating disorders  among  young women appears  to be an 
increasing health problem with potentially serious consequences.  · 
Among elderly women, one of the chief concerns is the rising incidence of osteoporosis 
which is due in part to the ageing of society, in part to insufficient attention to prevention 
and treatment opportunities. 
In closing, it is important to emphasise that this report on women's health is not intended 
to imply that greater emphasis should be placed on women's health compared to men's 
health but rather, that for biological, social, and other reasons, their health concerns are 
· different from those of  men, and that deserves recognition. Women may live longer than 
men today, but they do so with significant illness and disability. Recognition of  women's 
unique health problems is a first step towards improving their situation. 
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Glossary 
Anorexia nervosa: 
An eating and psychological disorder which affects mostly women. It involves extreme 
dieting, weight loss, and starvation, and is accompanied by a disturbed ·body' image and 
loss of  control and can lead to mortality
1
. 
Bulimia nervosa: 
An  eating  and  psychological  disorder  which  affects  mostly  women.  It  involves 
consuming large quantities of food in a short period of time  (bing~ing), accompanied 
by a sense of  lack of  control and recurrent compensatory behaviour in order to prevent 
weight gain, e.g., by vomiting
2
. 
Diseases of the circulatory system: 
These  include  acute  myocardial  infarctions  and  other  ischaemic  myocardiopathies. 
Ischaemia is the }()calised stoppage of  the blood supply
3
. 
Incidence: 
the number of  new cases of  a disease recorded over a given period (usually a yeart. 
Infant mortality rate: 
The yearly number of  deaths of  children aged less than one year per 1000 live births
5
. 
Life expectancy: 
The  mean  number  of years  which  a  person  of a  given  age  can  expected  to  live, 
assuming the current age-specific mortality rates remain constant. Life expectancy at 
65 years for instance, indicates the mean number of  years for which a person reaching · 
the age of  65 can expect to live
6
. 
Maternal mortality: 
Deaths related to childbirth; usuaUy reported per 100,000. 
Menopause: 
The cessation of monthly menstruation which  signifies  the end  of a woman's fertile 
period. The average age at the menopause in the EC is 50-52 years. 
Prevalence: 
The number of  existing cases of  a disease in a population at a give time or period
7
.  · 
136 Reduction of life expectancy (in years) through death before age 65 years: 
The hypothetical increase in life expectancy if  mortality in  age-group 0-64 years were 
completely eliminated
8
• 
Standardised death rate (SDR): 
The  number  of deaths  per  1  00,000  adjusted  to  the  age  structure  of a  standard 
European population.  Standardised death rates allow comparability between countries 
over time  as  they  measure  death  rates  independently of different  age  structures of 
populations. The death rates applied in this report are calculated by the WH0
9
. 
Total fertility rate: 
The average  number  of children  that  would  be  born  alive  to a woman  during  her 
lifetime,  if she were to bear children  at  each age in  accordance with prevailing age-
specific rates 
10
. 
References 
1  American Psychiatric Association  (1987),  Diagnostic and Statistical Manual  of  Mental  Disorders 
(DSM 111-R),  Washington, D.C.: American Psychiatric Association. 
2  Ibid 
3  Eurostat  (1995b),  Yearbook  1995,  Luxembourg:  Office  for  Official  Publications  of the  European 
Communities. 
4  CEC  (1995a),  Report from  the  Commission  on  the  Status of Health  in  the  European  Community, 
1995,COM(95) 357 final, Brussels: CEC. 
5  Ibid 
6  CEC  (1995b),  The  demographic  situation  in  the  European  Union,  1994,  Luxembourg:  Office  for 
Official ?ublications of  the European Communities. 
7  CEC (1995a),  Report from  the  Commission  on  the  Status of Health  in  the  European  Community, 
1995,COM(95) 357 final; Brussels: CEC. 
8  WHO (1996), Health for All Database, Copenhagen: WHO Regional Office for Europe. 
9  CEC (1995a),  Report from  the  Commission  on  the  Status of  Health  in  the  European  Community. 
1995,COM(95) 357 final, Brussels: CEC.  Eur~tat (1995b),  Yearbook 1995, Luxembourg:  Office for 
Official Publications of the European Communities. 
lO  CEC  (1995a),  Report  from the Commission on the  Status of Health in the European Community, 
1995,COM(95) 357 final, Brussels: CEC. 
137 Figure 1.1: 
Figure 1.2: 
Figure 2.1: 
Figure 2.2: 
Figure 2.3: 
Figure 2.4: 
Figure 2.5: 
Figure 2.6: 
Figure 3.1: 
Figure 3.2: 
Figure 3.3: 
Figure 3.4: 
Figure 3.5: 
Figure 3.6: 
. Figure 3.7: 
Figure 3.8: 
Figure 3.9: 
Figure 3.10: 
Figure 4.1: 
Figure 4.2: 
Figure 4.3: 
Figure 4.4: 
Figure4.5: 
Figure4.6: 
Figure 4.7: 
Figure4.8: 
Figure 4.9: 
Figure 4. 10: 
Figure 4. 11: 
Figure 4.12: 
Figure 5.1: 
Figure 5.2: 
Figure 5.3: 
Figure 5.4: 
Annex II 
List of Figures 
Sufficient Attention for Women's Health 1996, Women 15+ Years, EU 15 
.  Sufficient Attention Given To Women's Health, 1996, Women 15+ Years 
Feminisation Ratio, 1996 (EU 15) 
F  eminisation Ratio in the 0-19 Years and 60+ Years Age-Group, 1996 (EU 
15) 
Families Past and Present, EU 15 
Trends in Economic Indicator of  Fertility over the Past 40 Years 
Changes in Employment (EU) 
Present Demographic Structure and Structure of  the Active Population 
Life Expectancy at Birth, 1970-1995, Women, EU (15)  · 
Reduction in Life Expectancy Due to Premature Death 
Life Expectancy at Birth (in Years), EU·I5 (1995) 
Infant Mortality Rate 
Maternal Mortality 
Self-Perceived Health Status; 1996, Women 15+ Years, EU (15) 
Self-Perceived Health Status, Elderly Women, EU 15 (1996) 
Average Height (in em), Women 18+ Years, EU 15 (1996) 
Average Height (in em), Women 18 +Years by Age-Group, EU 15 (1996) 
Average Height (in em),' Women by Age-Group, EU 15 (1996) 
Percent with Disability Due to Long-Standing'lllness, Women 15+ Years, 
EU 15 (1996)  - .. 
Percent with Disability Due to. Long-Standing lliness by  Age-Group and 
Severity, EU 15 (1996)  . 
Percent with Disability Due to Long-Standing lllness, Women 65+ Years, 
EU 15 (1996)  . 
Percent with Restricted Activity in Past 2 Weeks Due to lllness or Injury, 
Women 16+ Years, EU 11  (1994) 
Percent with Restricted Activity in Past 2 Weeks Due to lliness or Injury, 
Women 65+ Years, EU 11  (1994) 
Percent with Restricted  Activity  in  Past  2  Weeks  Due to Emotional  or 
Mental Health Problem, Women 16+ Years, EU 12 (1994) 
Percent with Restricted  Activity  in  Past  2  Weeks  Due to Emotional  or 
Mental Health Problem, Women 65+ Years, EU 12 (1994) 
Percent Women with Doctor Consultation(s) in Past 2 Weeks, Women IS+ 
Years, EU 15 (1996) 
Percent Women with Doctor Consultation(s) in  Past 2 Weeks,  By Age-
Group, EU 15 ( 1996) 
Percentage with Non-Birth  Hospitalisation(s) in  Past  Year,  Women  16+ 
Years, EU 15 (1996)  . 
Percentage with Non-Birth Hospitalisation(s) in Past Year By Age-Group, 
EU 15 (1996) 
Average  Number  of Nights  in  the  Hospital  in  Past  Year,  Women  15+ · 
Years, EU 15 (1996) 
Main Causes of  Death (1992), All Women, EU (15) 
Motor Vehicle Traffic Accident Mortality (1992), All Women, EU 15 
Suicide and Self-Inflicted Injury Mortality (1992), All Women, EU 15 
Cancer Mortality (1992), Women 0-64 years, EU 15 
138 Figure 5.5: 
Figure 5.6: 
Figure 5.7: 
Figure 5.8: 
Figure 5.9: 
Figure 5.10: 
Figure 5.11: 
Figure 5.12: 
Figure 5. 13: 
Figure 5.14: 
Figure 5.15: 
Figure 5.16: 
' 
Figure 5.17: 
Figure 5.18: 
Figure 5. 19: 
Figure 5.20: 
Figure 5.21 : 
Figure 5.22: 
Figure 5.23: 
Figure 6.1: 
Figure 6.2: 
Figure 6.3: 
Figure 6.4: 
Figure 6.5: 
Figure 6.6: 
Figure 6.7: 
Figure 6.8: 
Figure 6.9: 
Figure 6.10: 
Figure 6.11: 
Figure 6.12: 
Figure 6.13: 
Figure 7.1: 
Figure 7.2: 
Figure 7.3: 
Figure 7.4: 
Figure 7.5: 
Cancer Mortality (1992), All Women, EU 15 
Cancer Mortality in Women (1992), All Women, EU 15 
Breast Cancer Mortality (1992), Women 0-64 Years, EU 15 
Breast Cancer Mortality (1992), All Women, EU 15 
Breast Cancer Mortality (1992), All Women 1970-1992, EU 15 
Cervical Cancer Mortality ( 1992  ), Women 0-64 Years, EU 15 
Cervical Cancer Mortality ( 1992), All Women, EU 15 
Respiratory  System Cancer Mortality  (1970-1992),  Women  0-64  Years, 
EU 15 
Respiratory System Cancer Mortality (1992), Women 0-64 Years, EU 15 
Respiratory System Cancer Mortality (1992), All Women, EU 15 
Perceptions of  which Gender Lung Cancer Affects More, All Women, EU 
15 (1996). 
Mortality from  Circulatory  System  Diseases (1992),  Women  0-64  Year, 
EU 15 
Mortality from Circulatory System Diseases (1992), All Women, EU 15 
Perceptions  of which  Gender  is  More  Affected  by  Heart  Disease,  All 
Women, EU 15 (1996) 
Ischaemic Heart Disease Mortality (1992), Women 0-64 Years, EU 15 
Ischaemic Heart Disease Mortality (1992), All Women, EU 15 
Perceived Main Risk Factors for Heart Diseas~ (1996), AU Women, EU 15 
Cerebrovascular Disea51.2: Mortality (1992), Women 0-64 Years, EU 15 
Cerebrovascular Disease Mortality (1992), All Women, EU .15 
Percentage of  smokers ( 1991 ), Women 15+ Years, Selected EU Countries 
Smoking Attributable Mortality (1990), Women 35 +Years, EU 15 
Liver Disease Mortality (1992), All Women, EU 15 
Percent Over- and Underweight, Women 18+ Years, EU 15 (1996) 
Percent with Heart Check-Up in  Past Year,  Women  15+  Years,  EU  15 
(1996)  ' 
Percent Reporting a Cholesterol Test in Past Year, Women 15+ Years, EU 
15 (1996) 
Percent Reporting a Diabetes Test in Past Year, Women 40+ Years, EU 15 
(1996) 
Percent Reporting an Osteoporosis Examination in Past Year, Women 50+ 
Years, EU 15 (1996) 
Percent Preferring Women Doctors, Women 15+ Years, EU 15 ( 1996) 
Percent Reporting a Cervical Smear Test in Past Year, Women 15+ Years, 
EU 15 (1996) 
Percent Reporting  a Breast Examination by  Hand  in  Past Year,  Women 
15+ Years, EU 15 (1996) 
Percent Favouring Mammography Screening,  Women  15+ Years,  EU ~15 
(1996) 
Percent Reporting a  Mammography  in  Past Year,  Women  50-69 Years, 
EU 15 (1996)  . 
Percent Dissatisfied with Body Weight, Women 15+ Years, EU 15 (1996) 
Percent Dieting during the Past Year, Women 15+ Years, EU 15 (1996) 
Percent Dissatisfied with Body Weight by Weight Category, Women  18+ 
Years, EU 15 (1996) 
Adolescent/Adult  AIDS  Cases  in  the  Two  Main  Transmission  Groups, 
1985-1995 
Percent Not Well Informed about HRT, Women 35+ Years, EU 15 (1996) 
139 Table 1.1: 
Table 2.1: 
Table 2.2: 
Table 2.3: 
Table 2.4: 
Table 2.5: 
Table 2.6: 
Table 2.7:  . 
Table 2.8:· 
Table 2.9: 
Table 3.1: 
Table 3.2: 
Table 3.3: 
Table 3.4: 
Table 3.5: 
Table 3.6: 
Table 3. 7: 
Table 3.8: 
·Table 4.1: 
Table 4.2: 
Table 4.3: 
Table 4.4: 
Table,4.5: 
Table 4.6: 
Table 4.7: 
Table 4.8: 
Table 4.9: 
Table 4.10: 
Table 4.11: 
Table 4.12: 
Table 5.1: 
Table 5.2: 
Annex III 
List of Tables 
Sufficient Attention Given To Women's Health,  1996, Women 15+ Years, 
EU 15 
Women in the Total Population of  the European Union 1993 (EU 15) 
Female and Male Population in the EU (15) 
Marriages and Divorces in the EU (15), 1960-1995 
Births and Fertility in the EU (15), 1960-1995 
Contraception Usage and Fertility (EU 15) 
Employment EU 15, (1993) 
Part-Time_ Employment as% ofTotal Employment EU 15, (1993) 
Unemployment Rates EU 15, (1993) 
Gender Related Development Indices 
Life Expectancy at Birth (in Years) EU 15 (1995) 
Life Expectancy at 15 Years (in Years) EU 15 (1995) 
Life Expectancy at 45 Years (in Years) EU 15 (1995) 
Life Expectancy at 65 Years (in Years) EU 15 (1995) 
Self-Perceived Health Status, 1996, Women 15+ Years, EU 15 
Self-Perceived Health Status, 1996, Women 65-74 Years, EU 15 
Self-Perceived Health Status, 1996, Women 75+ Years, EU 15 
Average Height (in em), Women 18 +Years by Age-Group, EU 15 (1996) 
Percent with Disability Due toLong-Standing.Dlness, Women  15+ Years, 
EU 15 (1996)  . 
Percent with Disability Due to Long-Standing Illness By Age-Group, EU 
15 (1996)  . 
Percent with Disability Due to Long-Standing Dlness Women 65+ Years, 
EU 15 (1996) 
Percent with Restricted Activity in Past 2 Weeks Due to Illness or Injury, 
Women 16+ Years, EU 11  (1994) 
Percent with Restricted Activity in  Past 2 Weeks Due to Illness or Injury 
Women 65+ Years, EU 11  (1994) 
. Percent with  Restricted  Activity  in  Past 2  Weeks  Due to Emotional  or 
Mental Health Problem Women 16+ Years, EU 12 (1994) 
Percent  with  Restricted  Activity  in  Past  2 Weeks Due to Emotional  or 
Mental Health Problem, Women 65+ Years, EU 12 (1994)  · 
Percent Women with Doctor Consultation(s) in Past 2 Weeks, Women 15+ 
Years, EU 15 (1996)  · 
Percent Women with Doctor Consultation(s) in  Past 2 Weeks,  By Age-
Group, EU 15 (1996) 
Percentage with Non-Birth Hospitalisation(s)  in  Past  Year,  Women  16+ 
Years, EU 15 (1996) 
Percentage with Non-Birth Hospitalisation(s) in Past Year By Age-Group, 
EU 15 (1996) 
Average  Number  of Nights  in  the  Hospital in  Past  Year,  Women  15+ 
Years,_ EU 15 ( 1996) 
Perceptions  of which  Gender  Lung  Cancer  Affects  More,  Women  15+ 
Years, EU 15 (1996) 
Perceptions  of which  Gender  is  More  Affected  by  H~alth Disease,  All 
Women, EU 15 (1996) 
140 Table 5.3: 
Table 6.1: 
Table 6.2: 
Table 6.3: 
Table 6.4: 
Table 6.5: 
Table 6.6: 
Table 6.7: 
Table 6.8: 
Table 6.9: 
Table 6.10: 
Table 6.11: 
Table 6.12: 
Table 7.1: 
Table 7.2: 
Table 7.3: 
Table 7.4: 
Table 7.5: 
Table 7.6: 
Table 7.7: 
Perceived Main Risk Factors for Heart Disease (1996), All Women, EU 15 
Percentage of  Smokers (1991), Women 15+ Years, Selected EU Countries 
Smoking Attributable Mortality (1990), Women 3S+ Years, EU 15 
Percent Over- and Underweight, Women 18+ Years, EU 15 (1996) 
Percent with Heart Check-Up in  Past Year,  Women  IS+ Years,  EU  1S 
(1996) 
Percent Reporting a Cholesterol Test in Past Year, Women I5+ Years, EU 
I5(1996) 
Percent Reporting a Diabetes Test in Past Year, Women IS+ Years, EU 15 
(1996) 
Percent Reporting an Osteoporosis Test in Past Year, Women 50+ Years, 
EU IS (1996) 
Percent Preferring Women Doctors, Women 15+ Years, EU I5 ( I996) 
Percent Reporting a Cervical Smear Test in Past Year, Women I5+ Years, 
EU 1S (1996) 
Percent Reporting a  Breast Examination by  Hand in  Past Year,  Women 
15+ Years, EU IS (I996) 
Percent Favouring Mammography Screening Women  IS+ Years,  EU  15 
(1996) 
Percent Reporting a Mammography in the Past Year, Women  I5+ Years, 
EU 15 (I996) 
Percent Dissatisfied with Body Weight, Women 15+ Years, EU 15 (I996) 
Percent Dieting during the Past Year, Women 15+ Years, EU 15 ( 1996) 
Cumulative Number of  AIDS Cases by Transmission Group, EU 15 (I996) 
Cumulative Number of  AIDS Cases for both Sexes, EU 15 ( 1996) 
Contraceptive Use and Fertility Rates among Women, EU IS 
Abortion, EU (15) 
Percent Not Well Informed about HRT, Women 15+ Years, EU 1S (1996) 
141 Annex IV 
Bibliog1raphy 
Abel-Smith,  B.,  Figueras,  J.,  Holland,  W.,  McKee,  M.,  Mossialos, 'E.  (1995),  Choices  in 
Health Policy. London: Dartmouth. 
Alary, M.  et al.  (1993), ''HIV infection in European female  sex workers: epidemiological link 
with the use of  petroleum based lubricants," AIDS, 7:401-408.  ·  . 
American  Psychiatric  ASsociation  (1987),  Diagnostic  and Statistical  Manual  of Mental 
Disorders (DSM  l/1-R), Washington, D.C.: American Psychiatric Association. 
Arcel, L.T., Mantonakis J., Petersson, B., et al.  (1992), "Suicide attempts among Greek and 
Danish women and the quality of their relationships  with husbands  or boyfiiertds," Acta 
Psychiatry Scandinavica, 85(3),  189~95. 
Azevedo, M.  H.  P.; Ferreira,  C.  P.  (1992), ·"Anorexia Nervosa and  Bulimia:  A  Prevalence 
Study," Acta Psychiatry Scandinavica, 86: 432-436. 
Bailey, J., Kraft van Ermel,  L.  (1995),  ''Hormone replacement therapy,  current practice and 
future trends,'' European Menopause Journal, 2(  1  ), 4-7. 
Baptista,  F.  et.  al.  (1996),  ''The  Prevalence  of Disturbances  of Eating  Behaviour  in  a 
Portuguese  Female  University  Population,"  European  Eating  Disorders  Review,  4(0), 
144.1-11. 
Bentham G.,  et al  (1995), "Factors affecting non-response to cervical  cyt<;>logy  screening  in 
Norfolk, England," Soc Sci Med, 40:  131-35. 
Bille-Brahe U., Jessen G.  (1994), "Suicide in Denmark,  1922-1991: The Choice of Method" 
Acta Psychiatrica Scandinavica, 90 (2) 91-96. 
Birbaumer, A  ( 1996), Austrian Report on Women's Health, Vienna: Unpublished. 
Blair,  S.N.  et  al.  (1989),  ''Physical  fitness  and  all-cause  mortality," Journal of American 
Medical Association, 262(17):2395-2401. 
Blumen-Kantz, M. (1996), "Obesity: The World's Oldest Metabolic Disorder," Mednews. 
Boulton, A  (1996), ''Hormone therapy may protect against Alzheimer's disease," BMJ, Vol. 
313, p. 442. 
British  Diabetic  Association  (1996),  Counting the. Cost:  The  Real Impact of Non-Insulin 
Dependent Diabetes, London: British Diabetic Association  .. 
British Heart Foundation (1996), personal communication. 
Bruggeman, K. (1996), Belgian Report on Women's Health, Brussels: Unpublished. 
Burdorf,  A.,  Swuste, P.  Maas, P.v.d.  (1988), "Asbest en gezondheid:  van patientbespreking 
naar erkenning van beroepsziekten in Nederland," Ned Tijdschr Geneeskunde, 132:2162-7. 
Canadian  Task  Force  on  the  Periodic· Health  Examination  (1986),  ''The Periodic  Health 
Examination: 2, 1985 update," Can Med  Assoc J,  134:724-729. 
Cancer screening for patients (1995), Mednews, 208/05499, December 1996. 
CancerNet (1996a), Screening for cervical cancer, 208/04728,. National Cancer Institute. 
CancerNet (1996b), Prevention of  cervical cancer, 208/04734, National Cancer Institute. 
Commission of the European  Communities  (CEC}  (1990},  Europe  against Cancer:  1990-
1994, Second Action Plan, Luxembourg.·  · 
CEC (1992}, Directive 92185/EEC, 10 October, 1992, Brussels: CEC. 
CEC  (1995a),  Report from  the  Commission  on  the  Status of Health  in  the  European 
Community, 1995, COM(95) 357 final, Brussels: CEC. 
CEC (1995b), The  demographic situation in the European Union,  1994,  Luxembourg: Office 
for Official Publications of  the European Communities. 
CEC (1995c), "The fight  against cancer:  an  action plan for  1996-2000," Social Europe  Two 
years of  community social policy: July 1993-June 1995. Luxembourg: Office of  the Official 
Publications of  the European Communities, pp~ 101-103. 
142 CEC (1996a), The demographic situation in theEuropean Union,  1995,  Luxembourg: Office 
for Official Publications of  the European Communities. 
CEC  (1996b),  Communication from  the  Commission  to  the  Council  and the  European 
Parliament on Tra.ficking in women for the purpose of  sexual exploitation, COM(96) 567 
final, Brussels: CEC. 
Chou,  S.P., Dawson, D.A (1994),  "A study of the gender differences  in  morbidity among 
individuals diagnosed with alcohol abuse and/or dependence," J Subst Abuse, 6:381-392. 
Coeytaux,  F.M.,  Leonard,  A.H.,  Bloomer,  C.M.  (1993),  "Abortion,"  in:  Koblinsky,  M., 
Timyan,  J.,  and Gay,  J.  (eds.),  The  health of women:  a  global perspective,  Coldrado: 
Westview Press. 
DaSilva, L.F. (1996), Portuguese Report on Women's Health, Port: Unpublished. 
Davey-Smith, G.; Blane, D., Bartley, M. (1994), "Explanations for socio-economic differentials 
in mortality. Evidence from Britain and elsewhere," European Journal of  Public Health, 4: 
131-144. 
Ditch, J., Bradshaw, J.', Eardley, T. (1994), Developments in national family policies in 1994. 
Y  crk: University of  York. 
Donaldson, R.J.  and Donaldson, L.J.  (1993), ESsential Public Health Medicine,  Dordrecht: 
Kluwer Academic Publishers. 
Dooghe,  G.  and  Appleton,  N.  (1995),  Elderly Women  in  Europe.  Choices  &  Challenges, 
Leuven: Centrum voor Bevolkings- en Gezinsstudies. 
Eslwj, 0., et al.  (1994), ''Increased prevalence of insulin-treated  diabetes mellitus  in  Funen 
County, Denmark," Journal oj1nternal Medicine, 235 (5) 405-10. 
European Bureau for  Action on Smoking Prevention  (  1994),  Tobacco  and health  in  the 
European Union,  an oven1iew. Brussels: BASP. 
European Centre for the Epidemiological Monitoring of  AIDS, IDV/AIDS Surveillance in tJ'le 
European Community and Cost countries Europe: Quarterly Report No. 36, 30 September 
1996, 
European Journal of  Cancer Prevention (1994), Vol3, Supplement I. 
European Observatory for SMEs, Fourth Annual Report 1996, p. 330. 
European  Working  Group  ( 1996),  Environmental  tobacco  smoke  and lung  cancer  risk. 
Trondheim: European Working Group. 
Eurostat (1993),.  Population  and social conditions.  Women  in  the  European  Community, 
Rapid  Reports,  No.  10,  Luxembourg:  Office  of Official  Publications  of the  European 
Communities.  .  · 
Eurostat  (1995a),  Women  and  Men  in  the  European  Union:  A  Statistical  Portrait, 
. Luxembourg: Office for Official Publications of  the European Communities. 
Eurostat  (1995b),  Yearbook  1995.  Luxembourg:  Office  for·  Official  Publications  of the 
European Communities. 
Eurostat ( 1996), Social Portrait of  Europe,  Luxembourg:  Office for Official Publications of 
the European Communities.·  · 
Fiebach, N.H., Viscoli, M. and Horwitz, R.I. (1990), ''Differences between Women and Men in 
Survival after Myocardial Infarction:  Biology or Methodology?" JAMA,  Vol.  263, No.  8, 
1092-1096. 
Fisher, N.J., Nielsen, P.K. (1993), ''Death after previous self-inflicted poisonings.  A ten-year 
study from an intensive care unit" (in Danish), Ugeskrift for Lt£ger, 155:  1857-61 
Folkhalsoinstitutet & Centralforbundet for alkohol- och narkotikaupplysning (1995),  Alkohol 
och narkotikautvecklingen i Sverige. Rapport 95. Stockholm, Sweden. 
Folkhalsoinstitutet  och  Socialstyrelsen  (1995),  Ett  liv  av  vikt.  Regeringens  uppdrag  av 
anorexia-bulemia, Stockholm, Sweden.  · 
Foster, R.S.,  Constanza, M.C.  (1984), "Breast self-examination practices and  breast  cancer 
survival,'~ Cancer, 53:999-1005. 
143 Foster, W.R., Burton, B.T. (eds) (1985), "National Institutes ofHealth Consensus Conference: 
Health Implications of  Obesity," Ann Intern Med, 103: 977-1077. 
Frigo, A. C. (1996), /ta/iari Report on Women's Health, Padova: Unpublished. 
Gatrell A, Maddocks A, Kirwan M., Garnett S.  (1995), ''Making GIS  sing and dance to a 
Purchaser's tune, "Proceedings AGI  1995  . . 
Glenn,  S.W.,  Parsons,  O.A:,  Stevens,  L.  (1989),  "Effects  of alcohol  abuse  and familial 
alcoholism on physical health in men and women," Health Psycho/, 8:325-341. 
Haas,  S.,  Schlfl:  I.  (1988),  "Symptoms  of oestrogen  deficiency,"  in:  Studd,  J.W.W.  and 
Whitehead, M. I. ( eds.), The Menqpause. Oxford: Blackwell Scientific Publications, pp.  15-
23. 
Haavio-Mannila  E.,  Kontula  K.  (eds.)  (1993),  Suoma/ainen  seksi.  Tietoa  suomqlaisten 
sukupuolieliimiin muutoksesta. WSOY.  ~ 
Hall, E.M., Johnson, J.V., Tsou, T.  (1993), ''Women, Occupation, and Risk of  Cardiovascular 
Morbidity and Mortality," Occupational Medicine, Vol. 8, No  .. 4, 709-719. 
Rein,  Suadicani,  Gyntelberg (1992), "Lung Cancer Risk and  Social Class," Danish Medical 
Bulletin, 39:173-6. 
Heise, L. (1993), ''Violence ~ainst women: the missing agenda," in:  Koblinsky, M., Timyan, 
J.,  and Gay,  J.  ( eds.),  The  health of  women:  a global Perspective.  Colorado:  Westview 
Press. 
Hoek, H.W.  ( 1995), "Impact ofUrbanization on Detection of Eating Disorders," Psychiatry 
152:8, 1272-1278.  ' 
Irish Department of Health (1995), Developing a Policy for women's Health: A Discussion 
Document. Dublin: Stationary Office. 
Kallinikos,  G.,  Roumeliotou,  A  (1996),  Greek  Report  on  Women's  Health,  Athens: 
Unpublished. 
Khan, S.  et al.  (1990), ''Increased Mortality of Women in Coronary Artery Bypass Surgery:  ' 
Evidence for Referral Bias," Ann Int Med, 112: 561-567. 
King, H., Zimmet, P.  (1988), ''Trends in the prevalence and incidence. of  diabetes: non-insulin-
dependent diabetes  mellitus,"  World Health  Statistics Quarterly.  Rappcrt Trimestriel  de 
Statistiques Sanitaires Mondiales, 41  (3-4) 190-6.  · 
Kliewer, E.V., Smith, K.R (l995), ''Breast cancer mortality among immigrants in Australia and 
Canada," Journal of  the National Cancer Institute, 87(15): 1154-1161. 
Kroger,  H.  (ed.)  (1995),  "Osteoporoosin  diagnoisointi  ja  hotio  Kuopion  yliopistollisen 
sairaalan  alueella," Pohjois-Savon sairaanhoitopiirin julkaisuja,  Publication  Series of the 
Pohjois-Savo Hospital District, No 22/1995, Kuopio.  · 
Laara,  E., Day N.E.,  Hakama M. (1987), ''Trends in  mortality from  cervical  cancer in the 
Nordic  countries:  association  with  organized  screening  programmes,"  The  Lancet, 
8544:1247-9. 
Law, M.R., Hackshaw, AK. (1996), ''Environmental Tobacco Smoke," Br Med Bull; 52:  22-
34. 
Lee, P.N. (1992), Environmental tobacco smoke and mortality. Bask:  I~.arger. 
Le, M.G.,  Hill,  C.,  Kramar,  A.,  Flamant,  R.  (1984),  "Alcoholic beverage  consumption and 
breast cancer in a French case-control study," Am J Epidemiol, 120:350-357. 
Le Geyte, M.,  Mant, D.,  Vessey, M.P., et  al.  (1992), ''Breast self-examination and  survival 
from breast cancer," BrJCancer, 66:917-918. 
Lerner, DJ., Kannel, W.B. (1986), ''Patterns of  coronary heart aisease morbidity and mortality 
in the sexes: A 26-year follow-up of  the Framingham population," American Heart Journal, 
Vol.l11, No.2, 383-390.  ·  · 
. Llewellyn-Jones, D., and Abraham, S. (1988), Menopause. Oxford: PengUin Books. 
Marmot, M., Brunner, E.  (1991), "Alcohol and  cardiovascular  disease:  the  status of the U 
shaped curve," BMJ; 303:565-568. 
144 Martinez,  F.J.,  Varela  E.,  Suarez  S.  (1994),  "The  menopause  and  hormone  replacement 
therapy: its prevalence in the town of  Lugo," Atenci6n Primaria,  14(9)~ 1052-7. 
McKeganey,  N.,  et  al.  (  1992),  "Female  streetworking  prostitution  and  IDV  infection  in 
Glasgow," BMJ, 305: 801-804. 
McWilliams,  M.,  Gray,  A.M.  ( 1996),  Nothern  Irish  Report  on  Women's  Health,  Belfast: 
Unpublished. 
Ministere de Ia Sante de Grand-Duche de Luxembourg (1994), Sante pour Taus,  Luxembourg. 
Ministry ofHealth, Denmark (  1994a), Lifetime in Denmark, Copenhagen: Ministry ofHealth. 
Ministry of Health, Denmark (  1994b  ),  Trends in Sucide Mortality in Denmark, (in Danish), 
Copenhagen: Ministry ofHealth. 
Ministry of  Health, Denmark ( 1994c  ), Cancer Trends and Cancer Mortality in Denmark, (in 
Danish), Copenhagen: Ministry ofHealth. 
Ministry of  Health, Denmark (  1994d), Heart Disease in Denmark, (in Danish), Copenhagen: 
Ministry of  Health.  · 
Moloney, E.  (1996), "Domestic violence 'suffered by  1 in  5 women'," Irish Independent,  30 
April, 1996. 
Mooney K.  (1993),  The  Hidden  Figure:  Domestic  Violence  in  North  London.  Islington: 
Islington Council. 
Nordentoft, M., et al.  ( 1993) "High mortality by natural and unnatural causes: A 10 year follow 
up sl.udy of  patients admitted to a poisoning treatment centre after suicide attempts, " BMJ, 
306:  1637-41. 
North, C.S.  (1996), "Alcoholism in women- more common-- and serious-- than you might 
think," PostgradMed,  100:221-224. 
Nystrom,  L.,  Rutqvist,  L.E.,  Wall,  S.  et  al.  (1993),  "Breast  cancer  screening  with 
mammography: an overview of Swedish randomised trails," Lancet, 341:973-978. 
O'Malley,  M.S.,  Fletcher,  S.W.  (1987),  "Screening  for  breast  cancer  with  breast  self 
examination," JAMA~  257:2197-2203. 
Paganini-Hill,  A.  (1995),  ·~he risks  artd  benents of estrogen  replacement  therapy:  leisure 
world," Int J Fertil Menopausal Stud, 40(suppl 1):54-62. 
Petersson, B.  (1996), Danish Report on Women's Health, Copenhagen: Unpublished. 
Peto, R.  et al.  (1994), Mortality from smoking in developed countries.  1950-2000.  Indirert 
estimates from vital statistics, Oxford: Oxford Medical Publications. 
Pi-Sunyer, F.X. (1993), "Medical Hazards ofObesity," AnnintemMed, 119:665-660. 
Piot,  P.,  et  al.  (1990),  HIV infection in female prostitutes,  Antwerp:  Institute  of Tropical 
Medicine. 
Platts  et  al.  ( 1992),  "WHO/EURO  Multi-Centre  Study  on  Parasuicide,"  Acta  Psychiatry 
Scandinavica, 85:97-104. 
Pukkala  (1993),  Women  and men  in  Finland,  Living Conditions  1995:1,  Finnish  Cancer 
Registry: Cancer Statistics ofNAWH. 
Riper, H., Cowley, H. (1996), Irish Report on Women's Health, Limerick: Unpublished. 
Roberts,  H.  (1992), "Introduction:  women's health  matters,"  in:  Women's Health Matters. 
Roberts, H. (ed.), London: Routledge, pp.  1-10. 
Roha'l, T.E., McMichael, A.J.  (1988), "Alcohol consumption and risk ofbreast cancer," Int J 
Cancer,  41: 695-699. 
Romkens, R. (  1992), Gewoon Geweld? Amsterdam!Lisse: Swets & Zeitlinger. 
Salonen, J.T., Nyyssonen, K., Korpela, H., Tuomilehto, J.,  Seppanen R.,  Salonen, R.  ( 1992), 
"High stored iron levels are associated with excess risk of myocardial infarction in  eastern 
Finnish men," Circulation,  86:803-811. 
Sanchis, C.  (1996) Spanish Report on Women's Health,  Valencia: Unpublished. 
Saurel-Cubizolles,  M.J.,  Blondel,  B.  (1996),  La  Sante  des  Femmes,  Paris:  Flammarion 
Medecine-Sciences. 
145 Schaapveld, K., Hirasing, R:A. (199:3), Preventiegids, Assen/Maastricht: Van Gorcum. 
Scientific American (1996),  Special Issue:  What you need to  know  about cancer,  Vol.  ?.75, 
No.3.  ·  " 
Screening for cervical cancer (1996), Mednews (208/04728), March 1996. 
Segal,  S.,  LaGuardia,  K.D.  et  al.,  (1990),  '"Termination  of pregnancy:  a  global  view," 
Baillieres Clin Obstet Gynecol, 4:235-247. 
Silva, L. (1995), "Entre Marido e Mulher Alguem Meta a Colher''. In: A  Boliua:  Colec9ao das 
Mulheres e dos Homens.  . 
Sinkk:onen, S.  (1996), Finnish Report on Women's Health, Kuopio: Unpublished. 
Smith, G.D.  and AN. Phillips (1996), ''Passive smoking and Health:  Should we beli~ve Philip 
Morris's 'experts'?" BMJ; 313: 929-33. 
Stray-Pedersen,  B.  (1996),  "Osteoporosis  - The  Silent  Thief'  iQ:  European  Institute. of 
Women's Health,  Women  in Europe:  Towards  Healthy  Ageing,  Conference  Report,  16 
October 1996, Dublin: European Institute of  Women's Health. 
Sundh, M., Rende, B.  (1996) Swedish Report on Women's Health, Karlstad: Unpublished. 
Sytkowski, P.A, Kannel,  W.B.,  D'  Agostino,  R.B.  (1990), "Changes in  risk factors  and  the 
decline in mortality from cardiovascular disease," N Eng! J Med, 322: 163 5-41. 
The National  Women's Health Resource  Center (1992), National  Women's  Health  Report, 
New York: The National Women's Health Resource Center.  \. 
. ~Thomas, C.  (1996), British Report on Women's Health, Lancaster: Unpublished. 
Thomasson,  H.R.  (1995), "Gender differences  in  alcohol  metabolism.  Physical  responses  to 
ethanol," Recent Dev Alcohol,  12:163-179. 
Thornton,  L.  (1992),  Smoking  in  pregnancy:  behaviour,  belief and attitudes  of women 
attending a Dublin maternity hospital.  Dublin: Ph.D. thesis submitted for Membership of 
the  Faculty  of Public  Health  Medicine  of the  Royal  Coltege  of Physicians  of Ireland 
(unpublished). 
Topo  Paivi,  Klaukka  Timo,  Hemminki  Elina  ja  Uutela  Am.ti  (1991),  "Use  of hormone 
replacement  therapy  in  1976-89  by  45-64  year-old  Finnish  women,"  Journal  of 
Epidemiology and Community Health, 45: 277-280. 
Tunstall-Pedoe, H.  et al.  (1994),  "Myocardial Infarction and Coronary Deaths in the WHO 
MONICA Project," Circulatio  ... , 90:583-612. 
· United Nations (1991),  The  World's  Women  1970-1990,  Trends  and Statistics.  New Yflrk: 
United Nations. 
United Nations (1994), A/RES/48/104. 
United Nations Development Pro,gramrne  (1995), Human  Development Report  1995.  New 
York: Oxford University Press. 
Vermeulen, M. (1996), Dutch Report on Women's Health, Amsterdam: Unpublished. 
Vervaet, M.  et al.  (undated), Attitudes of  schoolboys and  girls towards body-weight and  eating 
habits and  Eating-style as a risk factor for eating disorders: a pilot sh1dy in young  females. 
(Belgium, unpublished) 
Vioque J,  Fenollar J.  (1995), ''The distribution of mortality by  cervical cancer in  Spain from· 
1981 to 1986. An ecological study," Medicina Clinica,  104 (8): 287-92. 
West, R.  (1994), Eating disorders: anorexia nervosa and bulimia nervosa. London: Office of 
1Health Economics. 
Wielandt, C.  (1996), German Report on Women's Health, Bonn: Unpublished. 
World  Health  Organization  (WHO)  (1994),  Health  in  Europe,  European  Series,  No.  56, 
Regional Publications, Copenhagen: WHO Regional Office for Europe. 
WHO (1995a), Highlights on Women's Health {n Europe. Copenhagen: WHO Regional Office 
~~~  . 
WHO (1995b), Investing in women's health:. Central and Eastern Europe. Copenhagen: WHO 
Regional Publications, 55. 
146 WHO  (1995c), Highlights on Health  in  Belgium,  Copenhagen:  WHO  Regional  Office  for 
Europe (draft)  · 
WHO (1995d), Highlights on Health in Denmark,  Copenhagen:  WHO Regional  Office  for 
Europe (draft). 
WHO  (1995e),  Highlights  on  Health  in  France,  Copenhagen:  WHO  Regional  Office  for 
Europe (draft). 
WHO (1995f),  Highlights  on Health  in  Germany,  Copenhagen:  WHO  Regional  Office  for 
Europe (draft). 
WHO  (1995g),  Highlights  on  Health  in  Greece,  Copenhagen:  WHO  Regional  Office  for 
Europe (draft).  .  . 
WHO  ( 1995h),  Highlights  on  Health  in  Ireland,  Copenhagen:  WHO  Regional  Office  for 
Europe (draft). 
WHO (1995i), Highlights on Health in Italy, Copenhagen: WHO Regional Office for Europe 
(draft). 
WHO .(1995j), Highlights on Health in Luxembourg, Copenhagen:  WHO Regional Office for 
Europe (draft). 
WHO (1995k), Highlights on  Health  in Portugal,  Copenhagen:  WHO  Regional  Office  for 
Europe (draft). 
WHO  (1995m),  Highlights  on  Health  in  Spain,  Copenhagen:  WHO  Regional  Office  for 
Europe (draft). 
WHO (1995n), Highlights on Health in The Netherlands, Copenhagen: WHO Regional Office 
for Europe (draft). 
WHO (1995o  ), Highlights on Health in the  United Kingdom,  Copenhagen:  WHO Regional 
Office for Europe (draft). 
Willett, W.C., et al.  (1987), "Moderate alcohol consumption and the risk of breast cancer," N 
Eng J Med, 316:1174-1180. 
DATA SOURCES 
CEC (1995), The  demographic situation in the European Union,  1994,  Luxembourg:  Office 
for Official Publications of  the European Communities. 
CEC (1996a), The demographic situation in the European Union,  1995,  Luxembourg:  Office 
for Official Publications of  the European Communities. 
European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS Surveillance in the 
European Community and  COST countries:Quarterly Report no.  36,  30  September 1996. 
Eurostat  (1995a),  Women  and Men  in  the  European  Union:  A  Statistical  Portrait. 
Luxembourg: Office for Official Publications of  the European Communities. 
Eurostat  (1995b),  Yearbook  1995,  Luxembourg:  Office  for  Official  Publications  of the 
European Communities. 
Eurostat (1996),  Social Protrait of Europe,  Luxembourg:  Office for  Official  Publications of 
the European Communities. 
Eurostat database, 1997. 
OECD (1994), Employment Outlook. Paris: OECD, July, 1994. 
OECD (1995), The Labour Force Statistics: 1973-1993. Paris: OECD. 
Peto, R.  et al.  (1994), Mortality from smoking in developed countries.  1950-2000.  Indirect 
estimates from vital statistics, Oxford: Oxford Medical Publications. 
WHO (1995p), 1994 World Health Annual Statistics. Geneva: WHO. 
WHO ( 1996), Health for All Database, Copenhagen: WHO Regional Office for Europe. 
147 ANNEXV 
Member State Coordinators 
The  Member  State  Coordinators  prepared  unpublished  national  reports  on 
women's health which were used as input in the. preparation of  this report. 
Austria 
Ms. Andrea Birbaumer 
Technische Universitat Wien 
Inst.f. Gestaltungs- und Wirkungsforschung 
Abteilung fur CSCW 
Vienna 
Belgium 
Mrs. Katrien Bruggeman 
Prof. Mieke van Haegendoren 
Nederlandstalige Nationale Vrouwenraad 
'De Amazone 
Brussel 
Denmark 
Dr. Birgit Petersson 
Department of  Social Medicine 
Medical Female Research Unit 
University of  Copenhagen 
Panum Institute 
Copenhagen 
Finland 
Prof. Sirkka Sinkkonen 
Prof Katri V  ehvilainen-Julkunen 
Department for Health Policy and Management 
University ofKuopio 
Kuopio 
France 
(Collaboration  based  on:  Saurel-Cubizolles,  M.J.,  Blonde},  B.  (1996),  La Sante des 
Femmes.  Paris:  Flammarion  Medecine-Sciences,  see  bibliographical  reference,  this . 
publication is not initiated by the European Women's Health Project). 
Dr. Beatrice Blonde} 
INSERM 
Unite de Recherches ~pidemiologiques sur la Sante des Femmes et des Enfant-U 149 
Villejuif Cedex 
France 
148 Germany 
Dr. Caren Weilandt 
Ms. Adrienne Zeir 
Wisstmschaftliches Institut der Arzte Deutchslands (WIAD) 
Bonn 
Greece 
Dr. George Kallinikos 
Prof  Anastasia Roumeliotou 
National School ofPublic Health 
Athens 
Ireland 
Drs. H. Riper 
Mrs. H.  Cowley 
University ofLimerick 
Limerick 
Italy 
Prof. Francesco Grigoletto 
Dr.  Anna Chiara Frigo 
Universita' degli Studi di Padova. 
Instituto di lgiene 
Pad  ova 
Luxembourg 
Drs. H.  Riper 
University of  Limerick 
Limerick 
The Netherlands 
Ms. Mary Vermeulen 
Foundation Augustus 
Amsterdam 
Northern Irel~nd 
Dr.Monica McWilliams 
Dr.  Ann Marie Gray 
University ofUlster 
Belfast 
149 Portugal 
Prof. Luisa Ferreira DaSilva 
Comissao Para a Igualdade e Para os Direitos das Mulheres 
(Commission for Equality and Women's Rights) 
Ministry of  Employment and Social Security 
Porto 
Spain 
Mrs. Carmen Sanchis 
Institute of  Public Health of Valencia 
Generalitat Valenciana (Conselleria de Sanitat i Consum) 
Institut Valencia d'Estudis en Salut Publica (IVESP) 
Valencia 
Sweden 
· Ms. Mona Sundh 
Ms. Barbro Renck 
Centrum for Folkhalsoforskning 
Centre for Public Health Research 
Karlstad. 
United Kingdom 
Dr. Carol Thomas 
University ofLancaster 
Dept. of  Applied Social Science 
Lancaster 
150 
.  I 
'.'  I  • 
. \ ISSN 0254.:1475 
COM(97) 224 final 
DOCUMENTS 
EN  os 
Catalogue number  CB-C0-97-214-EN-C 
Office for Official Publications_ofthe European Communities 
L-2985 Luxembourg 
ISBN 92-78-19698-3 